WO2023164137A1 - Multiple-tube pinch valve assembly - Google Patents

Multiple-tube pinch valve assembly Download PDF

Info

Publication number
WO2023164137A1
WO2023164137A1 PCT/US2023/013826 US2023013826W WO2023164137A1 WO 2023164137 A1 WO2023164137 A1 WO 2023164137A1 US 2023013826 W US2023013826 W US 2023013826W WO 2023164137 A1 WO2023164137 A1 WO 2023164137A1
Authority
WO
WIPO (PCT)
Prior art keywords
pinch
tubing
valve assembly
protrusions
tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2023/013826
Other languages
French (fr)
Inventor
Andrew Gloor
Brian William Ward
Alexander Brown
Briden Ray Stanton
Brett BAEVERSTAD
Chuankun WANG
Stuart MCKNIGHT
Daniel Clement
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo BCT Inc
Original Assignee
Terumo BCT Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo BCT Inc filed Critical Terumo BCT Inc
Priority to JP2024550569A priority Critical patent/JP7836899B2/en
Priority to CN202380023967.9A priority patent/CN118765358A/en
Priority to EP23760694.2A priority patent/EP4487033A4/en
Publication of WO2023164137A1 publication Critical patent/WO2023164137A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01LCYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L1/00Valve-gear or valve arrangements, e.g. lift-valve gear
    • F01L1/02Valve drive
    • F01L1/04Valve drive by means of cams, camshafts, cam discs, eccentrics or the like
    • F01L1/047Camshafts
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K11/00Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves
    • F16K11/10Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit
    • F16K11/14Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by one actuating member, e.g. a handle
    • F16K11/16Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by one actuating member, e.g. a handle which only slides, or only turns, or only swings in one plane
    • F16K11/163Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by one actuating member, e.g. a handle which only slides, or only turns, or only swings in one plane only turns
    • F16K11/165Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by one actuating member, e.g. a handle which only slides, or only turns, or only swings in one plane only turns with the rotating spindles parallel to the closure members
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K11/00Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves
    • F16K11/10Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit
    • F16K11/14Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by one actuating member, e.g. a handle
    • F16K11/16Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by one actuating member, e.g. a handle which only slides, or only turns, or only swings in one plane
    • F16K11/163Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by one actuating member, e.g. a handle which only slides, or only turns, or only swings in one plane only turns
    • F16K11/166Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by one actuating member, e.g. a handle which only slides, or only turns, or only swings in one plane only turns with the rotating spindles at right angles to the closure members
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K11/00Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves
    • F16K11/10Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit
    • F16K11/20Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by separate actuating members
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K11/00Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves
    • F16K11/10Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit
    • F16K11/20Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by separate actuating members
    • F16K11/24Multiple-way valves, e.g. mixing valves; Pipe fittings incorporating such valves with two or more closure members not moving as a unit operated by separate actuating members with an electromagnetically-operated valve, e.g. for washing machines
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K27/00Construction of housing; Use of materials therefor
    • F16K27/003Housing formed from a plurality of the same valve elements
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K27/00Construction of housing; Use of materials therefor
    • F16K27/02Construction of housing; Use of materials therefor of lift valves
    • F16K27/0236Diaphragm cut-off apparatus
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K31/00Actuating devices; Operating means; Releasing devices
    • F16K31/02Actuating devices; Operating means; Releasing devices electric; magnetic
    • F16K31/04Actuating devices; Operating means; Releasing devices electric; magnetic using a motor
    • F16K31/047Actuating devices; Operating means; Releasing devices electric; magnetic using a motor characterised by mechanical means between the motor and the valve, e.g. lost motion means reducing backlash, clutches, brakes or return means
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K31/00Actuating devices; Operating means; Releasing devices
    • F16K31/44Mechanical actuating means
    • F16K31/52Mechanical actuating means with crank, eccentric, or cam
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K31/00Actuating devices; Operating means; Releasing devices
    • F16K31/44Mechanical actuating means
    • F16K31/52Mechanical actuating means with crank, eccentric, or cam
    • F16K31/524Mechanical actuating means with crank, eccentric, or cam with a cam
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K31/00Actuating devices; Operating means; Releasing devices
    • F16K31/44Mechanical actuating means
    • F16K31/52Mechanical actuating means with crank, eccentric, or cam
    • F16K31/524Mechanical actuating means with crank, eccentric, or cam with a cam
    • F16K31/52491Mechanical actuating means with crank, eccentric, or cam with a cam comprising a diaphragm cut-off apparatus
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K7/00Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves
    • F16K7/02Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm
    • F16K7/04Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm constrictable by external radial force
    • F16K7/045Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm constrictable by external radial force by electric or magnetic means
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K7/00Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves
    • F16K7/02Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm
    • F16K7/04Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm constrictable by external radial force
    • F16K7/06Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm constrictable by external radial force by means of a screw-spindle, cam, or other mechanical means
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K7/00Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves
    • F16K7/02Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm
    • F16K7/04Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm constrictable by external radial force
    • F16K7/06Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm constrictable by external radial force by means of a screw-spindle, cam, or other mechanical means
    • F16K7/063Lever clamps
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K7/00Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves
    • F16K7/02Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm
    • F16K7/04Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm constrictable by external radial force
    • F16K7/06Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with tubular diaphragm constrictable by external radial force by means of a screw-spindle, cam, or other mechanical means
    • F16K7/065Cam clamps
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16KVALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K7/00Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves
    • F16K7/12Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with flat, dished, or bowl-shaped diaphragm
    • F16K7/14Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with flat, dished, or bowl-shaped diaphragm arranged to be deformed against a flat seat
    • F16K7/16Diaphragm valves or cut-off apparatus, e.g. with a member deformed, but not moved bodily, to close the passage ; Pinch valves with flat, dished, or bowl-shaped diaphragm arranged to be deformed against a flat seat the diaphragm being mechanically actuated, e.g. by screw-spindle or cam
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01LCYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L1/00Valve-gear or valve arrangements, e.g. lift-valve gear
    • F01L1/02Valve drive
    • F01L1/04Valve drive by means of cams, camshafts, cam discs, eccentrics or the like
    • F01L1/047Camshafts
    • F01L2001/0471Assembled camshafts

Definitions

  • the present disclosure is generally directed to pinch valves, in particular, toward pinch valves for selectively controlling flow through multiple tubes.
  • valves have been used to selectively control the flow of a fluid (e.g., a gas, a liquid, etc., and/or combinations thereof) through tubing or some other conduit. These valves may be operated to completely or partially block fluid flow. While internal valves are arranged at least partially within a lumen of the tubing, external valves allow fluid flow control from outside of the tubing. In particular, an external valve allows a force to be applied to an external surface of the tubing, or soft conduit, deforming the lumen of the tubing from an unrestricted state to an occluded, or partially occluded, state.
  • a fluid e.g., a gas, a liquid, etc., and/or combinations thereof
  • External valves e.g., pinch valves, etc.
  • Typical pinch valves control fluid flow in tubing by compressing an outer portion of the tubing thereby closing a lumen disposed in an inner portion of the tubing.
  • pinch valves offer a sterile fluid flow control for tubing where the components of the pinch valve do not come into direct contact with fluid inside the tubing.
  • a tubing arrangement or system design may require that more than one tube, or section of tubing, be closed at the same time or at different times.
  • a pinch valve may be positioned at each discrete area where fluid flow control may be desired.
  • Each pinch valve may be independently operated by a respective actuator.
  • the cost and complexity of this conventional approach necessarily increases.
  • the number of components required to perform the fluid control operations under the conventional approach increases the potential for failure and the time required for routine maintenance operations.
  • the present disclosure provides a multiple-tubing, or multi-tubing, pinch valve assembly that is capable of pinching more than one tube, or section of tubing, with a single actuator.
  • the multi-tubing pinch valve assembly may be configured to pinch various tubes, or tubing sections, simultaneously. Additionally or alternatively, the multi-tubing pinch valve assembly may pinch a first set of tubes at a first time and pinch a second set of tubes at a different second time. In one example, the multi-tubing pinch valve assembly may allow flow through the first set of tubes while pinching the second set of tubes (e.g., preventing flow, etc.), and vice versa.
  • the multi-tubing pinch valve assembly may comprise a compact valve array that is capable of executing a sequence of opening and closing flow paths to each bioreactor in a multiple-bioreactor system.
  • the multi-tubing pinch valve assembly may comprise a valve mechanism that may be built into a bioreactor rocker assembly. This design, among other things, greatly simplifies a disposable set (e.g., tubing set, etc.) used in cell expansion systems, sterile fluid management systems, any suitable system that uses a multi-tubing valving scheme for sterile fluid pathway management, etc.
  • the multi-tubing pinch valve assembly may integrate with a soft cassette of a disposable set.
  • the multi-tubing pinch valve assembly may correspond to a cam- driven valve array that provides a compact method of opening/closing many parallel tubes in a set sequence. This approach may allow a multiple-bioreactor cell expansion system to execute a “time share” or “duty cycle” method of servicing multiple bioreactors, with the valve array being located on the bioreactor rocker rather than on a static cassette.
  • the multi-tubing pinch valve assembly is not limited to use in a multiple-bioreactor system.
  • the mechanism of the multi-tubing pinch valve assembly may be adapted to any situation where multiple valves may be required to have their positions fixed relative to others.
  • the multi-tubing pinch valve assembly may utilize a finger pump type mechanism having the orientation of the tube and fingers rotated 90 degrees relative to the cam. Rather than pumping a single tube, the multi-tubing pinch valve assembly is capable of valving many tubes simultaneously.
  • This multi-tubing pinch valve assembly design can be paired with a soft cassette, as the fingers actuate in a direction normal to the soft cassette plane.
  • the multi-tubing pinch valve assembly allows the occlusion depth to be tightly controlled, which allows for the possibility of intentionally partially occluding tubes (e.g., partial restriction of fluid flow, etc.).
  • Another benefit of the examples described herein include the compact size and simplified electronics of the multi-tubing pinch valve assembly.
  • valve unit to be mounted to a bioreactor rocker, in some cases, thereby simplifying a disposable set used in cell expansion systems, for example, by reducing the number of tubes that must run from the bioreactors to the static cassette.
  • multi-tubing pinch valve assembly may ensure that valve positions are locked relative to each other, allowing assurance of correct flow. For example, it can be assured that one of the tubes in the time share model is always open, preventing pressure buildup, or two tubes may always be open or closed relative to each other, assuring a complete fluid path.
  • the multi-tubing pinch valve assembly may be driven by a motor operatively connected to a camshaft comprising two cam profiles.
  • a first anvil assembly may be disposed adjacent a first cam profile of the two cam profiles and a second anvil assembly may be disposed adjacent a second cam profile of the two cam profiles.
  • the motor rotates the camshaft
  • the two cam profiles rotate relative to the first anvil assembly and the second anvil assembly.
  • at specific angles of rotation at least one cam lobe, or protrusion, disposed on the cam profile may contact the first anvil assembly and the second anvil assembly.
  • a first cam lobe associated with the first cam profile may contact the first anvil assembly at a first angle of rotation of the camshaft.
  • the shape of the first cam lobe may cause the first anvil assembly to move in a direction away from the camshaft toward a pinch plate.
  • a first section of tubing may be disposed in a first space between the first anvil and the pinch plate. In this arrangement, as the first anvil assembly moves toward the pinch plate, a first anvil of the first anvil assembly may contact and deform the first section of tubing such that a lumen of the first section of tubing closes.
  • the first section of tubing may remain closed while the first cam lobe is at, or within a predetermined angular range (e.g., 1-5 degrees) of, a highest displacement point of the first cam lobe and the first anvil maintains the first section of tubing in a closed state.
  • a predetermined angular range e.g. 1-5 degrees
  • the multi-tubing pinch valve assembly may be configured as an array of independently actuated multiple-tubing pinch valves.
  • the multi-tubing pinch valve assembly may include a five-valve array of independently actuated four-tube pinch valves.
  • At least one benefit to this independent actuation arrangement includes, but is in no way limited to, operating the multi-tubing pinch valve assembly in any combination of open or closed states.
  • a multi-tubing pinch valve assembly comprising an array that is split into discrete multi-tube valves (e.g., an array of five 4- tube pinch valves), each multi-tube valve in the array capable of being driven by a small linear actuator (e.g., a solenoid, piezoelectric actuator, screw-type actuator, pneumatic cylinder, hydraulic cylinder, and/or a stepper motor linear actuator, etc.).
  • a small linear actuator e.g., a solenoid, piezoelectric actuator, screw-type actuator, pneumatic cylinder, hydraulic cylinder, and/or a stepper motor linear actuator, etc.
  • valves may be opened during loading of a disposable (e.g., tubing set, etc.), valves may cycle continuously on a 10-second duty cycle during a cell feed, and valves may be opened sequentially for longer durations during tasks such as cell harvest, and/or the like.
  • a disposable e.g., tubing set, etc.
  • valves may cycle continuously on a 10-second duty cycle during a cell feed
  • valves may be opened sequentially for longer durations during tasks such as cell harvest, and/or the like.
  • each multi-tube valve e.g., 4-tube valve, etc.
  • the pinching jaws of each multi-tube valve assembly may be slightly offset from one another.
  • this arrangement may reduce the pinch force from the actuator that may be required to occlude the tubing and increase the jaw gap range that results in occlusion.
  • Such an increased jaw gap may provide enhanced cycling life and tubing integrity over time compared to designs including a decreased jaw gap.
  • a single set of opposing jaws may pinch four tubes at once.
  • the independent operability of each of the multi-tube valves may allow for disposable design optimization and simplification when compared with designs that require different valving.
  • FIG. 1A shows a first perspective view of a multi-tubing pinch valve assembly in accordance with embodiments of the present disclosure
  • Fig. IB shows a front elevation view of the multi-tubing pinch valve assembly shown in Fig. 1A;
  • FIG. 1C shows a second perspective view of the multi-tubing pinch valve shown in Fig. 1A;
  • Fig. ID shows a partially exploded perspective view of the multi-tubing pinch valve assembly shown in Fig. 1A;
  • FIG. 2A shows a schematic section view of the multi-tubing pinch valve assembly taken through line 2-2 shown in Fig. ID;
  • FIG. 2B shows a perspective view of an anvil assembly in accordance with examples of the present disclosure
  • FIG. 3A is a schematic section view of the anvil assembly and cam of a multi-tubing pinch valve assembly at a first rotational position in accordance with examples of the present disclosure
  • FIG. 3B is a schematic section view of the anvil assembly and cam of a multi-tubing pinch valve assembly at a second rotational position in accordance with examples of the present disclosure
  • FIG. 3C is a schematic section view of the anvil assembly and cam of a multi-tubing pinch valve assembly at a third rotational position in accordance with examples of the present disclosure
  • FIG. 4A shows a first perspective view of a multi-tubing pinch valve assembly in accordance with embodiments of the present disclosure
  • Fig. 4B shows a plan view of the multi-tubing pinch valve assembly shown in Fig. 4A;
  • FIG. 5A shows a schematic plan view of the multi-tubing pinch valve assembly shown in Fig. 4A in a closed, tubing-occluded, state in accordance with examples of the present disclosure
  • FIG. 5B shows a schematic plan view of the multi-tubing pinch valve assembly shown in Fig. 4A in a partially closed, tubing-partially-occluded, state in accordance with examples of the present disclosure
  • FIG. 5C shows a schematic plan view of the multi-tubing pinch valve assembly shown in Fig. 4A in an open, tubing-open, state in accordance with examples of the present disclosure
  • Fig. 6A shows a first perspective view of a multi-tubing pinch valve assembly in an array configuration in accordance with examples of the present disclosure
  • Fig. 6B shows a second perspective view of a multi-tubing pinch valve assembly in an array configuration in accordance with examples of the present disclosure
  • Fig. 7 shows a perspective view of a multi-tubing pinch valve assembly in an array configuration for a multiple-bioreactor system
  • FIG. 8 is a schematic block diagram of a hydraulic layout for a cell expansion system having a single bioreactor in accordance with examples of the present disclosure
  • FIG. 9 is a schematic block diagram of a hydraulic layout for a cell expansion system having multiple bioreactors and a multi-tubing pinch valve assembly in accordance with examples of the present disclosure
  • FIG. 10 is a perspective view of another exemplary multitube pinch valve assembly in accordance with the present disclosure.
  • FIG. 11 is a perspective view of the multitube pinch valve assembly of Fig. 10 with a cover removed;
  • Fig. 12 is a perspective view of an exemplary actuation member of the multitube pinch valve assembly of Fig. 10;
  • Fig. 13 is a perspective view of a bioreactor support frame configured for the multitube pinch valve assembly of Fig. 10;
  • FIG. 14 is a perspective view of an additional exemplary multitube pinch valve assembly in accordance with the present disclosure.
  • FIG. 15 is a perspective view of the multitube pinch valve assembly of Fig. 14 with a bioreactor support frame removed;
  • Fig. 16 is a perspective view of the multitube pinch valve assembly of Fig. 14 with a cover removed;
  • Fig. 17 is a cross-sectional view of the multitube pinch valve assembly of Fig. 14; and [0044] Fig. 18 is a perspective view of a bioreactor support frame configured for the multitube pinch valve assembly of Fig. 14.
  • the multiple-tube pinch valve assembly 100 may comprise a base 104 (e.g., baseplate, frame, support structure, etc.), a camshaft 108, at least one cam 112 attached to the camshaft 108, at least one anvil assembly 150, and a tubing platen 120.
  • the tubing platen 120 may comprise a plurality of tube receiving apertures 128 disposed along a length of the tubing platen 120.
  • Each tube receiving aperture 128 of the plurality of tube receiving apertures 128 may be configured to receive a tube, or section of tubing, therein.
  • the plurality of tube receiving apertures 128 may extend in a direction that is perpendicular to the longitudinal axis 110 of the camshaft 108.
  • the coordinate system 102 includes three- dimensions comprising an X-axis, a Y-axis, and a Z-axis. Additionally or alternatively, the coordinate system 102 may be used to define planes (e.g., the XY-plane, the XZ-plane, and the YZ-plane) of the multiple-tube pinch valve assembly 100. These planes may be disposed orthogonal, or at 90 degrees, to one another.
  • the origin of the coordinate system 102 may be placed at any point on or near the components of the multiple-tube pinch valve assembly 100, for the purposes of description, the axes of the coordinate system 102 are always disposed along the same directions from figure to figure. In some examples, reference may be made to dimensions, angles, directions, relative positions, and/or movements associated with one or more components of the multiple-tube pinch valve assembly 100 with respect to the coordinate system 102.
  • the width of the multiple-tube pinch valve assembly 100 may be defined as a dimension along the X-axis of the coordinate system 102
  • the height of the multiple-tube pinch valve assembly 100 may be defined as dimension along the Y-axis of the coordinate system 102
  • the depth of the multiple-tube pinch valve assembly 100 may be defined as a dimension along the Z-axis of the coordinate system 102.
  • the width of the tubing platen 120 may be defined as a dimension along the X-axis of the coordinate system 102
  • the height of the tubing platen 120 may be defined as dimension along the Y-axis of the coordinate system 102
  • the depth of the tubing platen 120 may be defined as a dimension along the Z- axis of the coordinate system 102.
  • the multiple-tube pinch valve assembly 100 may include a motor 132 having an output shaft 134, a drive body 136, and a cam drive body 140. As the output shaft 134 of the motor 132 rotates, power is transmitted from the drive body 136 to the cam drive body 140.
  • the drive body 136 and the cam drive body 140 may be configured as respective gears in meshing contact with one another.
  • the drive body 136 and the cam drive body 140 may correspond to pulleys (e.g., timing belt pulleys, V-pulleys, etc.). In this example, power may be transmitted from the drive body 136 to the cam drive body 140 via a drive belt 138.
  • the drive belt 138 may correspond to a timing belt, a V-belt, a ribbed V-belt, a link V-belt, etc., and/or any other continuous belt.
  • the camshaft 108 As the output shaft 134 of the motor 132 rotates, the camshaft 108 is caused to rotate about the longitudinal axis 110. Rotation of the camshaft 108 causes the cam 112 having at least one cam profile shape to rotate about the longitudinal axis 110.
  • the cam 112 may be keyed (e.g., via a key and keyway, a spline, etc.), fixed, formed from, and/or otherwise affixed to the camshaft 108.
  • the cam 112 may rotate through 360 degrees.
  • anvil assembly 150 different portions of the cam profile shape of the cam 112 may be presented to an anvil assembly 150. For instance, as a protrusion of the cam 112 contacts the anvil assembly 150, the anvil assembly 150 may lift (e.g., move in the positive Y-axis direction) toward the tubing platen 120 and as a recess, or heel, of the cam 112 contacts the anvil assembly 150, the anvil assembly 150 may lower (e.g., move in the negative Y-axis direction) away from the tubing platen 120. In this manner, the rotation of the camshaft 108 may cause the anvil assembly 150 to pinch the multiple tubes 124 in the tube receiving apertures 128 of the multiple-tube pinch valve assembly 100.
  • the multiple-tube pinch valve assembly 100 may include a bioreactor support frame 144.
  • the bioreactor support frame 144 may comprise a plurality of recesses 142 configured to receive and/or hold a respective bioreactor (e.g., hollow fiber bioreactor, cell expansion system bioreactor, etc.).
  • a respective bioreactor e.g., hollow fiber bioreactor, cell expansion system bioreactor, etc.
  • the multiple tubes 124 that are disposed in the tube receiving apertures 128 may be interconnected to the multiple bioreactors that are held, or supported, by the bioreactor support frame 144. Fluid flow control to multiple bioreactors may benefit from altering the timing associated with opening and closing the multiple tubes 124 associated with each bioreactor at a same time or at different times.
  • the multiple-tube pinch valve assembly 100 may be configured to have a valve array 148A-148E, or an array of valves, comprising a first multi-tube valve 148A, a second multi-tube valve 148B, a third multi-tube valve 148C, a fourth multi-tube valve 148D, and/or a fifth multi-tube valve 148E.
  • Each multi-tube valve of the valve array 148A-148E may be associated with a set of tubes dedicated to a particular bioreactor.
  • the first multi-tube valve 148A may control the fluid flow of multiple tubes 124 that are received in the tube receiving apertures 128 associated with the first multi-tube valve 148A.
  • the second multi-tube valve 148B may control the fluid flow of multiple tubes 124 that are received in the tube receiving apertures 128 associated with the second multitube valve 148B, and so on.
  • Each multi-tube valve of the valve array 148A-148E may include a respective anvil assembly 150 and a respective cam 112.
  • the cam 112 may be arranged on the camshaft 108 such that one multi-tube valve of the valve array 148A-148E can be operated at an individual, or independent, timing relative to the other multi-tube valves in the valve array 148A-148E.
  • a cam 112 of one multi-tube valve of the valve array 148A-148E may be rotationally oriented out of phase from at least one other multi-tube valve of the valve array 148A-148E.
  • the valves in the valve array 148A-148E may open and close at the same or different times.
  • the valve array 148A-148E may be disposed along a length of the longitudinal axis 110 (e.g., in the X-axis direction) of the camshaft 108.
  • the multi-tubing pinch valve assembly 100 may include any number of valves.
  • the number of valves may be configured to match a number of bioreactors or sets of multiple tubes 124 that require fluid flow control.
  • the valve array of the multi-tubing pinch valve assembly 100 may comprise one, two, three, four, five, or more valves.
  • Fig. ID shows a partially exploded perspective view of the multi-tubing pinch valve assembly 100, exposing the anvil grating plate 116.
  • the anvil grating plate 116 may comprise a number of apertures passing therethrough. The apertures may be arranged along the X-axis of the anvil grating plate 116. Each aperture may be sized to receive a portion of the anvil assembly 150. As the camshaft 108 rotates, the cam 112 may contact the anvil assembly 150 moving a portion of the anvil assembly 150 into and/or out of the apertures.
  • the anvil grating plate 116 may comprise a top surface that is arranged a distance from a tubing platen contact surface of the tubing platen 120.
  • This distance may provide a space in which the multiple tubes 124 are disposed.
  • the multiple tubes 124 may be closed (e.g., pinched) and as the portion of the anvil assembly 150 leaves this space, the multiple tubes 124 may be opened. Additional detail regarding this cam-actuated pinching and fluid flow control of multiple tubes is described in conjunction with Figs. 2A-3C.
  • FIG. 2A shows a schematic section view of the multi-tubing pinch valve assembly taken through line 2-2 shown in Fig. ID.
  • the camshaft 108 is shown having the cam 112 oriented rotationally in a position where the anvil assembly 150 is pinching the multiple tubes 124 disposed in the tube receiving apertures 128 (e.g., in the space between the anvil grating plate 116 and the tubing platen 120).
  • the anvil assembly 150 is in contact with a cam lobe of the cam 112 and the multiple tubes 124 are shown in a pinched state. Fluid flow through the multiple tubes 124 is restricted in the pinched state where the anvil assembly 150 contacts the multiple tubes 124.
  • the anvil assembly 150 shown in greater detail in Fig. 2B, includes an anvil 200 comprising an anvil body 204 and a pinch edge 208 extending from a first end 212 A to a second end 212B of the anvil assembly 150.
  • the anvil 200 may comprise a protrusion extending from at least one stop ledge 216 of the anvil body 204 in the Y-axis direction.
  • the protrusion may be sized to engage with an aperture, or receptacle, in the anvil grating plate 116 (e.g., in a slip fit, clearance fit, and/or the like).
  • the protrusion may terminate at the pinch edge 208.
  • the pinch edge 208 may be flat, radiused, or sharp.
  • the pinch edge 208 may comprise a tapered portion that slopes away from the pinch edge 208 toward the stop ledge 216.
  • the tapered portion may allow a section of the multiple tubes 124 being pinched to flex and move around the pinch edge 208. This shape, among other things, may reduce stresses placed on the multiple tubes 124 during pinching.
  • the anvil assembly 150 may comprise at least one cam contact portion disposed on a lower portion of the anvil body 204.
  • the at least one cam contact portion may extend past the anvil body 204.
  • the at least one cam contact portion may provide a contact surface between the anvil body 204 and the cam 112 of the multiple-tube pinch valve assembly 100.
  • the at least one cam contact portion may correspond to a cam follower 210, or other bearing.
  • the cam follower 210 in some cases, may be made to include a hardened steel wheel and a bearing (e.g., roller bearing, ball bearing, etc.).
  • the lower portion of the anvil body 204 may include a tapered surface 220 disposed on either side of a plane running through a center of the anvil body 204 (e.g., along the XY-plane).
  • the tapered surface 220 may provide clearance for portions of the cam 112 and the cam profile shape as the cam 112 moves relative to the anvil body 204 and anvil assembly 150.
  • Figs. 3A-3C shown schematic section views of the anvil assembly 150 as the cam 112 rotates about the longitudinal axis 110.
  • a rotation position fiducial 302 is shown on the cam 112 to illustrate the position from a first angular reference (e.g., illustrated as a zero degree line).
  • the cam 112 may comprise a cam profile shape (e.g., disposed around a periphery of the cam 112) including a cam heel 308 (e.g., a low point), a cam lobe 316 (e.g., a high point), and a cam transition 312 disposed between the cam heel 308 and the cam lobe 316.
  • the cam heel 308 may correspond to a first point along the cam profile shape where a distance from the periphery of the cam 112 to the center of the cam 112 (e.g., the longitudinal axis 110 of the camshaft 108) is closest than other points along the cam profile shape.
  • the cam lobe 316 may correspond to a second point along the cam profile shape where a distance from the periphery of the cam 112 to the center of the cam 112 (e.g., the longitudinal axis 110 of the camshaft 108) is further than other points along the cam profile shape.
  • the distance from the periphery of the cam 112 to the center of the cam 112 at the cam transition 312 may be a distance that is between the distance measured at the first point and the second point.
  • the multiple tubes 124 are disposed in a space between the anvil grating plate 116 and the tubing platen 120. In some examples, this space may correspond to the tube receiving apertures 128 described above.
  • Fig. 3A corresponds to the anvil assembly 150 at a first cam 112 rotational position
  • Fig. 3B corresponds to the anvil assembly 150 at a second cam 112 rotational position
  • Fig. 3C corresponds to the anvil assembly 150 at a third cam 112 rotational position.
  • the multiple tubes 124 are shown in an open fluid flow state. In this position, fluid may be allowed to flow through each of the multiple tubes 124.
  • the multiple tubes 124 are shown in a partially occluded, restricted fluid flow, state. In this position, fluid may be allowed to flow through each of the multiple tubes 124 but in a restricted, partially closed, state. For example, the flow rate of fluid flowing through the multiple tubes 124 may be reduced in the second rotational position when compared to the first rotational position.
  • the multiple tubes 124 are shown in a closed state. In this position, fluid is restricted from flowing through each of the multiple tubes 124.
  • This third rotational position may correspond to a completely occluded tubing state, which may also be referred to herein as a pinched or pinched closed state of the multiple tubes 124.
  • the anvil assembly 150 is in a lowermost position, where the protrusion of the anvil 200 is disposed in the anvil aperture 304 of the anvil grating plate 116.
  • the cam follower 210 of the anvil assembly 150 is disposed in contact with the cam heel 308 of the cam 112.
  • the pinch edge 208 may be disposed adjacent the multiple tubes 124.
  • the multiple tubes 124 are not pinched by the anvil 200 in Fig. 3A, allowing fluid flow through the multiple tubes 124 from the left-hand side of the page to the righthand side of the page, or vice versa.
  • first rotation 320A e.g., shown as a first clockwise rotation
  • the cam 112 rotates from the zero-degree reference to the al angular position (e.g., comprising a non-zero angle measured from the zero-degree reference), as shown in Fig. 3B.
  • the cam follower 210 of the anvil assembly 150 is shown in contact with the cam transition 312 of the cam 112.
  • the anvil assembly 150 raises, or lifts, upward disposing the pinch edge 208 in the space between the anvil grating plate 116 and the tubing platen 120. More specifically, the pinch edge 208 contacts the multiple tubes 124 disposed in the tube receiving apertures 128 and deforms the multiple tubes 124 restricting flow therethrough. In the rotational position shown in Fig. 3B, the anvil assembly 150 deforms the multiple tubes 124 providing a partially occluded flow path 324 at least along the pinch edge 208 (e.g., extending into the page).
  • the camshaft 108 is rotated by a second rotation 320B (e.g., shown as a second continuing clockwise rotation) further rotating the cam 112 from the al angular position to the a2 angular position.
  • a second rotation 320B e.g., shown as a second continuing clockwise rotation
  • the cam follower 210 of the anvil assembly 150 is shown in contact with the cam lobe 316 of the cam 112.
  • the anvil assembly 150 further raises, or lifts, upward disposing the pinch edge 208 further in the space between the anvil grating plate 116 and the tubing platen 120. In this raised position, the pinch edge 208 deforms the multiple tubes 124 disposed in the tube receiving apertures 128 completely restricting flow therethrough. In the rotational position shown in Fig. 3C, the anvil assembly 150 deforms the multiple tubes 124 providing a pinched tubing point 328 at least along the pinch edge 208 (e.g., extending into the page).
  • the cam 112 may also be configured to provide an “all-open” state in which all of the tubes 124 are open and not constricted by the anvil assembly 150. Such an “all open” state improves loading of the bioreactor support frame 144.
  • the cam 112 may also be configured to be removable from the assembly 100 to allow all of the bioreactors to be opened simultaneously.
  • camshaft 108 may be rotated in a counterclockwise direction, a clockwise direction, and/or combinations thereof.
  • the motor 132 may be rotated in any rotational direction causing the rotation of the camshaft 108.
  • cam heel 308, cam transitions 312, and a cam lobe 316 it should be appreciated that the cam 112 may include greater or fewer protrusions, shapes, dwells, lobes, and recesses than are shown and described in Figs. 1A-3C.
  • the multi-tubing pinch valve assembly 400 may provide an array of pinch valves that utilize independently controllable hinged clamp mechanisms.
  • the multi-tubing pinch valve assembly 400 may include at least one base 404, hinge plate 416, and clamp platen 420.
  • Multiple tubes 124 may be disposed between the hinge plate 416 and the clamp platen 420.
  • the multiple tubes 124 may be disposed in tube receiving apertures 128 associated with each valve.
  • the hinge plate 416 may be pivotally connected to a hinge support block 424 at a first point via a pivot axis.
  • An actuator for example, linear actuator 410, may be attached to a second point of the hinge plate 416.
  • the linear actuator 410 may correspond to a solenoid, a screw-type actuator, and/or a stepper motor-actuated screw-type actuator.
  • the linear actuator 410 may be mounted to a mount body 408 that is fixed relative to the base 404 of the multi-tubing pinch valve assembly 400. As the linear actuator 410 is actuated, a translation rod 412 may move between a retracted state and an extended state, or vice versa. Extending the translation rod 412 may move the hinge plate 416 toward the clamp platen 420. In this extended position, the multiple tubes 124 disposed in the tube receiving aperture 128 may be pinched by one or more features of the hinge plate 416 and the clamp platen 420.
  • the clamp platen 420 may be fixed relative to the base 404.
  • the linear actuator 410 As the linear actuator 410 is actuated, the translation rod 412 may move the hinge plate 416 from an open state to a closed state, or vice versa. In the open state, at least one portion of the hinge plate 416 may be separated further from the clamp platen 420 than when in the closed state.
  • the multiple tubes 124 When in the open state, the multiple tubes 124 may be loaded and/or removed from the tube receiving aperture 128. Stated another way, the multiple tubes 124 may not be clamped, or pinched, when in the open state. However, when in the closed state, the multiple tubes 124 may be pinched between the hinge plate 416 and the clamp platen 420. Additional detail regarding the construction of the hinge plate 416 and the clamp platen 420 and the fluid flow control (e.g., pinching) arrangement is described in conjunction with Figs. 5A-5C.
  • the multi-tubing pinch valve assembly 400 may comprise an array of valves arranged adjacent to one another. As shown in the plan view of Fig. 4B, four separate valves are shown, each valve configured to pinch multiple tubes 124 associated therewith. Each valve of the multi-tubing pinch valve assembly 400 may comprise a linear actuator 410, a translation rod 412, and a hinge plate 416. Although shown with separate clamp platens 420 in Figs. 4A and 4B, it should be appreciated that different valves may share a clamp platen 420. For instance, and as shown in Figs. 6A and 6B, the dual clamp platen 620 is used by more than one valve. The array of valves of the multi-tubing pinch valve assembly 400 shown in Fig.
  • the multi-tubing pinch valve assembly 400 may include any number of valves. In some examples, the number of valves may be configured to match a number of bioreactors or sets of multiple tubes 124 that require fluid flow control. As can be appreciated, the valve array of the multi-tubing pinch valve assembly 400 may comprise one, two, three, four, five, or more valves.
  • Figs. 5A-5C show schematic plan views of the multi-tubing pinch valve assembly 400 described above moving between a closed state and an open state.
  • the linear actuator 410 is shown attached to a mount body 408 that is fixed to the base 404.
  • a hinge plate 416 is shown pivotally attached to a hinge support block 424 that is fixed to the base 404.
  • the clamp platen 420 may be fixed to the base 404 or other portion of the multi-tubing pinch valve assembly 400.
  • the hinge plate 416 may comprise a hinge pinch protrusion 516 extending from a surface of the hinge plate 416 in a direction toward the clamp platen 420.
  • the clamp platen 420 may comprise a tubing contact portion that is configured to contact the multiple tubes 124 disposed in the tube receiving aperture 128.
  • the tubing contact portion may correspond to a flat plate surface and/or a platen pinch protrusion 520 that extends from a surface of the clamp platen 420 (e.g., in a direction of the hinge plate 416).
  • the linear actuator 410 may be attached to a mount body 408.
  • the mount body 408 may be fixed relative to the base 404.
  • the linear actuator 410 may include a translation rod 412 that moves relative to the mount body 408 (e.g., in a direction toward or away from the mount body 408).
  • the translation rod 412 may comprise a clevis pin 504 that engages with a clevis of the hinge plate 416.
  • the hinge plate 416 may comprise a clevis slot 508 in which the clevis pin 504 may be disposed.
  • FIG. 5A shows a schematic plan view of the multi-tubing pinch valve assembly 400 in a closed, tubing-occluded, state in accordance with examples of the present disclosure.
  • the translation rod 412 of the linear actuator 410 is extended by a first translation vector 502A.
  • the clevis pin 504 moving in the clevis slot 508 of the hinge plate 416 pivots the hinge plate 416 about the hinge pin 512 (e.g., pivot axis) in this state moving the hinge pinch protrusion 516 into contact with the multiple tubes 124 pinching the multiple tubes 124 between the hinge pinch protrusion 516 of the hinge plate 416 and the platen pinch protrusion 520 of the clamp platen 420.
  • the translation rod 412 is extended in this state, fluid flow through the multiple tubes 124 is occluded completely at the pinched tubing point 328.
  • Fig. 5B shows a schematic plan view of the multi-tubing pinch valve assembly 400 in a partially closed or partially open, tubing-partially-occluded, state in accordance with examples of the present disclosure.
  • the translation rod 412 of the linear actuator 410 is retracted by a second translation vector 502B from the position shown in Fig. 5A.
  • the clevis pin 504 moves in the clevis slot 508 of the hinge plate 416 pivoting the hinge plate 416 about the hinge pin 512 (e.g., pivot axis) in a first hinge plate rotation 506 A.
  • the hinge pinch protrusion 516 is in contact with the multiple tubes 124 partially deforming the multiple tubes 124 and the fluid flow lumens of each of the multiple tubes 124. More specifically, the multiple tubes 124 are captured between the hinge pinch protrusion 516 of the hinge plate 416 and the platen pinch protrusion 520 of the clamp platen 420 providing a partially occluded flow path 324 through the multiple tubes 124. In the tubing- partially-occluded state, fluid flow rate through the multiple tubes 124 disposed in the tube receiving aperture 128 may be reduced when compared to a tubing-open state.
  • Fig. 5C shows a schematic plan view of the multi-tubing pinch valve assembly 400 in an open, tubing-open, state in accordance with examples of the present disclosure.
  • the translation rod 412 of the linear actuator 410 is retracted by a third translation vector 502C from the position shown in Figs. 5A and 5B.
  • the clevis pin 504 moves in the clevis slot 508 of the hinge plate 416 pivoting the hinge plate 416 about the hinge pin 512 (e.g., pivot axis) in a second hinge plate rotation 506B.
  • the hinge pinch protrusion 516 is brought out of deforming contact with the multiple tubes 124.
  • the multiple tubes 124 may return to an undeformed state and the fluid flow lumens of each of the multiple tubes 124 may open in this state.
  • the multiple tubes 124 may be removed from, or loaded into, the clamp platen 420. While described as moving between a closed and an open state, it should be appreciated that the multi-tubing pinch valve assembly 400 may move between an open and closed state by reversing the order and movements described above.
  • Figs. 6A and 6B show perspective views of a multi-tubing pinch valve assembly 400 in an array configuration in accordance with examples of the present disclosure.
  • the array of valves may comprise a plurality of linear actuators 410 and hinge plates 616 that are similar, if not identical, to the hinge plate 416 described above.
  • the multitubing pinch valve assembly 400 and array may include two immediately adjacent valves that share a dual clamp platen 620.
  • the dual clamp platen 620 may comprise a first platen pinch protrusion 520 extending from a first surface toward a first hinge plate 616 and a second platen pinch protrusion 520 extending from an opposite second surface toward a second hinge plate 616.
  • this arrangement may allow for a more compact arrangement of valves in the array of valves making up the multi-tubing pinch valve assembly 400.
  • Fig. 7 shows a perspective view of a multi-tubing pinch valve assembly 700 in an array configuration, for example, in a multiple-bioreactor system.
  • the multi-tubing pinch valve assembly 700 may correspond to the multi-tubing pinch valve assembly 400 described in Figs. 4A-6B.
  • the bioreactor support frame 744 includes a plurality of recesses 142 configured to receive and hold a respective bioreactor 704A-704E.
  • the multitubing pinch valve assembly 700 may include five separate bioreactors 704A-704E.
  • the multi-tubing pinch valve assembly 700 may include an array of valves comprising five separate valves, one valve per bioreactor 704A-704E.
  • Each valve in the array of valves of the multi-tubing pinch valve assembly 700 may be configured to pinch multiple tubes 124 for each bioreactor 704A-704E.
  • each bioreactor 704A-704E may include at least four tubes. A first pair of these four tubes may be associated with an intracapillary loop of a respective bioreactor 704A-704E and a second pair of these four tubes may be associated with the extracapillary loop of the respective bioreactor 704A-704E.
  • the multi-tubing pinch valve assembly 700 may allow independent opening and closing of the multiple tubes 124 for each bioreactor 704A-704E.
  • Fig. 8 is a schematic block diagram 800 of a hydraulic layout for a cell expansion system having a single bioreactor 704A in accordance with examples of the present disclosure.
  • the bioreactor of Fig. 8 includes an intracapillary circulation (IC) loop 810 and an extracapillary circulation (EC) loop 812. In a single bioreactor these loops may be opened and closed by one or more valves.
  • a cell inlet bag attachment point is at 820.
  • a cell inlet line extends through a cell inlet valve 822 to an IC inlet pump 824. From the pump 824, the line extends to an air removal chamber/level detection 826.
  • the line branches off to waste 828 and to IC circulation valve 830. From valve 830 the line extends into the bioreactor 704A. From the bioreactor 704A, the line branches to waste 828, IC circulation pump 832, and to harvest 836. Harvest valve 892 controls flow to harvest 836. From pump 832, the line goes to IC inlet pressure sensor 834 and to the IC circulation valve 830.
  • a reagent attachment point is at 838.
  • a regent line extends through a reagent valve 840 to the cell inlet line.
  • An IC media attachment point is at 842.
  • An IC media line extends through IC media valve 844 to the reagent line.
  • An EC media attachment point is at 850. From the EC media attachment point 850, an EC line extends through EC media valve 852. A wash connection point is at 854, and a wash valve is at 856. A distribution valve is along a line connecting the EC loop 812 and the IC loop 810.
  • the EC loop 812 includes an EC inlet pump 870, which is downstream from an EC fluid detector 872.
  • the EC loop 812 further includes a GTM chamber 880, an EC inlet pressure sensor 882, an EC circulation pump 884, and an EC outlet pressure sensor 886.
  • An EC waste valve 888 is on an EC waste line extending to waste 828.
  • An IC waste valve 890 and an IC outlet pressure sensor 894 are upstream of waste 828 on the IC side.
  • Fig. 9 is a schematic block diagram 900 of a hydraulic layout for a cell expansion system having multiple bioreactors and a multi-tubing pinch valve assembly 100, 400, 700 in accordance with examples of the present disclosure.
  • the tubing associated with the IC loop and the EC loop of each of the five bioreactors may be controlled by the valves in the valve array.
  • These valves may correspond to any of valves shown in the multipletube pinch valve assemblies 100, 400, 700 described herein.
  • the valve array shown in the schematic block diagram 900 may correspond to the valve array 148A-148E described in conjunction with Figs. 1A-3C.
  • each valve in the valve array shown in the schematic block diagram 900 may correspond to the hinge plate 416 and clamp platen 420 of the multi-tubing pinch valve assembly 400 described in conjunction with Figs. 4A-5C and/or the hinge plate 616 and dual clamp platen 620 shown in Figs. 6A and 6B.
  • Figs. 10-13 illustrate a multitube pinch valve assembly 1100 in accordance with the present disclosure.
  • the assembly 1100 generally includes a base 1110 and a bioreactor support frame 1310.
  • the base 1110 includes a plurality of hinge plates 1112A-1112E. Any suitable number of the hinge plates may be included. In the example illustrated, five hinge plates 1112A, 1112B, 1112C, 1112D, and 1112E are included.
  • Each one of the hinge plates 1112A-1112E includes a hinge pinch protrusion 1114.
  • the hinge plates 1112A-1112E are each individually actuated by any suitable actuation mechanism.
  • each one of the hinge plates 1112A-1112E is actuated by a different actuation mechanism 1120A, 1120B, 1120C, 1120D, 1120E respectively.
  • Each one of the actuation mechanisms 1120A-1120E may include any suitable linear actuator, such as any suitable solenoid, linear stepper motor, pneumatic actuator, etc., for example.
  • the base 1110 further includes a plurality of support posts 1150.
  • the support posts 1150 are configured to cooperate with the bioreactor support frame 1310 as explained below to support the bioreactor support frame 1310 on the base 1110 and over the hinge plates 1112A-1112E.
  • a strap 1152 is included to hold the bioreactor support frame 1310 on the base 1110.
  • the multitube pinch valve assembly 1100 further includes a rocker assembly 1160.
  • the rocker assembly 1160 includes a rocker rod 1162, which cooperates with the base 1110 at an aperture 1164 defined by the base 1110.
  • the rocker assembly 1160 includes a motor configured to rotate the rocker rod 1162.
  • the rocker rod 1162 is mounted to the base 1110 in any suitable manner such that rotation of the rocker rod 1162 rocks the base 1110 and the bioreactors 704 A- 704E mounted thereto. In come configurations, the rocker assembly 1160 may be configured to invert the bioreactors 704A-704E.
  • the bioreactor support frame 1310 may be configured to support five bioreactors 704A, 704B, 704C, 704D, 704E, or any other suitable number of bioreactors.
  • the number of bioreactors included with the bioreactor support frame 1310 typically equals, or is less than, the number of hinge plates 1112A-1112E.
  • the support frame 1310 includes a tubing platen 1320.
  • the tubing platen 1320 includes a plurality of tube receiving apertures 1322 configured to secure the tubes 124 of the bioreactors 704A-704E to the tubing platen 1320.
  • the tubes 124 extend generally parallel to lengths of the bioreactors 704A- 704E.
  • the tubes 124 may extend perpendicular to the bioreactors 704A- 704E, or at any other suitable angle.
  • the bioreactor support frame 1310 further includes a plurality of receptacles 1340, each of which are configured to cooperate with the support posts 1150 of the base 1110.
  • the support posts 1150 support the bioreactor support frame 1310 on top of the base 1110 and position the support frame 1310 such that the tubes 124 are arranged opposite to, and extend perpendicularly across, the hinge pinch protrusions 1114 of the hinge plates 1112A-1112E.
  • Actuation of the different hinge plates 1112A-1112E moves the hinge pinch protrusions 1114 towards tubes to pinch the tubes 124 and restrict fluid flow through the tubes 124 and to the bioreactors 704A-704E in generally the same manner illustrated in Figs. 5A, 5B, and 5C illustrating the multi-tubing pinch valve assembly 400.
  • the hinge pinch protrusions 1114 When actuated upward, the hinge pinch protrusions 1114 will contact the tubes 124 on either side of any of the receiving apertures 1322 to bend the tubes 124 into occlusion. Bending the tubes 124 into occlusion reduces the amount of pinch force required from the actuation mechanisms 1120A-1120E as compared to when the pinch protrusions 1114 directly contact an opposing platen pinch protrusion.
  • the tubing platen 1320 may include platen pinch protrusions aligned with the hinge pinch protrusions 1114.
  • Figs. 14-18 illustrate an additional multitube pinch valve assembly 1500 in accordance with the present disclosure.
  • the assembly 1500 generally includes a base 1510 and a bioreactor support frame 1710.
  • the base 1510 includes a latch 1512, which is rotatable between a closed position and an open position. In the open position, a rail 1520 of the base 1510 is accessible.
  • the rail 1520 extends across the base 1510, and is configured to cooperate with the bioreactor support frame 1710, as explained herein.
  • the rail 1520 may include a planar undersurface, or a pinch protrusion similar to the platen pinch protrusion 1330.
  • actuation plates 1540A, 1540B, 1540C, 1540D, and 1540E Opposite to the rail 1520, and seated within a housing 1530, are a plurality of actuation plates 1540A, 1540B, 1540C, 1540D, and 1540E. In the example illustrated, five actuation plates 1540A-1540E are included.
  • the base 1510 may include any suitable number of actuation plates, however.
  • Each one of the actuation plates 1540A-1540E includes a pinch protrusion 1542.
  • the actuation plates 1540A-1540E are individually actuatable by any suitable actuation mechanism.
  • each one of the actuation plates 1540A-1540E is actuated by a different actuation mechanism 1550A, 1550B, 1550C, 1550D, 1550E respectively.
  • the actuation mechanisms 1550A-1550E may include any suitable linear actuator, such as any suitable solenoid, linear stepper motor, pneumatic actuator, etc.
  • the actuation mechanisms 1550A-1550E may be individually actuated to control fluid flow through tubes 124 of the bioreactors 704 A- 704E.
  • the bioreactor support frame 1710 includes a tubing platen 1730.
  • the tubing platen 1730 defines a plurality of tube receiving apertures 1732 configured to secure the tubes 124 of the bioreactors 704A-704E to the tubing platen 1730.
  • the tube receiving apertures 1732 are configured to support the tubes 124 so that the tubes 124 extend parallel to the lengths of the bioreactors 704A-704E.
  • the tubing platen 1730 further defines a center channel 1740 configured to receive the rail 1520 therein. At a rear of the center channel 1740 is a rear aperture 1742.
  • the center channel 1740 extends perpendicular to the lengths of the bioreactors 704A-704E, and perpendicular to the tubes 124 supported by the tube receiving apertures 1732.
  • rear tabs 1750 At a rear end of the tubing platen 1730 are rear tabs 1750.
  • front tabs 1752 At a front end of the tubing platen 1730.
  • the latch 1512 is folded downward, the tubing platen 1730 is positioned so that the rail 1520 enters through the rear aperture 1742, and then the tubing platen 1730 is slid onto the rail 1520 so that the rail 1520 extends along the center channel 1740.
  • the tubing platen 1730 is slid along the rail 1520 until the rear tabs 1750 are seated within rear openings 1560 of the base 1510.
  • the latch 1512 is then closed onto the front tabs 1752 so that the front tabs 1752 are seated within recesses 1562 defined on an inner surface of the latch 1512 to lock the tubing platen 1730 into position.
  • the rear tabs 1750 and the front tabs 1752 improve alignment of the tubes 124 relative to the pinch protrusions 1542, and prevent loading the bioreactors backwards. Also, when the assembly 1500 includes a rocker, the tabs 1750, 1752 keep the bioreactors 704A-704E and tubes 124 in the correct position relative to the rod 1520.
  • the tubing platen 1730 is oriented so that the pinch protrusions 1542 are perpendicular to the tubes 124.
  • Actuation of the different actuation plates 1540A-1540E moves the pinch protrusions 1542 towards and into the center channel 1740 to pinch the tubes 124 between the pinch protrusions 1542 and the rail 1520 to restrict fluid flow through the tubes 124 in generally the same manner illustrated in Figs. 5A, 5B, and 5C illustrating the multi-tubing pinch valve assembly 400.
  • the actuation plates 1540A-1540E may be individually actuated by the actuation mechanisms 1550A-1550E to selectively pinch the tubes 124, which selectively controls flow through the different tubes 124 and through the different bioreactors 704A-704E.
  • references in the specification to “one embodiment,” “an embodiment,” “an example embodiment,” “some embodiments,” etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in conjunction with one embodiment, it is submitted that the description of such feature, structure, or characteristic may apply to any other embodiment unless so stated and/or except as will be readily apparent to one skilled in the art from the description.
  • the present disclosure in various embodiments, configurations, and aspects, includes components, methods, processes, systems and/or apparatus substantially as depicted and described herein, including various embodiments, subcombinations, and subsets thereof. Those of skill in the art will understand how to make and use the systems and methods disclosed herein after understanding the present disclosure.
  • the present disclosure in various embodiments, configurations, and aspects, includes providing devices and processes in the absence of items not depicted and/or described herein or in various embodiments, configurations, or aspects hereof, including in the absence of such items as may have been used in previous devices or processes, e.g., for improving performance, achieving ease, and/or reducing cost of implementation.
  • Exemplary aspects are directed to a multiple-tube pinch valve assembly, comprising: a camshaft extending a length along a longitudinal axis of the camshaft, the camshaft comprising at least one cam disposed along the length, the at least one cam comprising a cam profile shape defined around the longitudinal axis and a periphery of the camshaft and; a platen offset a distance from the longitudinal axis, the distance at least partially defining a space configured to receive multiple fluid flow tubes; and an anvil assembly comprising a cam contact portion disposed on a first side of the anvil assembly and a pinch edge disposed on a second side of the anvil assembly, wherein the anvil assembly is moveable between a retracted state such that the pinch edge is disposed outside of the space and an extended state such that the pinch edge is disposed inside the space adjacent the platen, and wherein the anvil assembly moves between the retracted state and the extended state by a rotation of the camshaft and the at least one cam.
  • any one or more of the above aspects include wherein the cam profile shape comprises at least one cam lobe and at least one cam heel, wherein the anvil assembly is in the extended state when the cam lobe is disposed in contact with the cam contact portion, and wherein the anvil assembly is in the retracted state when the cam heel is disposed in contact with the cam contact portion.
  • the cam contact portion comprises at least one cam follower.
  • the space comprises a plurality of tube receiving apertures arranged side-by-side along a direction that is parallel to the longitudinal axis of the camshaft.
  • any one or more of the above aspects include wherein each tube receiving aperture of the plurality of tube receiving apertures extend in a direction that is perpendicular to the longitudinal axis of the camshaft. Any one or more of the above aspects further comprising: a plurality of tubes removably engaged with the plurality of tube receiving apertures such that a section of each tube of the plurality of tubes is disposed in the space adjacent the platen, wherein, in the retracted state, a lumen of each tube of the plurality of tubes is open along the section of each tube of the plurality of tubes, and wherein, in the extended state, the lumen of each tube of the plurality of tubes is closed at a point along the section of each tube of the plurality of tubes.
  • Any one or more of the above aspects further comprising: a motor comprising an output shaft; a drive body attached to the output shaft of the motor; and a cam drive body attached to the camshaft, wherein rotation of the output shaft of the motor transmits power from the drive body to the cam drive body causing the camshaft to rotate relative to the anvil assembly.
  • a support frame comprising a plurality of recesses, wherein each recess of the plurality of recesses is configured to hold a respective bioreactor, and wherein each tube of the plurality of tubes is associated with the respective bioreactor.
  • any one or more of the above aspects include wherein the anvil assembly, when moving between the retracted state and the extended state, translates along a plane that is perpendicular to a plane running through the plurality of tubes, and wherein, in the extended state, the pinch edge of the anvil assembly contacts and closes each tube of the plurality of tubes.
  • Any one or more of the above aspects further comprising: an array of valves disposed along a length of the longitudinal axis of the camshaft, wherein each valve in the array of valves comprises a plurality of tube receiving apertures, and wherein each valve in the array of valves comprises a respective anvil assembly that is capable of moving between the retracted state and the extended state by the rotation of the camshaft and the at least one cam.
  • any one or more of the above aspects include wherein the respective anvil assembly of each valve in the array of valves is capable of moving between the retracted state and the extended state based on a position of a respective cam connected to the camshaft. Any one or more of the above aspects include wherein a first valve in the array of valves is capable of closing tubing contained within a first set of tube receiving apertures associated with the first valve at a same time or a different time as a second valve in the array of valves closes tubing contained within a second set of tube receiving apertures associated with the second valve.
  • any one or more of the above aspects include wherein, at a first time as the camshaft rotates, a first valve in the array of valves closes tubing contained within a first set of tube receiving apertures associated with the first valve, wherein, at a second time as the camshaft rotates, a second valve in the array of valves closes tubing contained within a second set of tube receiving apertures associated with the second valve.
  • any one or more of the above aspects include wherein, at a third time as the camshaft rotates, a third valve in the array of valves closes tubing contained within a third set of tube receiving apertures associated with the third valve, wherein, at a fourth time as the camshaft rotates, a fourth valve in the array of valves closes tubing contained within a fourth set of tube receiving apertures associated with the fourth valve, and wherein at a fifth time as the camshaft rotates, a fifth valve in the array of valves closes tubing contained within a fifth set of tube receiving apertures associated with the fifth valve.
  • any one or more of the above aspects include wherein the first set of tube receiving apertures, the second set of tube receiving apertures, the third set of tube receiving apertures, the fourth set of tube receiving apertures, and the fifth set of tube receiving apertures each comprise four tube receiving apertures.
  • Exemplary aspects are directed to a multiple-tube pinch valve assembly, comprising: a motor comprising an output shaft; a drive body attached to the output shaft of the motor; a camshaft extending a length along a longitudinal axis of the camshaft, the camshaft comprising at least one cam disposed along the length, the at least one cam comprising a cam profile shape defined around the longitudinal axis and a periphery of the camshaft and; a cam drive body attached to the camshaft; a platen offset a distance from the longitudinal axis, the distance at least partially defining a space configured to receive multiple fluid flow tubes; and an anvil assembly comprising at least one cam follower disposed on a first side of the anvil assembly and a pinch edge disposed on a second side of the anvil assembly, wherein rotation of the output shaft of the motor transmits power from the drive body to the cam drive body causing the camshaft to rotate relative to the anvil assembly and move the anvil assembly between a retracted state, such
  • Exemplary aspects are directed to a multi-tubing pinch valve assembly, comprising: a hinge plate extending a length from a first point to a second point, the hinge plate comprising: a pivot axis disposed adjacent the first point of the hinge plate; and a pinch protrusion disposed between the first point and the second point, the pinch protrusion extending from a surface of the hinge plate; a platen comprising a body offset a distance from the hinge plate, the platen comprising a tubing contact portion disposed on a surface of the platen; an actuator operatively connected to the hinge plate adjacent the second point, wherein the actuator is moveable between a retracted state and an extended state, wherein, in the retracted state, the hinge plate is pivoted about the pivot axis such that the second point of the hinge plate is separated from the platen by a first distance, wherein, in the extended state, the hinge plate is pivoted about the pivot axis such that the second point of the hinge plate is separated from the platen by a first distance,
  • any one or more of the above aspects include wherein, in the extended state, the pinch protrusion of the hinge plate is adjacent the tubing contact portion of the platen, and wherein in the retracted state, the pinch protrusion of the hinge plate is offset from the tubing contact portion of the platen creating a receiving space between the hinge plate and the platen. Any one or more of the above aspects include wherein, in the retracted state, the pinch protrusion of the hinge plate is offset from the tubing contact portion of the platen by a first dimension defining a receiving space capable of receiving a plurality of tubes.
  • any one or more of the above aspects include wherein, in the extended state, the pinch protrusion of the hinge plate is offset from the tubing contact portion of the platen by a second dimension defining a pinched receiving space that is sized to pinch the plurality of tubes disposed between the hinge plate and the platen.
  • Any one or more of the above aspects further comprising the plurality of tubes disposed in between the hinge plate and the platen, wherein the plurality of tubes provide fluid flow paths therethrough when in the retracted state, and wherein the fluid flow paths are restricted by the pinch protrusion of the hinge plate and the tubing contact portion of the platen when in the extended state.
  • any one or more of the above aspects include wherein the pinch protrusion of the hinge plate and the tubing contact portion of the platen completely restrict fluid flow in the plurality of tubes when in the extended state. Any one or more of the above aspects further comprising: a clevis disposed adjacent the second point of the hinge plate; and a clevis pin engaged with the clevis, the clevis pin being connected to an end of a translation rod of the actuator. Any one or more of the above aspects include wherein the tubing contact portion comprises a platen pinch protrusion extending from a surface of the platen, and wherein the surface of the platen faces the hinge plate. Any one or more of the above aspects include wherein the pivot axis is defined by a hinge pin engaged with the hinge plate and a hinge support block.
  • any one or more of the above aspects include wherein the actuator is one of a solenoid, a screw-type actuator, and a stepper motor actuated screw. Any one or more of the above aspects include wherein the clevis pin engages with a slot in the clevis.
  • Exemplary aspects are directed to a multi-tubing pinch valve assembly, comprising: an array of valves disposed adjacent one another, wherein each valve in the array of valves comprises: a hinge plate extending a length from a first point to a second point, the hinge plate comprising: a pivot axis disposed adjacent the first point of the hinge plate; and a pinch protrusion disposed between the first point and the second point, the pinch protrusion extending from a surface of the hinge plate; a tubing contact body offset a distance from the hinge plate; an actuator operatively connected to the hinge plate adjacent the second point, wherein the actuator is moveable between a retracted state and an extended state, wherein, in the retracted state, the hinge plate is pivoted about the pivot axis such that the second point of the hinge plate is separated from the tubing contact body by a first distance, wherein, in the extended state, the hinge plate is pivoted about the pivot axis such that the second point of the hinge plate is separated from the tubing contact body by a first
  • any one or more of the above aspects include wherein, in the extended state, the pinch protrusion of the hinge plate is adjacent the tubing contact body, and wherein in the retracted state, the pinch protrusion of the hinge plate is offset from the tubing contact body creating a receiving space between the hinge plate and the tubing contact body.
  • any one or more of the above aspects include wherein each valve in the array of valves is configured to receive a plurality of tubes in the receiving space.
  • any one or more of the above aspects include wherein each valve in the array of valves is configured to pinch the plurality of tubes in the receiving space in the extended state of the actuator.
  • any one or more of the above aspects include wherein each valve in the array of valves is independently operable such that each hinge plate of each valve is moveable between the retracted state and the extended state independently. Any one or more of the above aspects include wherein a first valve in the array of valves is operable together with and/or separately from a second valve in the array of valves. Any one or more of the above aspects further comprising: a support frame comprising a plurality of recesses, wherein each recess of the plurality of recesses is configured to hold a respective bioreactor, and wherein each tube of the plurality of tubes is associated with the respective bioreactor.
  • Exemplary aspects are directed to a multiple-bioreactor assembly comprising the multitubing pinch valve assembly of any of the above aspects.
  • each of the expressions “at least one of A, B and C,” “at least one of A, B, or C,” “one or more of A, B, and C,” “one or more of A, B, or C,” and “A, B, and/or C” means A alone, B alone, C alone, A and B together, A and C together, B and C together, or A, B, and C together.
  • each one of A, B, and C in the above expressions refers to an element, such as X, Y, and Z, or a class of elements, such as Xl-Xn, Y 1- Ym, and Zl-Zo
  • the phrase is intended to refer to a single element selected from X, Y, and Z, a combination of elements selected from the same class (e.g., XI and X2) as well as a combination of elements selected from two or more classes (e.g., Y 1 and Zo).
  • the term “automatic” and variations thereof, as used herein, refers to any process or operation, which is typically continuous or semi-continuous, done without material human input when the process or operation is performed. However, a process or operation can be automatic, even though performance of the process or operation uses material or immaterial human input, if the input is received before performance of the process or operation. Human input is deemed to be material if such input influences how the process or operation will be performed. Human input that consents to the performance of the process or operation is not deemed to be “material.” [0119] The terms “determine,” “calculate,” “compute,” and variations thereof, as used herein, are used interchangeably and include any type of methodology, process, mathematical operation, or technique.

Landscapes

  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Reciprocating Pumps (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Mechanically-Actuated Valves (AREA)
  • Pipe Accessories (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

A multi-tubing pinch valve assembly including a receiving space defined between a pinch protrusion and tubing contact body. The multi-tubing pinch valve assembly is moveable between a retracted state and an extended state. In the extended state, multiple tubes disposed in the receiving space are pinched, restricting flow therethrough. In the retracted state, multiple tubes are capable of being loaded into and/or out of the receiving space.

Description

MULTIPLE-TUBE PINCH VALVE ASSEMBLY
CROSS-REFERENCE TO RELATED PATENT APPLICATION
[0001] This application claims priority to United States Patent Application No. 18/113,173, filed February 23, 2023, and the benefit of United States Provisional Patent Application No. 63/314,931 filed on February 28, 2022, the entire disclosures of which are incorporated herein by reference.
BACKGROUND
[0002] The present disclosure is generally directed to pinch valves, in particular, toward pinch valves for selectively controlling flow through multiple tubes.
[0003] In general, internal and/or external valves have been used to selectively control the flow of a fluid (e.g., a gas, a liquid, etc., and/or combinations thereof) through tubing or some other conduit. These valves may be operated to completely or partially block fluid flow. While internal valves are arranged at least partially within a lumen of the tubing, external valves allow fluid flow control from outside of the tubing. In particular, an external valve allows a force to be applied to an external surface of the tubing, or soft conduit, deforming the lumen of the tubing from an unrestricted state to an occluded, or partially occluded, state.
BRIEF SUMMARY
[0004] External valves (e.g., pinch valves, etc.) provide the ability to control fluid flow in tubing without requiring the installation of expensive and complex internal valves. Typical pinch valves control fluid flow in tubing by compressing an outer portion of the tubing thereby closing a lumen disposed in an inner portion of the tubing. As can be appreciated, pinch valves offer a sterile fluid flow control for tubing where the components of the pinch valve do not come into direct contact with fluid inside the tubing.
[0005] In some examples, a tubing arrangement or system design may require that more than one tube, or section of tubing, be closed at the same time or at different times. In conventional systems, a pinch valve may be positioned at each discrete area where fluid flow control may be desired. Each pinch valve may be independently operated by a respective actuator. In this conventional approach, as the number of the discrete fluid flow control areas increases, so does the number of pinch valves required to service the system. Since each pinch valve includes its own actuator, the cost and complexity of this conventional approach necessarily increases. In addition, the number of components required to perform the fluid control operations under the conventional approach increases the potential for failure and the time required for routine maintenance operations.
[0006] It is with respect to the above issues and other problems that the embodiments presented herein were contemplated. Among other things, the present disclosure provides a multiple-tubing, or multi-tubing, pinch valve assembly that is capable of pinching more than one tube, or section of tubing, with a single actuator. In some examples, the multi-tubing pinch valve assembly may be configured to pinch various tubes, or tubing sections, simultaneously. Additionally or alternatively, the multi-tubing pinch valve assembly may pinch a first set of tubes at a first time and pinch a second set of tubes at a different second time. In one example, the multi-tubing pinch valve assembly may allow flow through the first set of tubes while pinching the second set of tubes (e.g., preventing flow, etc.), and vice versa.
[0007] In one example, the multi-tubing pinch valve assembly may comprise a compact valve array that is capable of executing a sequence of opening and closing flow paths to each bioreactor in a multiple-bioreactor system. The multi-tubing pinch valve assembly may comprise a valve mechanism that may be built into a bioreactor rocker assembly. This design, among other things, greatly simplifies a disposable set (e.g., tubing set, etc.) used in cell expansion systems, sterile fluid management systems, any suitable system that uses a multi-tubing valving scheme for sterile fluid pathway management, etc. Additionally or alternatively, the multi-tubing pinch valve assembly may integrate with a soft cassette of a disposable set.
[0008] In some examples, the multi-tubing pinch valve assembly may correspond to a cam- driven valve array that provides a compact method of opening/closing many parallel tubes in a set sequence. This approach may allow a multiple-bioreactor cell expansion system to execute a “time share” or “duty cycle” method of servicing multiple bioreactors, with the valve array being located on the bioreactor rocker rather than on a static cassette. As can be appreciated, the multi-tubing pinch valve assembly is not limited to use in a multiple-bioreactor system. For instance, the mechanism of the multi-tubing pinch valve assembly may be adapted to any situation where multiple valves may be required to have their positions fixed relative to others.
[0009] In a cam-driven approach, the multi-tubing pinch valve assembly may utilize a finger pump type mechanism having the orientation of the tube and fingers rotated 90 degrees relative to the cam. Rather than pumping a single tube, the multi-tubing pinch valve assembly is capable of valving many tubes simultaneously. This multi-tubing pinch valve assembly design can be paired with a soft cassette, as the fingers actuate in a direction normal to the soft cassette plane. The multi-tubing pinch valve assembly allows the occlusion depth to be tightly controlled, which allows for the possibility of intentionally partially occluding tubes (e.g., partial restriction of fluid flow, etc.). Another benefit of the examples described herein include the compact size and simplified electronics of the multi-tubing pinch valve assembly. Among other things, these features allow the valve unit to be mounted to a bioreactor rocker, in some cases, thereby simplifying a disposable set used in cell expansion systems, for example, by reducing the number of tubes that must run from the bioreactors to the static cassette. Further, the multi-tubing pinch valve assembly may ensure that valve positions are locked relative to each other, allowing assurance of correct flow. For example, it can be assured that one of the tubes in the time share model is always open, preventing pressure buildup, or two tubes may always be open or closed relative to each other, assuring a complete fluid path.
[0010] In some examples, the multi-tubing pinch valve assembly may be driven by a motor operatively connected to a camshaft comprising two cam profiles. A first anvil assembly may be disposed adjacent a first cam profile of the two cam profiles and a second anvil assembly may be disposed adjacent a second cam profile of the two cam profiles. As the motor rotates the camshaft, the two cam profiles rotate relative to the first anvil assembly and the second anvil assembly. At specific angles of rotation, at least one cam lobe, or protrusion, disposed on the cam profile may contact the first anvil assembly and the second anvil assembly. For instance, a first cam lobe associated with the first cam profile may contact the first anvil assembly at a first angle of rotation of the camshaft. As the first cam lobe contacts the first anvil assembly, the shape of the first cam lobe may cause the first anvil assembly to move in a direction away from the camshaft toward a pinch plate. A first section of tubing may be disposed in a first space between the first anvil and the pinch plate. In this arrangement, as the first anvil assembly moves toward the pinch plate, a first anvil of the first anvil assembly may contact and deform the first section of tubing such that a lumen of the first section of tubing closes. The first section of tubing may remain closed while the first cam lobe is at, or within a predetermined angular range (e.g., 1-5 degrees) of, a highest displacement point of the first cam lobe and the first anvil maintains the first section of tubing in a closed state.
[0011] The multi-tubing pinch valve assembly may be configured as an array of independently actuated multiple-tubing pinch valves. For instance, the multi-tubing pinch valve assembly may include a five-valve array of independently actuated four-tube pinch valves. At least one benefit to this independent actuation arrangement includes, but is in no way limited to, operating the multi-tubing pinch valve assembly in any combination of open or closed states.
[0012] This present disclosure describes, among other things, a multi-tubing pinch valve assembly comprising an array that is split into discrete multi-tube valves (e.g., an array of five 4- tube pinch valves), each multi-tube valve in the array capable of being driven by a small linear actuator (e.g., a solenoid, piezoelectric actuator, screw-type actuator, pneumatic cylinder, hydraulic cylinder, and/or a stepper motor linear actuator, etc.). This approach allows for any combination of valve states during a protocol (e.g., system operation, etc.). For example, in a cell expansion system, all valves may be opened during loading of a disposable (e.g., tubing set, etc.), valves may cycle continuously on a 10-second duty cycle during a cell feed, and valves may be opened sequentially for longer durations during tasks such as cell harvest, and/or the like.
[0013] In some examples, the pinching jaws of each multi-tube valve (e.g., 4-tube valve, etc.) of the multi-tubing pinch valve assembly may be slightly offset from one another. Among other things, this arrangement may reduce the pinch force from the actuator that may be required to occlude the tubing and increase the jaw gap range that results in occlusion. Such an increased jaw gap may provide enhanced cycling life and tubing integrity over time compared to designs including a decreased jaw gap. In one example, a single set of opposing jaws may pinch four tubes at once. Additionally or alternatively, the independent operability of each of the multi-tube valves may allow for disposable design optimization and simplification when compared with designs that require different valving.
[0014] The preceding is a simplified summary of the disclosure to provide an understanding of some aspects of the disclosure. This summary is neither an extensive nor exhaustive overview of the disclosure and its various aspects, embodiments, and configurations. It is intended neither to identify key or critical elements of the disclosure nor to delineate the scope of the disclosure but to present selected concepts of the disclosure in a simplified form as an introduction to the more detailed description presented below. As will be appreciated, other aspects, embodiments, and configurations of the disclosure are possible utilizing, alone or in combination, one or more of the features set forth above or described in detail below.
[0015] Numerous additional features and advantages are described herein and will be apparent to those skilled in the art upon consideration of the following Detailed Description and in view of the figures.
BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
[0016] The accompanying drawings are incorporated into and form a part of the specification to illustrate several examples of the present disclosure. These drawings, together with the description, explain the principles of the disclosure. The drawings simply illustrate preferred and alternative examples of how the disclosure can be made and used and are not to be construed as limiting the disclosure to only the illustrated and described examples. Further features and advantages will become apparent from the following, more detailed, description of the various aspects, embodiments, and configurations of the disclosure, as illustrated by the drawings referenced below.
[0017] Fig. 1A shows a first perspective view of a multi-tubing pinch valve assembly in accordance with embodiments of the present disclosure;
[0018] Fig. IB shows a front elevation view of the multi-tubing pinch valve assembly shown in Fig. 1A;
[0019] Fig. 1C shows a second perspective view of the multi-tubing pinch valve shown in Fig. 1A;
[0020] Fig. ID shows a partially exploded perspective view of the multi-tubing pinch valve assembly shown in Fig. 1A;
[0021] Fig. 2A shows a schematic section view of the multi-tubing pinch valve assembly taken through line 2-2 shown in Fig. ID;
[0022] Fig. 2B shows a perspective view of an anvil assembly in accordance with examples of the present disclosure;
[0023] Fig. 3A is a schematic section view of the anvil assembly and cam of a multi-tubing pinch valve assembly at a first rotational position in accordance with examples of the present disclosure;
[0024] Fig. 3B is a schematic section view of the anvil assembly and cam of a multi-tubing pinch valve assembly at a second rotational position in accordance with examples of the present disclosure;
[0025] Fig. 3C is a schematic section view of the anvil assembly and cam of a multi-tubing pinch valve assembly at a third rotational position in accordance with examples of the present disclosure;
[0026] Fig. 4A shows a first perspective view of a multi-tubing pinch valve assembly in accordance with embodiments of the present disclosure;
[0027] Fig. 4B shows a plan view of the multi-tubing pinch valve assembly shown in Fig. 4A;
[0028] Fig. 5A shows a schematic plan view of the multi-tubing pinch valve assembly shown in Fig. 4A in a closed, tubing-occluded, state in accordance with examples of the present disclosure;
[0029] Fig. 5B shows a schematic plan view of the multi-tubing pinch valve assembly shown in Fig. 4A in a partially closed, tubing-partially-occluded, state in accordance with examples of the present disclosure;
[0030] Fig. 5C shows a schematic plan view of the multi-tubing pinch valve assembly shown in Fig. 4A in an open, tubing-open, state in accordance with examples of the present disclosure; [0031] Fig. 6A shows a first perspective view of a multi-tubing pinch valve assembly in an array configuration in accordance with examples of the present disclosure;
[0032] Fig. 6B shows a second perspective view of a multi-tubing pinch valve assembly in an array configuration in accordance with examples of the present disclosure;
[0033] Fig. 7 shows a perspective view of a multi-tubing pinch valve assembly in an array configuration for a multiple-bioreactor system;
[0034] Fig. 8 is a schematic block diagram of a hydraulic layout for a cell expansion system having a single bioreactor in accordance with examples of the present disclosure;
[0035] Fig. 9 is a schematic block diagram of a hydraulic layout for a cell expansion system having multiple bioreactors and a multi-tubing pinch valve assembly in accordance with examples of the present disclosure;
[0036] Fig. 10 is a perspective view of another exemplary multitube pinch valve assembly in accordance with the present disclosure;
[0037] Fig. 11 is a perspective view of the multitube pinch valve assembly of Fig. 10 with a cover removed;
[0038] Fig. 12 is a perspective view of an exemplary actuation member of the multitube pinch valve assembly of Fig. 10;
[0039] Fig. 13 is a perspective view of a bioreactor support frame configured for the multitube pinch valve assembly of Fig. 10;
[0040] Fig. 14 is a perspective view of an additional exemplary multitube pinch valve assembly in accordance with the present disclosure;
[0041] Fig. 15 is a perspective view of the multitube pinch valve assembly of Fig. 14 with a bioreactor support frame removed;
[0042] Fig. 16 is a perspective view of the multitube pinch valve assembly of Fig. 14 with a cover removed;
[0043] Fig. 17 is a cross-sectional view of the multitube pinch valve assembly of Fig. 14; and [0044] Fig. 18 is a perspective view of a bioreactor support frame configured for the multitube pinch valve assembly of Fig. 14.
DETAILED DESCRIPTION
[0045] Before any embodiments of the disclosure are explained in detail, it is to be understood that the disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The disclosure is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Further, the present disclosure may use examples to illustrate one or more aspects thereof. Unless explicitly stated otherwise, the use or listing of one or more examples (which may be denoted by “for example,” “by way of example,” “e.g.,” “such as,” or similar language) is not intended to and does not limit the scope of the present disclosure.
[0046] The ensuing description provides embodiments only, and is not intended to limit the scope, applicability, or configuration of the claims. Rather, the ensuing description will provide those skilled in the art with an enabling description for implementing the described embodiments. It being understood that various changes may be made in the function and arrangement of elements without departing from the spirit and scope of the appended claims.
[0047] Various aspects of the present disclosure will be described herein with reference to drawings that may be schematic illustrations of idealized configurations.
[0048] Conventional external valving solutions generally utilize a single pinch valve to control fluid flow in a single tube. When fluid flow control is required for multiple tubes, each tube of the multiple tubes may employ a respective pinch valve. As can be appreciated, this conventional arrangement increases the number of components needed for a multiple-tube fluid flow control application. With the increased number of components, the complexity of the conventional multiple-tube fluid flow control application increases. Additionally or alternatively, control of each pinch valve in a multiple-tube fluid flow control application, where each tube has its own pinch valve, requires complex valve controls, timing, wiring, and programming. In any event, employing a single pinch valve for every tube, or section of tubing, that is to be pinched in a conventional approach results in increased maintenance times, failures, and system complexity.
[0049] It is with respect to the above issues and other problems that the embodiments presented herein were contemplated.
[0050] Referring now to Figs. 1A-1D, a multiple-tube pinch valve assembly 100 is shown in accordance with embodiments of the present disclosure. The multiple-tube pinch valve assembly 100 may comprise a base 104 (e.g., baseplate, frame, support structure, etc.), a camshaft 108, at least one cam 112 attached to the camshaft 108, at least one anvil assembly 150, and a tubing platen 120. In some examples, the tubing platen 120 may comprise a plurality of tube receiving apertures 128 disposed along a length of the tubing platen 120. Each tube receiving aperture 128 of the plurality of tube receiving apertures 128 may be configured to receive a tube, or section of tubing, therein. The plurality of tube receiving apertures 128 may extend in a direction that is perpendicular to the longitudinal axis 110 of the camshaft 108.
[0051] Features of the multiple-tube pinch valve assembly 100 may be described in conjunction with a coordinate system 102. The coordinate system 102, as shown in the figures, includes three- dimensions comprising an X-axis, a Y-axis, and a Z-axis. Additionally or alternatively, the coordinate system 102 may be used to define planes (e.g., the XY-plane, the XZ-plane, and the YZ-plane) of the multiple-tube pinch valve assembly 100. These planes may be disposed orthogonal, or at 90 degrees, to one another. While the origin of the coordinate system 102 may be placed at any point on or near the components of the multiple-tube pinch valve assembly 100, for the purposes of description, the axes of the coordinate system 102 are always disposed along the same directions from figure to figure. In some examples, reference may be made to dimensions, angles, directions, relative positions, and/or movements associated with one or more components of the multiple-tube pinch valve assembly 100 with respect to the coordinate system 102. For example, the width of the multiple-tube pinch valve assembly 100 may be defined as a dimension along the X-axis of the coordinate system 102, the height of the multiple-tube pinch valve assembly 100 may be defined as dimension along the Y-axis of the coordinate system 102, and the depth of the multiple-tube pinch valve assembly 100 may be defined as a dimension along the Z-axis of the coordinate system 102. Additionally or alternatively, the width of the tubing platen 120 may be defined as a dimension along the X-axis of the coordinate system 102, the height of the tubing platen 120 may be defined as dimension along the Y-axis of the coordinate system 102, and the depth of the tubing platen 120 may be defined as a dimension along the Z- axis of the coordinate system 102.
[0052] The multiple-tube pinch valve assembly 100 may include a motor 132 having an output shaft 134, a drive body 136, and a cam drive body 140. As the output shaft 134 of the motor 132 rotates, power is transmitted from the drive body 136 to the cam drive body 140. In one example, the drive body 136 and the cam drive body 140 may be configured as respective gears in meshing contact with one another. In one example, the drive body 136 and the cam drive body 140 may correspond to pulleys (e.g., timing belt pulleys, V-pulleys, etc.). In this example, power may be transmitted from the drive body 136 to the cam drive body 140 via a drive belt 138. The drive belt 138 may correspond to a timing belt, a V-belt, a ribbed V-belt, a link V-belt, etc., and/or any other continuous belt. In any of these examples, as the output shaft 134 of the motor 132 rotates, the camshaft 108 is caused to rotate about the longitudinal axis 110. Rotation of the camshaft 108 causes the cam 112 having at least one cam profile shape to rotate about the longitudinal axis 110. The cam 112 may be keyed (e.g., via a key and keyway, a spline, etc.), fixed, formed from, and/or otherwise affixed to the camshaft 108. The cam 112 may rotate through 360 degrees. At various angular rotations, different portions of the cam profile shape of the cam 112 may be presented to an anvil assembly 150. For instance, as a protrusion of the cam 112 contacts the anvil assembly 150, the anvil assembly 150 may lift (e.g., move in the positive Y-axis direction) toward the tubing platen 120 and as a recess, or heel, of the cam 112 contacts the anvil assembly 150, the anvil assembly 150 may lower (e.g., move in the negative Y-axis direction) away from the tubing platen 120. In this manner, the rotation of the camshaft 108 may cause the anvil assembly 150 to pinch the multiple tubes 124 in the tube receiving apertures 128 of the multiple-tube pinch valve assembly 100.
[0053] In some examples, the multiple-tube pinch valve assembly 100 may include a bioreactor support frame 144. The bioreactor support frame 144 may comprise a plurality of recesses 142 configured to receive and/or hold a respective bioreactor (e.g., hollow fiber bioreactor, cell expansion system bioreactor, etc.). In some examples, the multiple tubes 124 that are disposed in the tube receiving apertures 128 may be interconnected to the multiple bioreactors that are held, or supported, by the bioreactor support frame 144. Fluid flow control to multiple bioreactors may benefit from altering the timing associated with opening and closing the multiple tubes 124 associated with each bioreactor at a same time or at different times.
[0054] As shown in the front elevation view of Fig. IB, the multiple-tube pinch valve assembly 100 may be configured to have a valve array 148A-148E, or an array of valves, comprising a first multi-tube valve 148A, a second multi-tube valve 148B, a third multi-tube valve 148C, a fourth multi-tube valve 148D, and/or a fifth multi-tube valve 148E. Each multi-tube valve of the valve array 148A-148E, may be associated with a set of tubes dedicated to a particular bioreactor. For instance, the first multi-tube valve 148A may control the fluid flow of multiple tubes 124 that are received in the tube receiving apertures 128 associated with the first multi-tube valve 148A. Continuing this example, the second multi-tube valve 148B may control the fluid flow of multiple tubes 124 that are received in the tube receiving apertures 128 associated with the second multitube valve 148B, and so on. Each multi-tube valve of the valve array 148A-148E may include a respective anvil assembly 150 and a respective cam 112. In this manner, the cam 112 may be arranged on the camshaft 108 such that one multi-tube valve of the valve array 148A-148E can be operated at an individual, or independent, timing relative to the other multi-tube valves in the valve array 148A-148E. Stated another way, a cam 112 of one multi-tube valve of the valve array 148A-148E may be rotationally oriented out of phase from at least one other multi-tube valve of the valve array 148A-148E. In this example, as the camshaft 108 rotates, the valves in the valve array 148A-148E may open and close at the same or different times. In some examples, the valve array 148A-148E may be disposed along a length of the longitudinal axis 110 (e.g., in the X-axis direction) of the camshaft 108. Although shown comprising five separate valves 148A-148E, the multi-tubing pinch valve assembly 100 may include any number of valves. In some examples, the number of valves may be configured to match a number of bioreactors or sets of multiple tubes 124 that require fluid flow control. As can be appreciated, the valve array of the multi-tubing pinch valve assembly 100 may comprise one, two, three, four, five, or more valves.
[0055] Fig. ID shows a partially exploded perspective view of the multi-tubing pinch valve assembly 100, exposing the anvil grating plate 116. The anvil grating plate 116 may comprise a number of apertures passing therethrough. The apertures may be arranged along the X-axis of the anvil grating plate 116. Each aperture may be sized to receive a portion of the anvil assembly 150. As the camshaft 108 rotates, the cam 112 may contact the anvil assembly 150 moving a portion of the anvil assembly 150 into and/or out of the apertures. The anvil grating plate 116 may comprise a top surface that is arranged a distance from a tubing platen contact surface of the tubing platen 120. This distance may provide a space in which the multiple tubes 124 are disposed. As can be appreciated, as the portion of the anvil assembly 150 enters this space, the multiple tubes 124 may be closed (e.g., pinched) and as the portion of the anvil assembly 150 leaves this space, the multiple tubes 124 may be opened. Additional detail regarding this cam-actuated pinching and fluid flow control of multiple tubes is described in conjunction with Figs. 2A-3C.
[0056] Fig. 2A shows a schematic section view of the multi-tubing pinch valve assembly taken through line 2-2 shown in Fig. ID. The camshaft 108 is shown having the cam 112 oriented rotationally in a position where the anvil assembly 150 is pinching the multiple tubes 124 disposed in the tube receiving apertures 128 (e.g., in the space between the anvil grating plate 116 and the tubing platen 120). In this position, the anvil assembly 150 is in contact with a cam lobe of the cam 112 and the multiple tubes 124 are shown in a pinched state. Fluid flow through the multiple tubes 124 is restricted in the pinched state where the anvil assembly 150 contacts the multiple tubes 124.
[0057] The anvil assembly 150, shown in greater detail in Fig. 2B, includes an anvil 200 comprising an anvil body 204 and a pinch edge 208 extending from a first end 212 A to a second end 212B of the anvil assembly 150. The anvil 200 may comprise a protrusion extending from at least one stop ledge 216 of the anvil body 204 in the Y-axis direction. The protrusion may be sized to engage with an aperture, or receptacle, in the anvil grating plate 116 (e.g., in a slip fit, clearance fit, and/or the like). The protrusion may terminate at the pinch edge 208. In some examples, the pinch edge 208 may be flat, radiused, or sharp. The pinch edge 208 may comprise a tapered portion that slopes away from the pinch edge 208 toward the stop ledge 216. In some examples, the tapered portion may allow a section of the multiple tubes 124 being pinched to flex and move around the pinch edge 208. This shape, among other things, may reduce stresses placed on the multiple tubes 124 during pinching.
[0058] The anvil assembly 150 may comprise at least one cam contact portion disposed on a lower portion of the anvil body 204. The at least one cam contact portion may extend past the anvil body 204. In any event, the at least one cam contact portion may provide a contact surface between the anvil body 204 and the cam 112 of the multiple-tube pinch valve assembly 100. In some examples, the at least one cam contact portion may correspond to a cam follower 210, or other bearing. The cam follower 210, in some cases, may be made to include a hardened steel wheel and a bearing (e.g., roller bearing, ball bearing, etc.). The lower portion of the anvil body 204 may include a tapered surface 220 disposed on either side of a plane running through a center of the anvil body 204 (e.g., along the XY-plane). The tapered surface 220 may provide clearance for portions of the cam 112 and the cam profile shape as the cam 112 moves relative to the anvil body 204 and anvil assembly 150.
[0059] Figs. 3A-3C shown schematic section views of the anvil assembly 150 as the cam 112 rotates about the longitudinal axis 110. A rotation position fiducial 302 is shown on the cam 112 to illustrate the position from a first angular reference (e.g., illustrated as a zero degree line). The cam 112 may comprise a cam profile shape (e.g., disposed around a periphery of the cam 112) including a cam heel 308 (e.g., a low point), a cam lobe 316 (e.g., a high point), and a cam transition 312 disposed between the cam heel 308 and the cam lobe 316. The cam heel 308 may correspond to a first point along the cam profile shape where a distance from the periphery of the cam 112 to the center of the cam 112 (e.g., the longitudinal axis 110 of the camshaft 108) is closest than other points along the cam profile shape. Additionally or alternatively, the cam lobe 316 may correspond to a second point along the cam profile shape where a distance from the periphery of the cam 112 to the center of the cam 112 (e.g., the longitudinal axis 110 of the camshaft 108) is further than other points along the cam profile shape. As can be appreciated, the distance from the periphery of the cam 112 to the center of the cam 112 at the cam transition 312 may be a distance that is between the distance measured at the first point and the second point.
[0060] In Figs. 3A-3C, the multiple tubes 124 are disposed in a space between the anvil grating plate 116 and the tubing platen 120. In some examples, this space may correspond to the tube receiving apertures 128 described above. Fig. 3A corresponds to the anvil assembly 150 at a first cam 112 rotational position, Fig. 3B corresponds to the anvil assembly 150 at a second cam 112 rotational position, and Fig. 3C corresponds to the anvil assembly 150 at a third cam 112 rotational position. In the first rotational position of the cam 112, the multiple tubes 124 are shown in an open fluid flow state. In this position, fluid may be allowed to flow through each of the multiple tubes 124. In the second rotational position of the cam 112, the multiple tubes 124 are shown in a partially occluded, restricted fluid flow, state. In this position, fluid may be allowed to flow through each of the multiple tubes 124 but in a restricted, partially closed, state. For example, the flow rate of fluid flowing through the multiple tubes 124 may be reduced in the second rotational position when compared to the first rotational position. In the third rotational position of the cam 112, the multiple tubes 124 are shown in a closed state. In this position, fluid is restricted from flowing through each of the multiple tubes 124. This third rotational position may correspond to a completely occluded tubing state, which may also be referred to herein as a pinched or pinched closed state of the multiple tubes 124.
[0061] As shown in Fig. 3A, the anvil assembly 150 is in a lowermost position, where the protrusion of the anvil 200 is disposed in the anvil aperture 304 of the anvil grating plate 116. In particular, the cam follower 210 of the anvil assembly 150 is disposed in contact with the cam heel 308 of the cam 112. In this lowermost position, the pinch edge 208 may be disposed adjacent the multiple tubes 124. The multiple tubes 124 are not pinched by the anvil 200 in Fig. 3A, allowing fluid flow through the multiple tubes 124 from the left-hand side of the page to the righthand side of the page, or vice versa.
[0062] When the camshaft 108 is rotated by a first rotation 320A (e.g., shown as a first clockwise rotation), the cam 112 rotates from the zero-degree reference to the al angular position (e.g., comprising a non-zero angle measured from the zero-degree reference), as shown in Fig. 3B. In the al angular position, the cam follower 210 of the anvil assembly 150 is shown in contact with the cam transition 312 of the cam 112. Since the distance from the periphery of the cam 112 at the cam transition 312 is greater than the distance from the periphery of the cam 112 at the cam heel 308, the anvil assembly 150 raises, or lifts, upward disposing the pinch edge 208 in the space between the anvil grating plate 116 and the tubing platen 120. More specifically, the pinch edge 208 contacts the multiple tubes 124 disposed in the tube receiving apertures 128 and deforms the multiple tubes 124 restricting flow therethrough. In the rotational position shown in Fig. 3B, the anvil assembly 150 deforms the multiple tubes 124 providing a partially occluded flow path 324 at least along the pinch edge 208 (e.g., extending into the page).
[0063] Continuing the rotation from Fig. 3B, the camshaft 108 is rotated by a second rotation 320B (e.g., shown as a second continuing clockwise rotation) further rotating the cam 112 from the al angular position to the a2 angular position. In the a2 angular position, the cam follower 210 of the anvil assembly 150 is shown in contact with the cam lobe 316 of the cam 112. Since the distance from the periphery of the cam 112 at the cam lobe 316 is greater than the distance from the periphery of the cam 112 measured at the cam transition 312, the anvil assembly 150 further raises, or lifts, upward disposing the pinch edge 208 further in the space between the anvil grating plate 116 and the tubing platen 120. In this raised position, the pinch edge 208 deforms the multiple tubes 124 disposed in the tube receiving apertures 128 completely restricting flow therethrough. In the rotational position shown in Fig. 3C, the anvil assembly 150 deforms the multiple tubes 124 providing a pinched tubing point 328 at least along the pinch edge 208 (e.g., extending into the page).
[0064] The cam 112 may also be configured to provide an “all-open” state in which all of the tubes 124 are open and not constricted by the anvil assembly 150. Such an “all open” state improves loading of the bioreactor support frame 144. The cam 112 may also be configured to be removable from the assembly 100 to allow all of the bioreactors to be opened simultaneously.
[0065] Although described as rotating in a clockwise direction, it should be appreciated that the camshaft 108 may be rotated in a counterclockwise direction, a clockwise direction, and/or combinations thereof. In some examples, the motor 132 may be rotated in any rotational direction causing the rotation of the camshaft 108. Additionally or alternatively, while described as having a cam heel 308, cam transitions 312, and a cam lobe 316, it should be appreciated that the cam 112 may include greater or fewer protrusions, shapes, dwells, lobes, and recesses than are shown and described in Figs. 1A-3C.
[0066] Referring to Figs. 4A and 4B, various views of a multi-tubing pinch valve assembly 400 is shown in accordance with embodiments of the present disclosure. The multi-tubing pinch valve assembly 400 may provide an array of pinch valves that utilize independently controllable hinged clamp mechanisms. In some examples, the multi-tubing pinch valve assembly 400 may include at least one base 404, hinge plate 416, and clamp platen 420. Multiple tubes 124 may be disposed between the hinge plate 416 and the clamp platen 420. In one example, the multiple tubes 124 may be disposed in tube receiving apertures 128 associated with each valve. The hinge plate 416 may be pivotally connected to a hinge support block 424 at a first point via a pivot axis. An actuator, for example, linear actuator 410, may be attached to a second point of the hinge plate 416. The linear actuator 410 may correspond to a solenoid, a screw-type actuator, and/or a stepper motor-actuated screw-type actuator.
[0067] The linear actuator 410 may be mounted to a mount body 408 that is fixed relative to the base 404 of the multi-tubing pinch valve assembly 400. As the linear actuator 410 is actuated, a translation rod 412 may move between a retracted state and an extended state, or vice versa. Extending the translation rod 412 may move the hinge plate 416 toward the clamp platen 420. In this extended position, the multiple tubes 124 disposed in the tube receiving aperture 128 may be pinched by one or more features of the hinge plate 416 and the clamp platen 420.
[0068] The clamp platen 420 may be fixed relative to the base 404. As the linear actuator 410 is actuated, the translation rod 412 may move the hinge plate 416 from an open state to a closed state, or vice versa. In the open state, at least one portion of the hinge plate 416 may be separated further from the clamp platen 420 than when in the closed state. When in the open state, the multiple tubes 124 may be loaded and/or removed from the tube receiving aperture 128. Stated another way, the multiple tubes 124 may not be clamped, or pinched, when in the open state. However, when in the closed state, the multiple tubes 124 may be pinched between the hinge plate 416 and the clamp platen 420. Additional detail regarding the construction of the hinge plate 416 and the clamp platen 420 and the fluid flow control (e.g., pinching) arrangement is described in conjunction with Figs. 5A-5C.
[0069] In some examples, the multi-tubing pinch valve assembly 400 may comprise an array of valves arranged adjacent to one another. As shown in the plan view of Fig. 4B, four separate valves are shown, each valve configured to pinch multiple tubes 124 associated therewith. Each valve of the multi-tubing pinch valve assembly 400 may comprise a linear actuator 410, a translation rod 412, and a hinge plate 416. Although shown with separate clamp platens 420 in Figs. 4A and 4B, it should be appreciated that different valves may share a clamp platen 420. For instance, and as shown in Figs. 6A and 6B, the dual clamp platen 620 is used by more than one valve. The array of valves of the multi-tubing pinch valve assembly 400 shown in Fig. 4B, show a first row comprising two valves with linear actuators 410 that are configured to extend from right to left and a second row comprising two valves with linear actuators 410 that are configured to extend from left to right. Although shown comprising four separate valves, the multi-tubing pinch valve assembly 400 may include any number of valves. In some examples, the number of valves may be configured to match a number of bioreactors or sets of multiple tubes 124 that require fluid flow control. As can be appreciated, the valve array of the multi-tubing pinch valve assembly 400 may comprise one, two, three, four, five, or more valves.
[0070] Figs. 5A-5C show schematic plan views of the multi-tubing pinch valve assembly 400 described above moving between a closed state and an open state. The linear actuator 410 is shown attached to a mount body 408 that is fixed to the base 404. A hinge plate 416 is shown pivotally attached to a hinge support block 424 that is fixed to the base 404. The clamp platen 420 may be fixed to the base 404 or other portion of the multi-tubing pinch valve assembly 400. The hinge plate 416 may comprise a hinge pinch protrusion 516 extending from a surface of the hinge plate 416 in a direction toward the clamp platen 420. In some examples, the clamp platen 420 may comprise a tubing contact portion that is configured to contact the multiple tubes 124 disposed in the tube receiving aperture 128. In some examples, the tubing contact portion may correspond to a flat plate surface and/or a platen pinch protrusion 520 that extends from a surface of the clamp platen 420 (e.g., in a direction of the hinge plate 416).
[0071] The linear actuator 410 may be attached to a mount body 408. The mount body 408 may be fixed relative to the base 404. The linear actuator 410 may include a translation rod 412 that moves relative to the mount body 408 (e.g., in a direction toward or away from the mount body 408). The translation rod 412 may comprise a clevis pin 504 that engages with a clevis of the hinge plate 416. In some examples, the hinge plate 416 may comprise a clevis slot 508 in which the clevis pin 504 may be disposed.
[0072] Fig. 5A shows a schematic plan view of the multi-tubing pinch valve assembly 400 in a closed, tubing-occluded, state in accordance with examples of the present disclosure. In this state, the translation rod 412 of the linear actuator 410 is extended by a first translation vector 502A. The clevis pin 504 moving in the clevis slot 508 of the hinge plate 416 pivots the hinge plate 416 about the hinge pin 512 (e.g., pivot axis) in this state moving the hinge pinch protrusion 516 into contact with the multiple tubes 124 pinching the multiple tubes 124 between the hinge pinch protrusion 516 of the hinge plate 416 and the platen pinch protrusion 520 of the clamp platen 420. When the translation rod 412 is extended in this state, fluid flow through the multiple tubes 124 is occluded completely at the pinched tubing point 328.
[0073] Fig. 5B shows a schematic plan view of the multi-tubing pinch valve assembly 400 in a partially closed or partially open, tubing-partially-occluded, state in accordance with examples of the present disclosure. In this tubing-partially-occluded state, the translation rod 412 of the linear actuator 410 is retracted by a second translation vector 502B from the position shown in Fig. 5A. As the translation rod 412 retracts, the clevis pin 504 moves in the clevis slot 508 of the hinge plate 416 pivoting the hinge plate 416 about the hinge pin 512 (e.g., pivot axis) in a first hinge plate rotation 506 A. In this position, the hinge pinch protrusion 516 is in contact with the multiple tubes 124 partially deforming the multiple tubes 124 and the fluid flow lumens of each of the multiple tubes 124. More specifically, the multiple tubes 124 are captured between the hinge pinch protrusion 516 of the hinge plate 416 and the platen pinch protrusion 520 of the clamp platen 420 providing a partially occluded flow path 324 through the multiple tubes 124. In the tubing- partially-occluded state, fluid flow rate through the multiple tubes 124 disposed in the tube receiving aperture 128 may be reduced when compared to a tubing-open state.
[0074] Fig. 5C shows a schematic plan view of the multi-tubing pinch valve assembly 400 in an open, tubing-open, state in accordance with examples of the present disclosure. In this tubing- open state, the translation rod 412 of the linear actuator 410 is retracted by a third translation vector 502C from the position shown in Figs. 5A and 5B. As the translation rod 412 retracts, the clevis pin 504 moves in the clevis slot 508 of the hinge plate 416 pivoting the hinge plate 416 about the hinge pin 512 (e.g., pivot axis) in a second hinge plate rotation 506B. In this open position, the hinge pinch protrusion 516 is brought out of deforming contact with the multiple tubes 124. In some examples, the multiple tubes 124 may return to an undeformed state and the fluid flow lumens of each of the multiple tubes 124 may open in this state. When the multi-tubing pinch valve assembly 400 is in the tubing-open state, the multiple tubes 124 may be removed from, or loaded into, the clamp platen 420. While described as moving between a closed and an open state, it should be appreciated that the multi-tubing pinch valve assembly 400 may move between an open and closed state by reversing the order and movements described above.
[0075] Figs. 6A and 6B show perspective views of a multi-tubing pinch valve assembly 400 in an array configuration in accordance with examples of the present disclosure. As described above, the array of valves may comprise a plurality of linear actuators 410 and hinge plates 616 that are similar, if not identical, to the hinge plate 416 described above. In Figs. 6 A and 6B, the multitubing pinch valve assembly 400 and array may include two immediately adjacent valves that share a dual clamp platen 620. The dual clamp platen 620 may comprise a first platen pinch protrusion 520 extending from a first surface toward a first hinge plate 616 and a second platen pinch protrusion 520 extending from an opposite second surface toward a second hinge plate 616. Among other things, this arrangement may allow for a more compact arrangement of valves in the array of valves making up the multi-tubing pinch valve assembly 400.
[0076] Fig. 7 shows a perspective view of a multi-tubing pinch valve assembly 700 in an array configuration, for example, in a multiple-bioreactor system. In some examples, the multi-tubing pinch valve assembly 700 may correspond to the multi-tubing pinch valve assembly 400 described in Figs. 4A-6B. In Fig. 7, the bioreactor support frame 744 includes a plurality of recesses 142 configured to receive and hold a respective bioreactor 704A-704E. As shown in Fig. 7, the multitubing pinch valve assembly 700 may include five separate bioreactors 704A-704E. In this example, the multi-tubing pinch valve assembly 700 may include an array of valves comprising five separate valves, one valve per bioreactor 704A-704E. Each valve in the array of valves of the multi-tubing pinch valve assembly 700 may be configured to pinch multiple tubes 124 for each bioreactor 704A-704E. For instance, each bioreactor 704A-704E may include at least four tubes. A first pair of these four tubes may be associated with an intracapillary loop of a respective bioreactor 704A-704E and a second pair of these four tubes may be associated with the extracapillary loop of the respective bioreactor 704A-704E. Among other things, the multi-tubing pinch valve assembly 700 may allow independent opening and closing of the multiple tubes 124 for each bioreactor 704A-704E.
[0077] Fig. 8 is a schematic block diagram 800 of a hydraulic layout for a cell expansion system having a single bioreactor 704A in accordance with examples of the present disclosure. As shown, the bioreactor of Fig. 8 includes an intracapillary circulation (IC) loop 810 and an extracapillary circulation (EC) loop 812. In a single bioreactor these loops may be opened and closed by one or more valves. A cell inlet bag attachment point is at 820. A cell inlet line extends through a cell inlet valve 822 to an IC inlet pump 824. From the pump 824, the line extends to an air removal chamber/level detection 826. From the air removal chamber/level detection 826, the line branches off to waste 828 and to IC circulation valve 830. From valve 830 the line extends into the bioreactor 704A. From the bioreactor 704A, the line branches to waste 828, IC circulation pump 832, and to harvest 836. Harvest valve 892 controls flow to harvest 836. From pump 832, the line goes to IC inlet pressure sensor 834 and to the IC circulation valve 830.
[0078] A reagent attachment point is at 838. A regent line extends through a reagent valve 840 to the cell inlet line. An IC media attachment point is at 842. An IC media line extends through IC media valve 844 to the reagent line.
[0079] An EC media attachment point is at 850. From the EC media attachment point 850, an EC line extends through EC media valve 852. A wash connection point is at 854, and a wash valve is at 856. A distribution valve is along a line connecting the EC loop 812 and the IC loop 810. The EC loop 812 includes an EC inlet pump 870, which is downstream from an EC fluid detector 872. The EC loop 812 further includes a GTM chamber 880, an EC inlet pressure sensor 882, an EC circulation pump 884, and an EC outlet pressure sensor 886. An EC waste valve 888 is on an EC waste line extending to waste 828. An IC waste valve 890 and an IC outlet pressure sensor 894 are upstream of waste 828 on the IC side.
[0080] Fig. 9 is a schematic block diagram 900 of a hydraulic layout for a cell expansion system having multiple bioreactors and a multi-tubing pinch valve assembly 100, 400, 700 in accordance with examples of the present disclosure. As shown in the schematic block diagram 900, the tubing associated with the IC loop and the EC loop of each of the five bioreactors may be controlled by the valves in the valve array. These valves may correspond to any of valves shown in the multipletube pinch valve assemblies 100, 400, 700 described herein. In some examples, the valve array shown in the schematic block diagram 900 may correspond to the valve array 148A-148E described in conjunction with Figs. 1A-3C. In one example, each valve in the valve array shown in the schematic block diagram 900 may correspond to the hinge plate 416 and clamp platen 420 of the multi-tubing pinch valve assembly 400 described in conjunction with Figs. 4A-5C and/or the hinge plate 616 and dual clamp platen 620 shown in Figs. 6A and 6B.
[0081] Figs. 10-13 illustrate a multitube pinch valve assembly 1100 in accordance with the present disclosure. The assembly 1100 generally includes a base 1110 and a bioreactor support frame 1310. With particular reference to Figs. 11 and 12, the base 1110 includes a plurality of hinge plates 1112A-1112E. Any suitable number of the hinge plates may be included. In the example illustrated, five hinge plates 1112A, 1112B, 1112C, 1112D, and 1112E are included. Each one of the hinge plates 1112A-1112E includes a hinge pinch protrusion 1114. The hinge plates 1112A-1112E are each individually actuated by any suitable actuation mechanism. In the example illustrated, each one of the hinge plates 1112A-1112E is actuated by a different actuation mechanism 1120A, 1120B, 1120C, 1120D, 1120E respectively. Each one of the actuation mechanisms 1120A-1120E may include any suitable linear actuator, such as any suitable solenoid, linear stepper motor, pneumatic actuator, etc., for example.
[0082] The base 1110 further includes a plurality of support posts 1150. The support posts 1150 are configured to cooperate with the bioreactor support frame 1310 as explained below to support the bioreactor support frame 1310 on the base 1110 and over the hinge plates 1112A-1112E. A strap 1152 is included to hold the bioreactor support frame 1310 on the base 1110.
[0083] The multitube pinch valve assembly 1100 further includes a rocker assembly 1160. The rocker assembly 1160 includes a rocker rod 1162, which cooperates with the base 1110 at an aperture 1164 defined by the base 1110. The rocker assembly 1160 includes a motor configured to rotate the rocker rod 1162. The rocker rod 1162 is mounted to the base 1110 in any suitable manner such that rotation of the rocker rod 1162 rocks the base 1110 and the bioreactors 704 A- 704E mounted thereto. In come configurations, the rocker assembly 1160 may be configured to invert the bioreactors 704A-704E.
[0084] With particular reference to Fig. 13, the bioreactor support frame 1310 may be configured to support five bioreactors 704A, 704B, 704C, 704D, 704E, or any other suitable number of bioreactors. The number of bioreactors included with the bioreactor support frame 1310 typically equals, or is less than, the number of hinge plates 1112A-1112E. The support frame 1310 includes a tubing platen 1320. The tubing platen 1320 includes a plurality of tube receiving apertures 1322 configured to secure the tubes 124 of the bioreactors 704A-704E to the tubing platen 1320. The tubes 124 extend generally parallel to lengths of the bioreactors 704A- 704E. In some applications, the tubes 124 may extend perpendicular to the bioreactors 704A- 704E, or at any other suitable angle. [0085] The bioreactor support frame 1310 further includes a plurality of receptacles 1340, each of which are configured to cooperate with the support posts 1150 of the base 1110. The support posts 1150 support the bioreactor support frame 1310 on top of the base 1110 and position the support frame 1310 such that the tubes 124 are arranged opposite to, and extend perpendicularly across, the hinge pinch protrusions 1114 of the hinge plates 1112A-1112E. Actuation of the different hinge plates 1112A-1112E moves the hinge pinch protrusions 1114 towards tubes to pinch the tubes 124 and restrict fluid flow through the tubes 124 and to the bioreactors 704A-704E in generally the same manner illustrated in Figs. 5A, 5B, and 5C illustrating the multi-tubing pinch valve assembly 400. When actuated upward, the hinge pinch protrusions 1114 will contact the tubes 124 on either side of any of the receiving apertures 1322 to bend the tubes 124 into occlusion. Bending the tubes 124 into occlusion reduces the amount of pinch force required from the actuation mechanisms 1120A-1120E as compared to when the pinch protrusions 1114 directly contact an opposing platen pinch protrusion. In some applications, the tubing platen 1320 may include platen pinch protrusions aligned with the hinge pinch protrusions 1114.
[0086] Figs. 14-18 illustrate an additional multitube pinch valve assembly 1500 in accordance with the present disclosure. The assembly 1500 generally includes a base 1510 and a bioreactor support frame 1710. With particular reference to Figs. 14 and 15, the base 1510 includes a latch 1512, which is rotatable between a closed position and an open position. In the open position, a rail 1520 of the base 1510 is accessible. The rail 1520 extends across the base 1510, and is configured to cooperate with the bioreactor support frame 1710, as explained herein. The rail 1520 may include a planar undersurface, or a pinch protrusion similar to the platen pinch protrusion 1330.
[0087] Opposite to the rail 1520, and seated within a housing 1530, are a plurality of actuation plates 1540A, 1540B, 1540C, 1540D, and 1540E. In the example illustrated, five actuation plates 1540A-1540E are included. The base 1510 may include any suitable number of actuation plates, however. Each one of the actuation plates 1540A-1540E includes a pinch protrusion 1542.
[0088] The actuation plates 1540A-1540E are individually actuatable by any suitable actuation mechanism. In the example illustrated, each one of the actuation plates 1540A-1540E is actuated by a different actuation mechanism 1550A, 1550B, 1550C, 1550D, 1550E respectively. The actuation mechanisms 1550A-1550E may include any suitable linear actuator, such as any suitable solenoid, linear stepper motor, pneumatic actuator, etc. The actuation mechanisms 1550A-1550E may be individually actuated to control fluid flow through tubes 124 of the bioreactors 704 A- 704E. [0089] With particular reference to FIG. 18, the bioreactor support frame 1710 includes a tubing platen 1730. The tubing platen 1730 defines a plurality of tube receiving apertures 1732 configured to secure the tubes 124 of the bioreactors 704A-704E to the tubing platen 1730. The tube receiving apertures 1732 are configured to support the tubes 124 so that the tubes 124 extend parallel to the lengths of the bioreactors 704A-704E.
[0090] The tubing platen 1730 further defines a center channel 1740 configured to receive the rail 1520 therein. At a rear of the center channel 1740 is a rear aperture 1742. The center channel 1740 extends perpendicular to the lengths of the bioreactors 704A-704E, and perpendicular to the tubes 124 supported by the tube receiving apertures 1732. At a rear end of the tubing platen 1730 are rear tabs 1750. At a front end of the tubing platen 1730 are front tabs 1752.
[0091] To connect the bioreactor support frame 1710 to the base 1510, the latch 1512 is folded downward, the tubing platen 1730 is positioned so that the rail 1520 enters through the rear aperture 1742, and then the tubing platen 1730 is slid onto the rail 1520 so that the rail 1520 extends along the center channel 1740. The tubing platen 1730 is slid along the rail 1520 until the rear tabs 1750 are seated within rear openings 1560 of the base 1510. The latch 1512 is then closed onto the front tabs 1752 so that the front tabs 1752 are seated within recesses 1562 defined on an inner surface of the latch 1512 to lock the tubing platen 1730 into position. The rear tabs 1750 and the front tabs 1752 improve alignment of the tubes 124 relative to the pinch protrusions 1542, and prevent loading the bioreactors backwards. Also, when the assembly 1500 includes a rocker, the tabs 1750, 1752 keep the bioreactors 704A-704E and tubes 124 in the correct position relative to the rod 1520. The tubing platen 1730 is oriented so that the pinch protrusions 1542 are perpendicular to the tubes 124. Actuation of the different actuation plates 1540A-1540E moves the pinch protrusions 1542 towards and into the center channel 1740 to pinch the tubes 124 between the pinch protrusions 1542 and the rail 1520 to restrict fluid flow through the tubes 124 in generally the same manner illustrated in Figs. 5A, 5B, and 5C illustrating the multi-tubing pinch valve assembly 400. In some applications, there may be a material between the tubes 124 and the rail 1520. The actuation plates 1540A-1540E may be individually actuated by the actuation mechanisms 1550A-1550E to selectively pinch the tubes 124, which selectively controls flow through the different tubes 124 and through the different bioreactors 704A-704E.
[0092] While the operations and steps above have been discussed and illustrated in relation to a particular sequence of events, it should be appreciated that changes, additions, and omissions to this sequence can occur without materially affecting the operation of the disclosed embodiments, configuration, and aspects. [0093] The exemplary systems and methods of this disclosure have been described in relation to pinch valves and multiple-tubing systems. However, to avoid unnecessarily obscuring the present disclosure, the preceding description omits a number of known structures and devices. This omission is not to be construed as a limitation of the scope of the claimed disclosure. Specific details are set forth to provide an understanding of the present disclosure. It should, however, be appreciated that the present disclosure may be practiced in a variety of ways beyond the specific detail set forth herein.
[0094] A number of variations and modifications of the disclosure can be used. It would be possible to provide for some features of the disclosure without providing others.
[0095] References in the specification to “one embodiment,” “an embodiment,” “an example embodiment,” “some embodiments,” etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in conjunction with one embodiment, it is submitted that the description of such feature, structure, or characteristic may apply to any other embodiment unless so stated and/or except as will be readily apparent to one skilled in the art from the description. The present disclosure, in various embodiments, configurations, and aspects, includes components, methods, processes, systems and/or apparatus substantially as depicted and described herein, including various embodiments, subcombinations, and subsets thereof. Those of skill in the art will understand how to make and use the systems and methods disclosed herein after understanding the present disclosure. The present disclosure, in various embodiments, configurations, and aspects, includes providing devices and processes in the absence of items not depicted and/or described herein or in various embodiments, configurations, or aspects hereof, including in the absence of such items as may have been used in previous devices or processes, e.g., for improving performance, achieving ease, and/or reducing cost of implementation.
[0096] The foregoing discussion of the disclosure has been presented for purposes of illustration and description. The foregoing is not intended to limit the disclosure to the form or forms disclosed herein. In the foregoing Detailed Description for example, various features of the disclosure are grouped together in one or more embodiments, configurations, or aspects for the purpose of streamlining the disclosure. The features of the embodiments, configurations, or aspects of the disclosure may be combined in alternate embodiments, configurations, or aspects other than those discussed above. This method of disclosure is not to be interpreted as reflecting an intention that the claimed disclosure requires more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed embodiment, configuration, or aspect. Thus, the following claims are hereby incorporated into this Detailed Description, with each claim standing on its own as a separate preferred embodiment of the disclosure.
[0097] Moreover, though the description of the disclosure has included description of one or more embodiments, configurations, or aspects and certain variations and modifications, other variations, combinations, and modifications are within the scope of the disclosure, e.g., as may be within the skill and knowledge of those in the art, after understanding the present disclosure. It is intended to obtain rights, which include alternative embodiments, configurations, or aspects to the extent permitted, including alternate, interchangeable and/or equivalent structures, functions, ranges, or steps to those claimed, whether or not such alternate, interchangeable and/or equivalent structures, functions, ranges, or steps are disclosed herein, and without intending to publicly dedicate any patentable subject matter.
[0098] Exemplary aspects are directed to a multiple-tube pinch valve assembly, comprising: a camshaft extending a length along a longitudinal axis of the camshaft, the camshaft comprising at least one cam disposed along the length, the at least one cam comprising a cam profile shape defined around the longitudinal axis and a periphery of the camshaft and; a platen offset a distance from the longitudinal axis, the distance at least partially defining a space configured to receive multiple fluid flow tubes; and an anvil assembly comprising a cam contact portion disposed on a first side of the anvil assembly and a pinch edge disposed on a second side of the anvil assembly, wherein the anvil assembly is moveable between a retracted state such that the pinch edge is disposed outside of the space and an extended state such that the pinch edge is disposed inside the space adjacent the platen, and wherein the anvil assembly moves between the retracted state and the extended state by a rotation of the camshaft and the at least one cam.
[0099] Any one or more of the above aspects include wherein the cam profile shape comprises at least one cam lobe and at least one cam heel, wherein the anvil assembly is in the extended state when the cam lobe is disposed in contact with the cam contact portion, and wherein the anvil assembly is in the retracted state when the cam heel is disposed in contact with the cam contact portion. Any one or more of the above aspects include wherein the cam contact portion comprises at least one cam follower. Any one or more of the above aspects include wherein the space comprises a plurality of tube receiving apertures arranged side-by-side along a direction that is parallel to the longitudinal axis of the camshaft. Any one or more of the above aspects include wherein each tube receiving aperture of the plurality of tube receiving apertures extend in a direction that is perpendicular to the longitudinal axis of the camshaft. Any one or more of the above aspects further comprising: a plurality of tubes removably engaged with the plurality of tube receiving apertures such that a section of each tube of the plurality of tubes is disposed in the space adjacent the platen, wherein, in the retracted state, a lumen of each tube of the plurality of tubes is open along the section of each tube of the plurality of tubes, and wherein, in the extended state, the lumen of each tube of the plurality of tubes is closed at a point along the section of each tube of the plurality of tubes. Any one or more of the above aspects further comprising: a motor comprising an output shaft; a drive body attached to the output shaft of the motor; and a cam drive body attached to the camshaft, wherein rotation of the output shaft of the motor transmits power from the drive body to the cam drive body causing the camshaft to rotate relative to the anvil assembly. Any one or more of the above aspects further comprising: a support frame comprising a plurality of recesses, wherein each recess of the plurality of recesses is configured to hold a respective bioreactor, and wherein each tube of the plurality of tubes is associated with the respective bioreactor. Any one or more of the above aspects include wherein the anvil assembly, when moving between the retracted state and the extended state, translates along a plane that is perpendicular to a plane running through the plurality of tubes, and wherein, in the extended state, the pinch edge of the anvil assembly contacts and closes each tube of the plurality of tubes. Any one or more of the above aspects further comprising: an array of valves disposed along a length of the longitudinal axis of the camshaft, wherein each valve in the array of valves comprises a plurality of tube receiving apertures, and wherein each valve in the array of valves comprises a respective anvil assembly that is capable of moving between the retracted state and the extended state by the rotation of the camshaft and the at least one cam. Any one or more of the above aspects include wherein the respective anvil assembly of each valve in the array of valves is capable of moving between the retracted state and the extended state based on a position of a respective cam connected to the camshaft. Any one or more of the above aspects include wherein a first valve in the array of valves is capable of closing tubing contained within a first set of tube receiving apertures associated with the first valve at a same time or a different time as a second valve in the array of valves closes tubing contained within a second set of tube receiving apertures associated with the second valve. Any one or more of the above aspects include wherein, at a first time as the camshaft rotates, a first valve in the array of valves closes tubing contained within a first set of tube receiving apertures associated with the first valve, wherein, at a second time as the camshaft rotates, a second valve in the array of valves closes tubing contained within a second set of tube receiving apertures associated with the second valve. Any one or more of the above aspects include wherein, at a third time as the camshaft rotates, a third valve in the array of valves closes tubing contained within a third set of tube receiving apertures associated with the third valve, wherein, at a fourth time as the camshaft rotates, a fourth valve in the array of valves closes tubing contained within a fourth set of tube receiving apertures associated with the fourth valve, and wherein at a fifth time as the camshaft rotates, a fifth valve in the array of valves closes tubing contained within a fifth set of tube receiving apertures associated with the fifth valve. Any one or more of the above aspects include wherein the first set of tube receiving apertures, the second set of tube receiving apertures, the third set of tube receiving apertures, the fourth set of tube receiving apertures, and the fifth set of tube receiving apertures each comprise four tube receiving apertures. [0100] Exemplary aspects are directed to a multiple-tube pinch valve assembly, comprising: a motor comprising an output shaft; a drive body attached to the output shaft of the motor; a camshaft extending a length along a longitudinal axis of the camshaft, the camshaft comprising at least one cam disposed along the length, the at least one cam comprising a cam profile shape defined around the longitudinal axis and a periphery of the camshaft and; a cam drive body attached to the camshaft; a platen offset a distance from the longitudinal axis, the distance at least partially defining a space configured to receive multiple fluid flow tubes; and an anvil assembly comprising at least one cam follower disposed on a first side of the anvil assembly and a pinch edge disposed on a second side of the anvil assembly, wherein rotation of the output shaft of the motor transmits power from the drive body to the cam drive body causing the camshaft to rotate relative to the anvil assembly and move the anvil assembly between a retracted state, such that the pinch edge is disposed outside of the space, and an extended state, such that the pinch edge is disposed inside the space adjacent the platen, and wherein the anvil assembly moves between the retracted state and the extended state by rotation of the camshaft and the at least one cam.
[0101] Exemplary aspects are directed to a multi-tubing pinch valve assembly, comprising: a hinge plate extending a length from a first point to a second point, the hinge plate comprising: a pivot axis disposed adjacent the first point of the hinge plate; and a pinch protrusion disposed between the first point and the second point, the pinch protrusion extending from a surface of the hinge plate; a platen comprising a body offset a distance from the hinge plate, the platen comprising a tubing contact portion disposed on a surface of the platen; an actuator operatively connected to the hinge plate adjacent the second point, wherein the actuator is moveable between a retracted state and an extended state, wherein, in the retracted state, the hinge plate is pivoted about the pivot axis such that the second point of the hinge plate is separated from the platen by a first distance, wherein, in the extended state, the hinge plate is pivoted about the pivot axis such that the second point of the hinge plate is separated from the platen by a second distance, and wherein the first distance is greater than the second distance. [0102] Any one or more of the above aspects include wherein, in the extended state, the pinch protrusion of the hinge plate is adjacent the tubing contact portion of the platen, and wherein in the retracted state, the pinch protrusion of the hinge plate is offset from the tubing contact portion of the platen creating a receiving space between the hinge plate and the platen. Any one or more of the above aspects include wherein, in the retracted state, the pinch protrusion of the hinge plate is offset from the tubing contact portion of the platen by a first dimension defining a receiving space capable of receiving a plurality of tubes. Any one or more of the above aspects include wherein, in the extended state, the pinch protrusion of the hinge plate is offset from the tubing contact portion of the platen by a second dimension defining a pinched receiving space that is sized to pinch the plurality of tubes disposed between the hinge plate and the platen. Any one or more of the above aspects further comprising the plurality of tubes disposed in between the hinge plate and the platen, wherein the plurality of tubes provide fluid flow paths therethrough when in the retracted state, and wherein the fluid flow paths are restricted by the pinch protrusion of the hinge plate and the tubing contact portion of the platen when in the extended state. Any one or more of the above aspects include wherein the pinch protrusion of the hinge plate and the tubing contact portion of the platen completely restrict fluid flow in the plurality of tubes when in the extended state. Any one or more of the above aspects further comprising: a clevis disposed adjacent the second point of the hinge plate; and a clevis pin engaged with the clevis, the clevis pin being connected to an end of a translation rod of the actuator. Any one or more of the above aspects include wherein the tubing contact portion comprises a platen pinch protrusion extending from a surface of the platen, and wherein the surface of the platen faces the hinge plate. Any one or more of the above aspects include wherein the pivot axis is defined by a hinge pin engaged with the hinge plate and a hinge support block. Any one or more of the above aspects include wherein the actuator is one of a solenoid, a screw-type actuator, and a stepper motor actuated screw. Any one or more of the above aspects include wherein the clevis pin engages with a slot in the clevis. [0103] Exemplary aspects are directed to a multi-tubing pinch valve assembly, comprising: an array of valves disposed adjacent one another, wherein each valve in the array of valves comprises: a hinge plate extending a length from a first point to a second point, the hinge plate comprising: a pivot axis disposed adjacent the first point of the hinge plate; and a pinch protrusion disposed between the first point and the second point, the pinch protrusion extending from a surface of the hinge plate; a tubing contact body offset a distance from the hinge plate; an actuator operatively connected to the hinge plate adjacent the second point, wherein the actuator is moveable between a retracted state and an extended state, wherein, in the retracted state, the hinge plate is pivoted about the pivot axis such that the second point of the hinge plate is separated from the tubing contact body by a first distance, wherein, in the extended state, the hinge plate is pivoted about the pivot axis such that the second point of the hinge plate is separated from the tubing contact body by a second distance, and wherein the first distance is greater than the second distance.
[0104] Any one or more of the above aspects include wherein, in the extended state, the pinch protrusion of the hinge plate is adjacent the tubing contact body, and wherein in the retracted state, the pinch protrusion of the hinge plate is offset from the tubing contact body creating a receiving space between the hinge plate and the tubing contact body. Any one or more of the above aspects include wherein each valve in the array of valves is configured to receive a plurality of tubes in the receiving space. Any one or more of the above aspects include wherein each valve in the array of valves is configured to pinch the plurality of tubes in the receiving space in the extended state of the actuator. Any one or more of the above aspects include wherein each valve in the array of valves is independently operable such that each hinge plate of each valve is moveable between the retracted state and the extended state independently. Any one or more of the above aspects include wherein a first valve in the array of valves is operable together with and/or separately from a second valve in the array of valves. Any one or more of the above aspects further comprising: a support frame comprising a plurality of recesses, wherein each recess of the plurality of recesses is configured to hold a respective bioreactor, and wherein each tube of the plurality of tubes is associated with the respective bioreactor.
[0105] Exemplary aspects are directed to a multiple-bioreactor assembly comprising the multitubing pinch valve assembly of any of the above aspects.
[0106] Any one or more of the above aspects/embodiments as substantially disclosed herein.
[0107] Any one or more of the aspects/embodiments as substantially disclosed herein optionally in combination with any one or more other aspects/embodiments as substantially disclosed herein. [0108] One or means adapted to perform any one or more of the above aspects/embodiments as substantially disclosed herein.
[0109] Any one or more of the features disclosed herein.
[0110] Any one or more of the features as substantially disclosed herein.
[0111] Any one or more of the features as substantially disclosed herein in combination with any one or more other features as substantially disclosed herein.
[0112] Any one of the aspects/features/embodiments in combination with any one or more other aspects/features/embodiments .
[0113] Use of any one or more of the aspects or features as disclosed herein. [0114] It is to be appreciated that any feature described herein can be claimed in combination with any other feature(s) as described herein, regardless of whether the features come from the same described embodiment.
[0115] As used herein, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “include,” “including,” “includes,” “comprise,” “comprises,” and/or “comprising,” when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof. The term “and/or” includes any and all combinations of one or more of the associated listed items.
[0116] The term “a” or “an” entity refers to one or more of that entity. As such, the terms “a” (or “an”), “one or more,” and “at least one” can be used interchangeably herein. It is also to be noted that the terms “comprising,” “including,” and “having” can be used interchangeably.
[0117] The phrases “at least one,” “one or more,” “or,” and “and/or” are open-ended expressions that are both conjunctive and disjunctive in operation. For example, each of the expressions “at least one of A, B and C,” “at least one of A, B, or C,” “one or more of A, B, and C,” “one or more of A, B, or C,” and “A, B, and/or C” means A alone, B alone, C alone, A and B together, A and C together, B and C together, or A, B, and C together. When each one of A, B, and C in the above expressions refers to an element, such as X, Y, and Z, or a class of elements, such as Xl-Xn, Y 1- Ym, and Zl-Zo, the phrase is intended to refer to a single element selected from X, Y, and Z, a combination of elements selected from the same class (e.g., XI and X2) as well as a combination of elements selected from two or more classes (e.g., Y 1 and Zo).
[0118] The term “automatic” and variations thereof, as used herein, refers to any process or operation, which is typically continuous or semi-continuous, done without material human input when the process or operation is performed. However, a process or operation can be automatic, even though performance of the process or operation uses material or immaterial human input, if the input is received before performance of the process or operation. Human input is deemed to be material if such input influences how the process or operation will be performed. Human input that consents to the performance of the process or operation is not deemed to be “material.” [0119] The terms “determine,” “calculate,” “compute,” and variations thereof, as used herein, are used interchangeably and include any type of methodology, process, mathematical operation, or technique.
[0120] Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and this disclosure.
[0121] It should be understood that every maximum numerical limitation given throughout this disclosure is deemed to include each and every lower numerical limitation as an alternative, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this disclosure is deemed to include each and every higher numerical limitation as an alternative, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this disclosure is deemed to include each and every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.

Claims

CLAIMS What is claimed is:
1. A multiple-tube pinch valve assembly comprising: a frame configured to hold a plurality of bioreactors and tubing connected to the bioreactors; a base configured to support the frame, the base including a plurality of pinch protrusions; and a plurality of actuators included with the base, each one of the plurality of actuators is connected to, and configured to actuate, a different one of the plurality of pinch protrusions; wherein: the frame and the base are configured to cooperate to retain the frame on the base and orient the frame such that the plurality of pinch protrusions are opposite to, and perpendicular to, the tubing connected to the bioreactors; and the plurality of actuators are configured to individually actuate each one of the plurality of pinch protrusions between a retracted position and an extended position, in the retracted position the pinch protrusions are spaced apart from the tubing, in the extended position the plurality of pinch protrusions pinch the tubing to restrict fluid flow through the tubing.
2. The multiple-tube pinch valve assembly of claim 1, wherein the plurality of actuators are linear actuators.
3. The multiple-tube pinch valve assembly of claim 1, further comprising a rocker assembly configured to rock the frame and the plurality of bioreactors.
4. The multiple-tube pinch valve assembly of claim 1, wherein in the retracted position the pinch protrusions are within a housing of the base, and in the extended position the pinch protrusions protrude out from within the housing.
5. The multiple-tube pinch valve assembly of claim 1, wherein the plurality of actuators are configured to individually actuate each one of the plurality of pinch protrusions to an intermediate position that is between the retracted position and the extended position, in the intermediate position the pinch protrusions pinch the tubing less than in the extended position.
6. The multiple-tube pinch valve assembly of claim 1, wherein the frame is configured to hold the tubing such that the tubing extends across the frame parallel to lengths of the plurality of bioreactors.
7. The multiple-tube pinch valve assembly of claim 1, further comprising a plurality of hinge plates, each one of the plurality of hinge plates includes one of the plurality of pinch protrusions; wherein the plurality of actuators are each connected to a first end of the plurality of hinge plates, and actuation of the plurality of hinge plates by the plurality of actuators pivots the plurality of hinge plates about a rotation axis at a second end of the plurality of hinge plates.
8. The multiple-tube pinch valve assembly of claim 1, wherein the frame includes a platen pinch protrusion opposite to the pinch protrusions such that in the extended position the pinch protrusions pinch the tubing against the platen pinch protrusion.
9. The multiple-tube pinch valve assembly of claim 1, wherein the pinch protrusions are oriented such that in the extended position the pinch protrusions bend the tubing.
10. The multiple-tube pinch valve assembly of claim 1, wherein: the base further includes a rail suspended over the pinch protrusions; and in the extended position the pinch protrusions pinch the tubing against the rail.
11. The multiple-tube pinch valve assembly of claim 10, wherein the frame is configured to slide onto the rail, the frame defining a channel configured to receive the rail therein.
12. A multiple-tube pinch valve assembly configured to cooperate with a frame holding a plurality of bioreactors and tubing connected to the bioreactors, the multiple-tube pinch valve assembly comprising: a plurality of hinge plates, each one of the plurality of hinge plates including a hinge pinch protrusion; a plurality of actuators, each one of the plurality of actuators is connected to, and configured to actuate, a different one of the plurality of hinge plates; and mounts configured to cooperate with the frame to support and orientate the frame such that the tubes are opposite to, and extend perpendicular to, the hinge pinch protrusions; wherein the plurality of actuators are configured to individually actuate each one of the plurality of hinge plates between a retracted position and an extended position, in the retracted position the hinge pinch protrusions are spaced apart from the tubing, in the extended position the hinge pinch protrusions pinch the tubing to restrict fluid flow through the tubing.
13. The multiple-tube pinch valve assembly of claim 12, wherein the mounts include mounting posts configured to cooperate with receptacles of the frame.
14. The multiple-tube pinch valve assembly of claim 12, further comprising a rocker assembly configured to rock the frame when the frame is in cooperation with the mounts.
15. The multiple-tube pinch valve assembly of claim 12, further comprising a housing including the plurality of hinge plates and the plurality of actuators; wherein in the retracted position the hinge pinch protrusions are within the housing, and in the extended position the hinge pinch protrusions protrude out from within the housing.
16. A multiple-tube pinch valve assembly configured to cooperate with a frame holding a plurality of bioreactors and tubing connected to the bioreactors, the multiple-tube pinch valve assembly comprising: a plurality of pinch protrusions; a plurality of actuators, each one of the plurality of actuators is connected to, and configured to actuate, a different one of the plurality of pinch protrusions; and a rail supported over the pinch protrusions, the rail configured to cooperate with the frame to support the frame over the pinch protrusions and orientate the frame such that the tubes are opposite to, and extend perpendicular to, the pinch protrusions; wherein the plurality of actuators are configured to individually actuate each one of the plurality of pinch protrusions between a retracted position and an extended position, in the retracted position the pinch protrusions are spaced apart from the tubing, in the extended position the pinch protrusions pinch the tubing against the rail to restrict fluid flow through the tubing.
17. The multiple-tube pinch valve assembly of claim 16, further comprising a housing including the plurality of pinch protrusions and the plurality of actuators; wherein in the retracted position the pinch protrusions are within the housing, and in the extended position the pinch protrusions protrude out from within the housing.
18. The multiple-tube pinch valve assembly of claim 16, further comprising the frame, the frame including a channel configured to cooperate with the rail.
19. The multiple-tube pinch valve assembly of claim 16, further comprising a latch, the latch movable between an open position and a closed position, in the open position the rail is accessible to allow the frame to slide onto the rail, and in the closed position the frame is locked onto the rail.
20. The multiple-tube pinch valve assembly of claim 16, wherein the plurality of actuators are linear actuators.
PCT/US2023/013826 2022-02-28 2023-02-24 Multiple-tube pinch valve assembly Ceased WO2023164137A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2024550569A JP7836899B2 (en) 2022-02-28 2023-02-24 Pinch valve assembly for multiple tubes
CN202380023967.9A CN118765358A (en) 2022-02-28 2023-02-24 Multi-tube clamp valve assembly
EP23760694.2A EP4487033A4 (en) 2022-02-28 2023-02-24 Multi-tube pinch valve assembly

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263314931P 2022-02-28 2022-02-28
US63/314,931 2022-02-28
US18/113,173 US12152699B2 (en) 2022-02-28 2023-02-23 Multiple-tube pinch valve assembly
US18/113,173 2023-02-23

Publications (1)

Publication Number Publication Date
WO2023164137A1 true WO2023164137A1 (en) 2023-08-31

Family

ID=87761492

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2023/013826 Ceased WO2023164137A1 (en) 2022-02-28 2023-02-24 Multiple-tube pinch valve assembly
PCT/US2023/013819 Ceased WO2023164133A1 (en) 2022-02-28 2023-02-24 Multiple-tube pinch valve assembly

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2023/013819 Ceased WO2023164133A1 (en) 2022-02-28 2023-02-24 Multiple-tube pinch valve assembly

Country Status (5)

Country Link
US (2) US12209689B2 (en)
EP (2) EP4487034A4 (en)
JP (2) JP7836899B2 (en)
CN (2) CN118541557A (en)
WO (2) WO2023164137A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3135276B1 (en) * 2022-05-03 2025-07-18 Julien Maruotti Valve system for cell culture automation.
US12378105B1 (en) * 2025-05-08 2025-08-05 Pierre Vincent Boucher Beer bottling flow control apparatus

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010019705A1 (en) * 1997-09-22 2001-09-06 Waldemar Ruediger Apparatus for synthesis of multiple organic compounds with pinch valve block
DE102014116592A1 (en) * 2014-11-13 2016-05-19 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Multi-channel tube valve
WO2019155027A1 (en) * 2018-02-09 2019-08-15 General Electric Company Apparatus for fluid line management in a bioprocessing system
US20190344269A1 (en) * 2016-07-28 2019-11-14 Kyle K. Johnson Self-Contained Nucleic Acid Processing

Family Cites Families (1023)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB103930A (en) * 1916-05-24 1917-02-15 Thomas Jones Improvements in and relating to Fluid Cocks.
US2821434A (en) * 1955-11-21 1958-01-28 Edwin J Hunter Automatic irrigation control apparatus
US2997077A (en) 1959-04-06 1961-08-22 Microchemical Specialties Co Fraction collector
US3013435A (en) 1959-04-06 1961-12-19 Microchemical Specialties Co Buret
US3067915A (en) 1960-05-23 1962-12-11 Microchemical Specialties Co Liquid dispensing devices
US3191807A (en) 1961-11-13 1965-06-29 Microchemical Specialties Co Dispenser adapted for ultra-micro range
US3283727A (en) 1964-11-02 1966-11-08 Microchemical Specialties Co Liquid dispenser with automatic air purge
FR2035725A5 (en) 1969-02-26 1970-12-18 Nunc As
BE756422A (en) * 1969-09-22 1971-03-22 Technicon Instr METHOD AND DEVICE FOR SIMULTANEOUS CONTROL OF FLUID FLOW ALONG A PLURALITY OF FLOW CHANNELS
US3613729A (en) * 1970-02-16 1971-10-19 Packard Instrument Co Inc Valve system
BE793952A (en) 1972-01-14 1973-05-02 Nunc As PROCESS FOR IMPROVING THE SURFACE PROPERTIES OF AN ARTICLE SHAPED FROM A PLASTIC MATERIAL
US4037817A (en) 1975-10-28 1977-07-26 Tomlinson Industries, Inc. Pinch tube valve
US4173415A (en) 1976-08-20 1979-11-06 Science Spectrum, Inc. Apparatus and process for rapidly characterizing and differentiating large organic cells
DE2848529A1 (en) 1978-11-09 1980-05-29 Behringwerke Ag METHOD FOR PRODUCING THE REFRIGERABLE GLOBULIN AND MEDICINAL PRODUCTS CONTAINING IT
US4301118A (en) 1980-03-06 1981-11-17 Spectrum Medical Industries, Inc. Protein concentrator
US4301010A (en) 1980-03-10 1981-11-17 Spectrum Medical Industries, Inc. Vacuum filter
US4486188A (en) 1980-08-14 1984-12-04 Applied Medical Devices, Inc. Bone marrow transplant method and apparatus
US4450862A (en) 1981-02-13 1984-05-29 Syntex (U.S.A.) Inc. Pinch valve assembly
US4418691A (en) 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
US4629686A (en) 1982-02-19 1986-12-16 Endotronics, Inc. Apparatus for delivering a controlled dosage of a chemical substance
US4412990A (en) 1982-07-02 1983-11-01 Cutter Laboratories, Inc. Composition having enhanced opsonic activity
US4439901A (en) 1983-03-28 1984-04-03 Spectrum Medical Industries, Inc. Clamp
US4618586A (en) 1983-04-08 1986-10-21 Endotronics, Inc. Apparatus for administering a controlled dosage of a chemical substance having an improved culture chamber
US4478829A (en) 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
US4585654A (en) 1983-04-29 1986-04-29 Armour Pharmaceutical Co. Process for pasteurizing fibronectin
US4509695A (en) 1983-07-18 1985-04-09 Spectrum Medical Industries, Inc. Tissue pulverizer
US4484599A (en) 1983-09-23 1984-11-27 Organon Teknika Corporation Pinch-type pressure- or flow-regulating valve
AT385658B (en) 1985-03-28 1988-05-10 Serotherapeutisches Inst Wien METHOD FOR PRODUCING A FIBRONEKTIN SOLUTION SUITABLE FOR HUMAN USE
US4897358A (en) 1985-12-02 1990-01-30 Carrasco Jose I Tissue storage system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US6022742A (en) 1986-11-26 2000-02-08 Kopf; Henry B. Culture device and method
US5868930A (en) 1986-11-26 1999-02-09 Kopf; Henry B. Filtration cassette article and filter comprising same
US4885087A (en) 1986-11-26 1989-12-05 Kopf Henry B Apparatus for mass transfer involving biological/pharmaceutical media
US5593580A (en) 1986-11-26 1997-01-14 Kopf; Henry B. Filtration cassette article, and filter comprising same
US5744347A (en) 1987-01-16 1998-04-28 Ohio University Edison Biotechnology Institute Yolk sac stem cells and their uses
US5476922A (en) 1987-06-24 1995-12-19 Arch Development Corporation Methods and compositions for the preparation and use of autocrine growth factors
US5192553A (en) 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5015585A (en) 1988-02-23 1991-05-14 Robinson James R Method and apparatus for culturing and diffusively oxygenating cells on isotropic membranes
US4828706A (en) 1988-03-07 1989-05-09 Spectrum Medical Industries Process for performing a dialysis operation
WO1989009787A2 (en) 1988-04-08 1989-10-19 Creative Biomolecules, Inc. Osteogenic devices
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US5605835A (en) 1988-05-23 1997-02-25 Regents Of The University Of Minnesota Bioreactor device with application as a bioartificial liver
US5595909A (en) 1988-05-23 1997-01-21 Regents Of The University Of Minnesota Filter device
US5130141A (en) 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US4988623A (en) 1988-06-30 1991-01-29 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Rotating bio-reactor cell culture apparatus
US5240861A (en) 1988-07-29 1993-08-31 Spectrum Medical Industries, Inc. Device and process for concentrating biologic specimens in liquid form
ATE92107T1 (en) 1989-04-29 1993-08-15 Delta Biotechnology Ltd N-TERMINAL FRAGMENTS OF HUMAN SERUM ALBUMIN-CONTAINING FUSION PROTEINS.
IL94611A (en) 1989-06-05 1994-12-29 Organogenesis Inc Cell culture medium containing insulin or an insulin-like growth factor, transferrin or ferrous ion and triiodothyronine or thyroxin and a method for its use
USH1509H (en) 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
US5605822A (en) 1989-06-15 1997-02-25 The Regents Of The University Of Michigan Methods, compositions and devices for growing human hematopoietic cells
US5763266A (en) 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5635386A (en) 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US4960521A (en) 1989-06-16 1990-10-02 Andreas Keller Process for performing a dialysis operation using a magnetic weighted clamp
CA1340565C (en) 1989-06-29 1999-05-25 Thomas B. Okarma Device and process for cell capture and recovery
AU6355790A (en) 1989-08-04 1991-03-11 Peter Grandics An integrated cell culture-protein purification system for the automated production and purification of cell culture products
US5112745A (en) 1989-09-29 1992-05-12 Space Medical Systems, Inc. Rapid identification of microbial organisms and determination of antibiotic sensitivity by infrared spectroscopy
US6248319B1 (en) 1989-10-16 2001-06-19 Krisztina M. Zsebo Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides
EP0500652A4 (en) 1989-10-30 1992-12-02 California Institute Of Technology Enhancement of cell growth by expression of a cloned hemoglobin gene
US5019054A (en) 1989-11-06 1991-05-28 Mectra Labs, Inc. Medical device valving mechanism
US5149544A (en) 1989-11-13 1992-09-22 Research Corporation Technologies, Inc. Method of inhibiting progenitor cell proliferation
US5215895A (en) 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
NO168721C (en) 1989-12-20 1992-03-25 Steinar Risa APPLIANCES FOR AUTOMATIC SETTING OF BROWY STICKERS O.L.
US5169930A (en) 1990-01-05 1992-12-08 La Jolla Cancer Research Foundation Fibronectin receptor
US5834312A (en) 1990-01-29 1998-11-10 Hy-Gene, Inc. Process and media for the growth of human epithelia
US5126238A (en) 1990-02-15 1992-06-30 Unisyn Fibertec Corporation Hollow fiber cell propagation system and method
US5656421A (en) 1990-02-15 1997-08-12 Unisyn Technologies, Inc. Multi-bioreactor hollow fiber cell propagation system and method
DE4007703A1 (en) 1990-03-10 1991-09-12 Helmut Pelzer Purifying contaminated ground - by using multiple independent bio-reactors drawn in series or parallel over affected area
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
ZA912842B (en) 1990-04-16 1992-03-25 Cryopharm Corp Method of inactivation of viral and bacterial blood contaminants
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5840580A (en) 1990-05-01 1998-11-24 Becton Dickinson And Company Phenotypic characterization of the hematopoietic stem cell
US5612211A (en) 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US6326198B1 (en) 1990-06-14 2001-12-04 Regents Of The University Of Michigan Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
EP0471947A1 (en) 1990-06-29 1992-02-26 Sekisui Chemical Co., Ltd. Culture bag
US5283058A (en) 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
US5202254A (en) 1990-10-11 1993-04-13 Endotronics, Inc. Process for improving mass transfer in a membrane bioreactor and providing a more homogeneous culture environment
CA2094258A1 (en) 1990-10-18 1992-04-19 Dale Kalamasz An apparatus and method for separating particles using a pliable vessel
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5197985A (en) 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
JPH06510899A (en) 1991-02-18 1994-12-08 コンピューター セル カルチャー センター Supports for culturing cells and methods for producing such supports
CA2363965C (en) 1991-03-11 2010-05-18 Curis, Inc. Protein-induced morphogenesis
EP0578774B1 (en) 1991-04-05 1998-07-29 The Board Of Regents Of The University Of Washington Monoclonal antibodies to stem cell factor receptors
US6069005A (en) 1991-08-07 2000-05-30 Albert Einstein College Of Medicine Of Yeshwa University Hapatoblasts and method of isolating same
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5240856A (en) 1991-10-23 1993-08-31 Cellpro Incorporated Apparatus for cell separation
US5310676A (en) 1991-11-15 1994-05-10 A/S Nunc Cell cultivating device
US5240614A (en) 1992-01-10 1993-08-31 Baxter International Inc. Process for removing unwanted materials from fluids and for producing biological products
US5527467A (en) 1992-01-10 1996-06-18 Baxter International Inc. Rectifying dialyzer, bioreactor and membrane
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5549674A (en) 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US6060270A (en) 1992-03-02 2000-05-09 The University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US6410320B1 (en) 1992-03-02 2002-06-25 The University Of Michigan Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
ATE170091T1 (en) 1992-03-20 1998-09-15 Monsanto Co EXTRACTION OF ORGANIC COMPOUNDS FROM AQUEOUS SOLUTIONS
US5507949A (en) 1992-03-20 1996-04-16 Monsanto Company Supported liquid membrane and separation process employing same
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
US5436151A (en) 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5439757A (en) 1992-10-14 1995-08-08 National Power Plc Electrochemical energy storage and/or power delivery cell with pH control
US5496659A (en) 1992-10-14 1996-03-05 National Power Plc Electrochemical apparatus for energy storage and/or power delivery comprising multi-compartment cells
US5422197A (en) 1992-10-14 1995-06-06 National Power Plc Electrochemical energy storage and power delivery process utilizing iron-sulfur couple
US5545492A (en) 1992-10-14 1996-08-13 National Power Plc Electrochemical apparatus for power delivery utilizing an air electrode
US5478739A (en) 1992-10-23 1995-12-26 Advanced Tissue Sciences, Inc. Three-dimensional stromal cell and tissue culture system
JPH08506007A (en) 1992-11-16 1996-07-02 アプライド イミューン サイエンシーズ,インコーポレイテッド Pluripotent dormant stem cell population
EP1361273A3 (en) 1992-11-24 2004-02-11 G.D. Searle & Co. Interleukin-3 (IL-3) multiple mutation polypeptides
US5804446A (en) 1993-02-26 1998-09-08 The Picower Institute For Medical Research Blood-borne mesenchymal cells
US5654186A (en) 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
US6054121A (en) 1993-02-26 2000-04-25 The Picower Institute For Medical Research Modulation of immune responses in blood-borne mesenchymal cells
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
IL106255A0 (en) 1993-04-23 1993-11-15 Baxter Int Method for isolating human blood cells
US5772994A (en) 1993-05-28 1998-06-30 The University Of Pittsburgh Hematopoietic facilitatory cells and their uses
US5324428A (en) 1993-07-19 1994-06-28 Spectrum Medical Industries, Inc. Disposable dialysis apparatus
IL111181A0 (en) 1993-10-06 1994-12-29 Univ Florida Stem cell proliferation factor, its preparation, purification and uses
US5866420A (en) 1993-10-08 1999-02-02 The United States Of America As Represented By The Secretary Of Agriculture Artificial liver device
US6686198B1 (en) 1993-10-14 2004-02-03 President And Fellows Of Harvard College Method of inducing and maintaining neuronal cells
US5599703A (en) 1993-10-28 1997-02-04 The United States Of America As Represented By The Secretary Of The Navy In vitro amplification/expansion of CD34+ stem and progenitor cells
IL107483A0 (en) 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
US6432711B1 (en) 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
US6555324B1 (en) 1993-11-04 2003-04-29 Becton Dickinson & Company Method to distinguish hematopoietic progenitor cells
WO1995013088A1 (en) 1993-11-12 1995-05-18 Regents Of The University Of Minnesota Stroma-derived stem cell growth factors
US5591625A (en) 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US6451562B1 (en) 1993-12-22 2002-09-17 Human Genome Sciences, Inc. Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US5622857A (en) 1995-08-08 1997-04-22 Genespan Corporation High performance cell culture bioreactor and method
US5882918A (en) 1995-08-08 1999-03-16 Genespan Corporation Cell culture incubator
US5607844A (en) 1994-02-16 1997-03-04 University Of Pittsburgh Mammalian augmenter of liver regeneration and variants thereof
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
US5679340A (en) 1994-03-31 1997-10-21 Diacrin, Inc. Cells with multiple altered epitopes on a surface antigen for use in transplantation
GB9407048D0 (en) 1994-04-08 1994-06-01 Nat Power Plc Method for the fabrication of an electrochemical cell
ZA952384B (en) 1994-04-13 1996-09-23 Nat Power Plc Cation exchange membranes and method for the preparation of such membranes
DE4412794A1 (en) 1994-04-14 1995-12-14 Univ Ludwigs Albert Process for producing dendritic cells, cells thus obtained and containers for carrying out this process
US5543316A (en) 1994-04-20 1996-08-06 Diacrin, Inc. Injectable culture medium for maintaining viability of myoblast cells
US7033339B1 (en) 1998-05-29 2006-04-25 Becton Dickinson And Company (Part Interest) Self sealing luer receiving stopcock
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US6001647A (en) 1994-04-28 1999-12-14 Ixion Biotechnology, Inc. In vitro growth of functional islets of Langerhans and in vivo uses thereof
US5855608A (en) 1994-05-13 1999-01-05 Thm Biomedical, Inc. Device and methods for in vivo culturing of diverse tissue cells
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
CA2192103C (en) 1994-06-06 2002-02-05 Arnold I. Caplan Biomatrix for tissue regeneration
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
GB9413029D0 (en) 1994-06-29 1994-08-17 Common Services Agency Stem cell immobilisation
US6103522A (en) 1994-07-20 2000-08-15 Fred Hutchinson Cancer Research Center Human marrow stromal cell lines which sustain hematopoiesis
US5935849A (en) 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5795790A (en) 1994-07-20 1998-08-18 Cytotherapeutics, Inc. Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
US5972703A (en) 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US5840502A (en) 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US6054433A (en) 1994-11-03 2000-04-25 The Regents Of The University Of California Methods and compositions for stimulating tissue growth and epithelial moisturization
WO1996014400A1 (en) 1994-11-08 1996-05-17 Bradley Michael John Stringer Human cell-lines
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
PT793714E (en) 1994-11-16 2002-12-31 Amgen Inc USE OF THE FACTOR OF STEM CELLS AND THE INTERLEUCIN 6 RECEPTOR SOLUABLE FOR THE EX EXPANSION OF MULTI-POTENTIAL HEMATOPHOUSE CELLS
US6472200B1 (en) 1999-07-23 2002-10-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Device and method for performing a biological modification of a fluid
US6558664B1 (en) 1994-12-13 2003-05-06 Cell Factors Plc Chondrocyte cell-lines
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US7410773B2 (en) 1995-02-02 2008-08-12 Ghazi Jaswinder Dhoot Method of preparing an undifferentiated cell
US5643736A (en) 1995-02-06 1997-07-01 Osiris Therapeutics, Inc. Monoclonal antibodies for human osteogenic cell surface antigens
US5788851A (en) 1995-02-13 1998-08-04 Aksys, Ltd. User interface and method for control of medical instruments, such as dialysis machines
GB9503197D0 (en) 1995-02-18 1995-04-05 Atomic Energy Authority Uk A bioreactor
US7008634B2 (en) 1995-03-03 2006-03-07 Massachusetts Institute Of Technology Cell growth substrates with tethered cell growth effector molecules
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US7094564B1 (en) 1995-03-15 2006-08-22 Human Genome Sciences, Inc. Human tumor necrosis factor receptor
GB9505663D0 (en) 1995-03-21 1995-05-10 Stringer Bradley M J Genetically modified neural cells
US6653134B2 (en) 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US5733541A (en) 1995-04-21 1998-03-31 The Regent Of The University Of Michigan Hematopoietic cells: compositions and methods
US7429646B1 (en) 1995-06-05 2008-09-30 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like 2
BE1009306A5 (en) 1995-04-28 1997-02-04 Baxter Int Bioreactor.
US5674750A (en) 1995-05-19 1997-10-07 T. Breeders Continuous selective clonogenic expansion of relatively undifferentiated cells
US5925567A (en) 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US6495364B2 (en) 1995-05-23 2002-12-17 Neurotech, S.A. Mx-1 conditionally immortalized cells
DE19520188C2 (en) 1995-06-01 1999-04-08 Geesthacht Gkss Forschung Process for the production of polymer hollow fiber membranes
MY115206A (en) 1995-06-04 2003-04-30 Regenesys Tech Ltd Method for the preparation of cation exchange membranes doped with insoluble metal salts
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
WO1996039628A1 (en) 1995-06-06 1996-12-12 Stemcell Therapeutics L.L.C. GLYCOPROTEIN gp105 ON BL3 HEMATOPOIETIC STEM CELLS
DE69637669D1 (en) 1995-06-06 2008-10-16 Osiris Therapeutics Inc MYOGENE DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS
US5728581A (en) 1995-06-07 1998-03-17 Systemix, Inc. Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
US5655546A (en) 1995-06-07 1997-08-12 Halpern; Alan A. Method for cartilage repair
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US5877149A (en) 1995-06-07 1999-03-02 Beaulieu; Andre Deepithelialized skin diffusion cell system
US5688687A (en) 1995-06-07 1997-11-18 Aastrom Biosciences, Inc. Bioreactor for mammalian cell growth and maintenance
US6015554A (en) 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US6238908B1 (en) 1995-06-07 2001-05-29 Aastrom Biosciences, Inc. Apparatus and method for maintaining and growth biological cells
US6117985A (en) 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US6306575B1 (en) 1995-06-16 2001-10-23 Stemcell Technologies, Inc. Methods for preparing enriched human hematopoietic cell preparations
CA2180222C (en) 1995-06-30 2006-10-10 Masaaki Shimagaki Polysulfone hollow fiber semipermeable membrane
US5627070A (en) 1995-07-26 1997-05-06 Celltherapy, Inc. Cell growing device for in vitro cell population expansion
WO1997005826A1 (en) 1995-08-08 1997-02-20 Laser Centers Of America System for extracting tissue samples in laparoscopy
US5705534A (en) 1995-09-22 1998-01-06 National Power Plc Method for the preparation of cation exchange membranes doped with insoluble metal salts
US5780300A (en) 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
US5855613A (en) 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
US5700289A (en) 1995-10-20 1997-12-23 North Shore University Hospital Research Corporation Tissue-engineered bone repair using cultured periosteal cells
US5858782A (en) 1995-11-13 1999-01-12 Regents Of The University Of Michigan Functional human hematopoietic cells
EP0877941B1 (en) 1995-11-13 2003-02-26 Biotransplant, Inc Method for bulk enrichment of a population or subpopulation of cells
WO1997018298A1 (en) 1995-11-14 1997-05-22 Regents Of The University Of Minnesota Ex vivo culture of stem cells
CA2237890C (en) 1995-11-16 2011-03-29 Case Western Reserve University In vitro chondrogenic induction of human mesenchymal stem cells
IT1282207B1 (en) 1995-11-20 1998-03-16 Fidia Advanced Biopolymers Srl HUMAN BONE MARROW STEM CELL CULTURE SYSTEMS IN THREE-DIMENSIONAL MATRIXES CONSISTING OF HYALURONIC ACID ESTERS
US6482231B1 (en) 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
US5658995A (en) 1995-11-27 1997-08-19 Rutgers, The State University Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
GB9526577D0 (en) 1995-12-28 1996-02-28 Nat Power Plc Method for the fabrication of electrochemical cells
US6200606B1 (en) 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US6322786B1 (en) 1996-02-15 2001-11-27 Kansas University Medical Center Research Institute, Inc. Method of producing bone-inducing agent
EP0885020A1 (en) 1996-02-20 1998-12-23 Cohesion Corporation Tissue sealant compositions and methods of use thereof
US5842477A (en) 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
CA2198978A1 (en) 1996-03-01 1997-09-01 Clemens Antoni Van Blitterswijk Method for the in vitro production of bone
EP0891419A4 (en) 1996-03-12 2000-03-01 Life Technologies Inc ADDITIVE FOR NUTRITIVE CULTURE MEDIA FOR HEMATOPOIETIC CELLS
US6479254B2 (en) 1996-03-22 2002-11-12 Human Genome Sciences, Inc. Apoptosis inducing molecule II
US20010017188A1 (en) 1996-04-10 2001-08-30 Cooley Graham Edward Process for the fabrication of electrochemical cell components
AU2730497A (en) 1996-04-17 1997-11-07 Case Western Reserve University Cryopreservation and extensive subculturing of human mesenchymal stem cells
ATE439849T1 (en) 1996-04-19 2009-09-15 Osiris Therapeutics Inc THE RESTORATION AND STRENGTHENING OF BONE USING MESENCHYMAL STEM CELLS
US6455678B1 (en) 1996-04-26 2002-09-24 Amcell Corporation Human hematopoietic stem and progenitor cell antigen
JP2000508922A (en) 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ Skin regeneration using mesenchymal stem cells
US5843633A (en) 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
JPH09303582A (en) * 1996-05-10 1997-11-25 Mitsubishi Heavy Ind Ltd Multipe small type pinch valve
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US6165785A (en) 1996-05-24 2000-12-26 University Of Cincinnati Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications
EP0907721A1 (en) 1996-05-28 1999-04-14 Brown University Research Foundation Hyaluronan based biodegradable scaffolds for tissue repair
DE59710789D1 (en) 1996-06-04 2003-10-30 Sulzer Orthopedics Ltd METHOD FOR PRODUCING CARTILAGE TISSUE AND IMPLANTS
US5824084A (en) 1996-07-03 1998-10-20 The Cleveland Clinic Foundation Method of preparing a composite bone graft
US6145688A (en) 1996-07-17 2000-11-14 Smith; James C. Closure device for containers
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US6458585B1 (en) 1996-08-14 2002-10-01 Nexell Therapeutics Inc. Cytokine-free culture of dendritic cells
GB9617058D0 (en) 1996-08-14 1996-09-25 Sandoz Ltd Organic compounds
US6787355B1 (en) 1996-08-26 2004-09-07 Mcgill University Multipotent neural stem cells from peripheral tissues and uses thereof
US5989269A (en) 1996-08-30 1999-11-23 Vts Holdings L.L.C. Method, instruments and kit for autologous transplantation
US5667985A (en) 1996-09-24 1997-09-16 Becton Dickinson And Company Tissue biopsy cell suspender for cell analysis
US6150164A (en) 1996-09-30 2000-11-21 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US5980887A (en) 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
ATE336240T1 (en) 1996-11-13 2006-09-15 Cold Spring Harbor Lab THERAPEUTIC USE OF NITROGEN MONOXYDINHIBITORS
US6372796B1 (en) 1996-11-13 2002-04-16 Cold Spring Harbor Laboratory Therapeutic uses for nitric oxide inhibitors
CA2271758A1 (en) 1996-11-15 1998-05-22 Osiris Therapeutics, Inc. Msc-megakaryocyte precursor composition and method of isolating mscs associated with isolated megakaryocytes by isolating megakaryocytes
US5928945A (en) 1996-11-20 1999-07-27 Advanced Tissue Sciences, Inc. Application of shear flow stress to chondrocytes or chondrocyte stem cells to produce cartilage
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
US6331409B1 (en) 1996-11-21 2001-12-18 The Regents Of The University Of Michigan Methods and compositions for wound healing
US6120491A (en) 1997-11-07 2000-09-19 The State University Rutgers Biodegradable, anionic polymers derived from the amino acid L-tyrosine
US6084060A (en) 1996-12-09 2000-07-04 Imclone Systems Incorporated Composition and method for preserving progenitor cells
AU732726B2 (en) 1996-12-10 2001-04-26 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US6114307A (en) 1996-12-16 2000-09-05 Zymogenetics, Inc. Methods for stimulating pancreatic islet cell regeneration
US5766944A (en) 1996-12-31 1998-06-16 Ruiz; Margaret Eileen T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments
JP2001505060A (en) 1997-01-14 2001-04-17 ヒューマン ジノーム サイエンシーズ,インコーポレイテッド Tumor necrosis factor receptor 5
AU716137B2 (en) 1997-01-16 2000-02-17 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
US20020031757A1 (en) 1997-01-24 2002-03-14 Asahi Medical Co., Ltd. Method of regenerating a tissue
PT1012274E (en) 1997-01-28 2007-08-14 Craig A Rosen Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l)
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
JP4388602B2 (en) 1997-02-07 2009-12-24 ストライカー コーポレイション Bone-forming device not containing matrix, graft, and method of use thereof
US6632425B1 (en) 1997-03-20 2003-10-14 Human Genome Sciences, Inc. Chemokine compositions
WO1998042838A1 (en) 1997-03-25 1998-10-01 Morphogenesis, Inc. Universal stem cells
WO1998051812A2 (en) 1997-05-12 1998-11-19 Metabolix, Inc. Polyhydroxyalkanoates for in vivo applications
EP0989855A4 (en) 1997-05-13 2002-06-12 Osiris Therapeutics Inc REGENERATION OF CARTILAGE IN ARTHROSIS USING HUMAN MESENCHYMAL STEM CELLS
WO1998051785A1 (en) 1997-05-14 1998-11-19 The General Hospital Corporation Co-cultivation of cells in a micropatterned configuration
US5955353A (en) 1997-05-22 1999-09-21 Excorp Medical, Inc. Hollow fiber bioreactor with an extrafilament flow plug
US5853247A (en) 1997-05-27 1998-12-29 Shroyer; John Bruce Sample bag container
US5783075A (en) 1997-06-23 1998-07-21 Spectrum Medical Laboratories, Inc. Disposable dialyzer apparatus
US6310195B1 (en) 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US6979307B2 (en) 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US5913859A (en) 1997-07-01 1999-06-22 Shapira; Ira L. Apparatus for extracting bone marrow
EP1009944A4 (en) * 1997-07-03 2004-06-30 Prec Dispensing Systems Ltd FLEXIBLE TUBE PINCHING MECHANISM
DE69837491T2 (en) 1997-07-03 2008-01-17 Osiris Therapeutics, Inc. HUMAN MESENCHYMAL STEM CELLS OF PERIPHERAL BLOOD
US6387369B1 (en) 1997-07-14 2002-05-14 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US7514074B2 (en) 1997-07-14 2009-04-07 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
DE69805920T2 (en) 1997-07-16 2003-01-02 Isotis N.V., Bilthoven Bone treatment device consisting of degradable thermoplastic copolyester and cultured cells
TWI239352B (en) 1997-07-23 2005-09-11 Takara Bio Inc Gene transfer method with the use of serum-free medium
AU8662798A (en) 1997-07-28 1999-02-16 Academy Of Finland Collagen type i and type iii adhesive compositions
US6001643A (en) 1997-08-04 1999-12-14 C-Med Inc. Controlled hydrodynamic cell culture environment for three dimensional tissue growth
EP0896825B1 (en) 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
US6511958B1 (en) 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
US6908763B1 (en) 1997-08-22 2005-06-21 The Board Of Trustees Of The Leland Stanford Junior University Mammalian common lymphoid progenitor cell
AU9127098A (en) 1997-09-04 1999-03-22 Osiris Therapeutics, Inc. Ligands that modulate differentiation of mesenchymal stem cells
EP1003847A4 (en) 1997-09-04 2005-04-06 Science Res Lab Inc CELL SEPARATION BY ELECTRIC FIELDS
US6149906A (en) 1997-09-20 2000-11-21 Osiris Therapeutics, Inc. Antigen presenting cells of the adipocyte lineage
US6440734B1 (en) 1998-09-25 2002-08-27 Cytomatrix, Llc Methods and devices for the long-term culture of hematopoietic progenitor cells
ATE357509T1 (en) 1997-09-29 2007-04-15 Point Therapeutics Inc STIMULATION OF HEMATOPOIETIC CELLS IN VITRO
US6194168B1 (en) 1997-09-30 2001-02-27 Human Genome Sciences, Inc. Expression control sequences
US6429012B1 (en) 1997-10-06 2002-08-06 Viacell, Inc. Cell population containing non-fetal hemangioblasts and method for producing same
US5998184A (en) 1997-10-08 1999-12-07 Unisyn Technologies, Inc. Basket-type bioreactor
US6649631B1 (en) 1997-10-23 2003-11-18 The Board Of Regents Of The University Of Texas System Compositions and methods for treating bone deficit conditions
CA2307807C (en) 1997-10-23 2008-09-02 Andrea G. Bodnar Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
AU1203999A (en) 1997-10-31 1999-05-24 Osiris Therapeutics, Inc. Human slit polypeptide and polynucleotides encoding same
AU737151B2 (en) 1997-11-07 2001-08-09 Rutgers, The State University Radio-opaque polymeric biomaterials government license rights
US6576465B1 (en) 1997-11-10 2003-06-10 The Regents Of The University Of Michigan Human bone accessory cells
US6001585A (en) 1997-11-14 1999-12-14 Cellex Biosciences, Inc. Micro hollow fiber bioreactor
US6475481B2 (en) 1997-11-18 2002-11-05 Canji Inc Purging of stem cell products
US6248587B1 (en) 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
GB9724879D0 (en) 1997-11-26 1998-01-21 Univ London Process for the production of protein and products thereof
WO1999028486A1 (en) 1997-12-04 1999-06-10 Duke University Methods of isolating and using cd7+cd34-lin-hematopoietic cells
US6082364A (en) 1997-12-15 2000-07-04 Musculoskeletal Development Enterprises, Llc Pluripotential bone marrow cell line and methods of using the same
EP1215497B1 (en) 1997-12-16 2009-01-07 University Of Zurich Diagnostics for transmissible spongiform encephalopathy
CA2315741A1 (en) 1997-12-29 1999-07-08 Monsanto Company A membrane process for making enhanced flavor fluids
US6171548B1 (en) 1997-12-29 2001-01-09 Spectrum Environmental Technologies, Inc. Surface and air sterilization using ultraviolet light and ultrasonic waves
US6074366A (en) 1998-01-16 2000-06-13 Tandem Medical Inc. Medication delivery apparatus
US6852533B1 (en) 1998-01-23 2005-02-08 Cornell Research Foundation, Inc. Purified populations of stem cells
US6653105B2 (en) 1998-02-11 2003-11-25 Vitagen, Inc. Clonal cells and cell lines derived from C3A cells and methods of making and using them
US6962698B1 (en) 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US20020034819A1 (en) 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
AU749675B2 (en) 1998-03-13 2002-07-04 Mesoblast International Sarl Uses for human non-autologous mesenchymal stem cells
US6328960B1 (en) 1998-03-18 2001-12-11 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
DE69903800T2 (en) 1998-03-18 2003-10-02 Massachusetts Institute Of Technology, Cambridge VASCULARIZED PERFUNDED ARRANGEMENTS FOR MICRO TISSUE AND MICROORGANES
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
AU3112499A (en) 1998-03-23 1999-10-18 Zymogenetics Inc. Cardiac-derived stem cells
US6143293A (en) 1998-03-26 2000-11-07 Carnegie Mellon Assembled scaffolds for three dimensional cell culturing and tissue generation
PT1066060E (en) 1998-04-03 2003-12-31 Osiris Therapeutics Inc MESENCHINEAL STAMINA CELLS AS IMMUNOSUPRESSORS
US5882929A (en) 1998-04-07 1999-03-16 Tissue Engineering, Inc. Methods and apparatus for the conditioning of cartilage replacement tissue
US5882295A (en) 1998-04-13 1999-03-16 Spectrum Medical Industries, Inc. Video camera drape
US6071691A (en) 1998-04-27 2000-06-06 Oregon Health Science University Materials and methods for modulating differentiation
GB2337150B (en) 1998-05-07 2000-09-27 Nat Power Plc Carbon based electrodes
AU3888699A (en) 1998-05-07 1999-11-23 University Of South Florida Bone marrow cells as a source of neurons for brain and spinal cord repair
AU765085B2 (en) 1998-05-11 2003-09-11 Miltenyi Biotec Gmbh Method of direct selection of antigen-specific T cells
US6835377B2 (en) 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
EP1078042A1 (en) 1998-05-22 2001-02-28 Osiris Therapeutics, Inc. Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
AU4219899A (en) 1998-05-28 1999-12-13 President And Fellows Of Harvard College Methods and compositions relating to modulation of cartilage cell growth and/or differentiation by modulation of nfatp activity
AU4221399A (en) 1998-05-29 1999-12-13 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
JP2002516085A (en) 1998-05-29 2002-06-04 トーマス・ジェファーソン・ユニバーシティ Compositions and uses that affect hematopoietic stem cell populations in mammals
EP1108011A2 (en) 1998-06-08 2001-06-20 Osiris Therapeutics, Inc. In vitro maintenance of hematopoietic stem cells
JP2003505006A (en) 1998-06-08 2003-02-12 オシリス セラピューティクス,インコーポレイテッド Regulation of hematopoietic stem cell differentiation by using human mesenchymal stem cells
RU2139085C1 (en) 1998-06-23 1999-10-10 Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" Agent stimulating reparative processes and method of its use
US6414219B1 (en) 1998-06-30 2002-07-02 Rutgers, The State University Of New Jersey Osteopontin knock-out mouse and methods of use thereof
US20090047289A1 (en) 1998-06-30 2009-02-19 Denhardt David T Osteopontin Specific Antibodies and Methods of Use Thereof
US6129911A (en) 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
GB9815173D0 (en) 1998-07-13 1998-09-09 Nat Power Plc Process for the removal of sulphate ions
US6258778B1 (en) 1998-07-13 2001-07-10 University Of Southern California Methods for accelerating bone and cartilage growth and repair
DE19833476B4 (en) 1998-07-24 2005-08-25 Huss, Ralf, Dr. Genetically modified CD34 negatives, adherently growing hematopoietic stem cells and their use in gene therapy
IL125532A0 (en) 1998-07-27 1999-03-12 Yeda Res & Dev Hematopoietic cell composition for use in transplantation
US6677306B1 (en) 1998-07-29 2004-01-13 Northwestern University Chondrogenic and osteogenic inducing molecule
US20020015724A1 (en) 1998-08-10 2002-02-07 Chunlin Yang Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
AU5671899A (en) 1998-08-10 2000-03-06 Fibrogen, Inc. Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
US6703209B1 (en) 1998-08-13 2004-03-09 Biotransplant, Inc. Porcine totipotent cells and method for long-term culture
US6849255B2 (en) 1998-08-18 2005-02-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods and compositions for enhancing cartilage repair
US6894022B1 (en) 1998-08-27 2005-05-17 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US6767737B1 (en) 1998-08-31 2004-07-27 New York University Stem cells bearing an FGF receptor on the cell surface
GB9820109D0 (en) 1998-09-15 1998-11-11 Nat Power Plc Vitrified carbon compositions
CZ2001915A3 (en) 1998-09-15 2001-09-12 Regenesys Technologies Limited Process for preparing cross-linked monomer grafted polymer
US7338798B2 (en) 1998-09-15 2008-03-04 The Regents Of The University Of Michigan System and method for forming a cardiac muscle construct
AU766735B2 (en) 1998-09-15 2003-10-23 Isotis N.V. Osteoinduction
GB2341601B (en) 1998-09-15 2000-07-26 Nat Power Plc Process for the preparation of reticulated copper or nickel sulfide
US6569654B2 (en) 1998-09-18 2003-05-27 Massachusetts Institute Of Technology Electroactive materials for stimulation of biological activity of stem cells
AU6056299A (en) 1998-09-21 2000-04-10 Musc Foundation For Research Development Non-hematopoietic cells, including cardiomyocytes and skeletal muscle cells, derived from hematopoietic stem cells and methods of making and using them
GB9821156D0 (en) 1998-09-29 1998-11-25 Nat Power Plc Manufacturable electrochemical cell
US6632934B1 (en) 1998-09-30 2003-10-14 Board Of Regents, The University Of Texas System MORC gene compositions and methods of use
JP2000106882A (en) 1998-10-02 2000-04-18 Chemo Sero Therapeut Res Inst Plasma protein fragment-producing enzyme having cancer metastasis growth inhibitory activity and plasma protein fragment fragmented by the enzyme
US20070166834A1 (en) 1998-10-05 2007-07-19 Biopath Automation, L.L.C. Apparatus and method for harvesting and handling tissue samples for biopsy analysis
US8026096B1 (en) 1998-10-08 2011-09-27 Protein Sciences Corporation In vivo active erythropoietin produced in insect cells
AU768641B2 (en) 1998-10-12 2003-12-18 Massachusetts Institute Of Technology Composites for tissue regeneration and methods of manufacture thereof
AU770729B2 (en) 1998-10-21 2004-02-26 Steven Jay Smith Protein quantitation with cell imaging densitometry
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US7410798B2 (en) 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
CA2348687A1 (en) 1998-11-09 2000-05-18 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Serum free medium for chondrocyte-like cells
CA2348514A1 (en) 1998-11-13 2000-05-25 Osiris Therapeutics, Inc. In utero transplantation of human mesenchymal stem cells
WO2000029001A1 (en) 1998-11-13 2000-05-25 Osiris Therapeutics, Inc. Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation
US6761887B1 (en) 1998-11-16 2004-07-13 Osiris Therapeutics, Inc. Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells
US6184035B1 (en) 1998-11-18 2001-02-06 California Institute Of Technology Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
GB9826658D0 (en) 1998-12-03 1999-01-27 Univ London Tissue repair
US6328765B1 (en) 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6642049B1 (en) 1998-12-04 2003-11-04 The United States Of America As Represented By The Secretary Of The Navy Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cells
GB2346006B (en) 1999-01-20 2001-01-31 Nat Power Plc Method of carrying out electrochemical reactions
ES2147163B1 (en) 1999-01-25 2001-03-01 Esp Farmaceuticas Centrum Sa A PHARMACEUTICAL COMPOSITION WITH REGULATORY ACTIVITY OF THE EXPRESSION OF THE ADHESION MOLECULES.
US6627191B1 (en) 1999-01-25 2003-09-30 Seattle Biomedical Research Institute Anti-transforming growth factor Beta (TGF-β) treated stem cell composition and method
AU781750B2 (en) 1999-02-04 2005-06-09 Mcgill University Platform for the differentiation of cells
BR0009403A (en) 1999-02-04 2001-11-27 Technion Res & Dev Foundation Method of expansion / conservation of undifferentiated hemopoietic stem cells or progenitor cells, method of preparing a conditioned stomach cell medium useful in the expansion / conservation of undifferentiated hemopoietic stem cells or progenitor cells, method of transplanting undifferentiated hemopoietic stem cells or progenitor cells into a container , buffer of bioreactor and bioreactor
WO2000047720A2 (en) 1999-02-10 2000-08-17 Curis, Inc. Pancreatic progenitor cells, methods and uses related thereto
US6767738B1 (en) 1999-02-11 2004-07-27 The Salk Institute For Biological Studies Method of isolating adult mammalian CNS-derived progenitor stem cells using density gradient centrifugation
US6468794B1 (en) 1999-02-12 2002-10-22 Stemcells, Inc. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
US6376742B1 (en) 1999-02-17 2002-04-23 Richard J. Zdrahala In vivo tissue engineering with biodegradable polymers
US6821790B2 (en) 1999-03-02 2004-11-23 Vijay Mahant Methods and apparatus for separation of biological fluids
EP1173744A4 (en) 1999-03-02 2002-10-16 Qualigen Inc Methods and apparatus for separation of biological fluids
KR100979664B1 (en) 1999-03-10 2010-09-02 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 Adipose-derived stem cells and lattices
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
AU3881100A (en) 1999-03-15 2000-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like genes
WO2000056405A2 (en) 1999-03-22 2000-09-28 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like 2
US6662805B2 (en) 1999-03-24 2003-12-16 The Johns Hopkins University Method for composite cell-based implants
GB9907243D0 (en) 1999-03-29 1999-05-26 Reneuron Ltd Therapy
US20040131601A1 (en) 2000-03-30 2004-07-08 Foundry Networks, Inc., A Delaward Corporation Injection of bone marrow-derived cells and medium for angiogenesis
EP1163338A2 (en) 1999-04-01 2001-12-19 Osiris Therapeutics, Inc. HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS
US20030007954A1 (en) 1999-04-12 2003-01-09 Gail K. Naughton Methods for using a three-dimensional stromal tissue to promote angiogenesis
US7759113B2 (en) 1999-04-30 2010-07-20 The General Hospital Corporation Fabrication of tissue lamina using microfabricated two-dimensional molds
US6423681B1 (en) 1999-05-04 2002-07-23 The Trustees Of Columbia University In The City Of New York Method of inducing formation of kidney epithelia from mesenchymal precursors
WO2000068689A1 (en) 1999-05-10 2000-11-16 Prolinx Inc. Cell separation device and methods for use
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6339141B1 (en) 1999-05-20 2002-01-15 Hycey Inc. Interleukin-1 Hy2 materials and methods
US6312952B1 (en) 1999-05-27 2001-11-06 The Research Foundation Of State University Of New York In vitro cell culture device including cartilage and methods of using the same
US7135335B2 (en) 1999-05-28 2006-11-14 Stemcell Technologies Inc. Method for separating cells using immunorosettes
GB9913185D0 (en) 1999-06-07 1999-08-04 Nat Power Plc Sulfur precipitation detector
GB2350895B (en) 1999-06-07 2001-08-29 Nat Power Plc Methods for monitoting sulfonyl halide functional group content of materials
AU6403700A (en) 1999-06-15 2001-01-02 Genetrol Biotherapeutics, Inc. Methods for enhancing the production of cytokines in cell culture
WO2000078920A1 (en) 1999-06-21 2000-12-28 The General Hospital Corporation Methods and devices for cell culturing and organ assist systems
DE60036385T2 (en) 1999-06-21 2008-06-26 The General Hospital Corp., Boston CELL CULTURE SYSTEMS AND METHOD FOR ORGAN SUPPORT INSTITUTIONS
US6821513B1 (en) 1999-06-23 2004-11-23 Oregon Health & Science University Method for enhancing hematopoiesis
WO2001000783A2 (en) 1999-06-25 2001-01-04 Advanced Tissue Sciences, Inc. Monitorable three-dimensional scaffolds and tissue culture systems
US6761883B2 (en) 1999-06-29 2004-07-13 The Board Of Trustees Of The Leland Stanford Junior University Mammalian myeloid progenitor cell subsets
CA2375974C (en) 1999-06-29 2010-11-02 The Board Of Trustees Of The Leland Stanford Junior University Mammalian myeloid progenitor cell subsets
US6306424B1 (en) 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6333029B1 (en) 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
GB9915413D0 (en) 1999-07-01 1999-09-01 Glaxo Group Ltd Propagation method
PT1192680E (en) 1999-07-02 2004-04-30 Regenesys Tech Ltd ELECTROLYTE RE-BALANCE SYSTEM
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
US20050158289A1 (en) 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US6872389B1 (en) 1999-07-08 2005-03-29 Rhode Island Hospital Liver stem cell
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
ATE408667T1 (en) 1999-07-20 2008-10-15 Univ Southern California IDENTIFICATION OF PLURIPOTENT PREMESENCHYMAL, PREHEMOTOPOIETIC PRONECTOR CELLS
EP1200110B1 (en) 1999-07-22 2014-04-23 Organogenesis Inc. In vivo induction for enhanced function of isolated hepatocytes
ATE440602T1 (en) 1999-07-28 2009-09-15 Univ Leland Stanford Junior NICOTINE RECEPTOR AGONISTS IN STEM CELLS AND PROGRESSOR CELL INDUCTION
ES2313900T3 (en) 1999-07-28 2009-03-16 The Board Of Trustees Of The Leland Stanford Junior University NICOTINE IN ANGIOGENESIS AND THERAPEUTIC VASCULOGENESIS.
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US7927587B2 (en) 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2001011011A2 (en) 1999-08-05 2001-02-15 Mcl Llc Multipotent adult stem cells and methods for isolation
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
WO2002064748A2 (en) 2001-02-14 2002-08-22 Furcht Leo T Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US6719969B1 (en) 1999-08-09 2004-04-13 The Regents Of The University Of Michigan Treatment of liver disease and injury with CXC chemokines
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
AU6934600A (en) 1999-08-27 2001-03-26 Board Of Regents, The University Of Texas System Cd40 ligand and cd40 agonist compositions and methods of use
ATE346911T1 (en) 1999-09-07 2006-12-15 Tyco Healthcare SUPPORT MATERIAL FOR GROWING CELLS
EP1087010B1 (en) 1999-09-08 2011-11-09 Levitronix LLC Bioreactor with single-use pump
US6239157B1 (en) 1999-09-10 2001-05-29 Osiris Therapeutics, Inc. Inhibition of osteoclastogenesis
EP1218487A2 (en) 1999-09-23 2002-07-03 Cell Science Therapeutics Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
WO2001021767A2 (en) 1999-09-24 2001-03-29 Morphogen Pharmaceuticals, Inc. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
WO2001022810A2 (en) 1999-09-28 2001-04-05 Us Transgenics, Inc. Transgenic animals expressing von willebrand factor (vwf) and vwf-related polypeptides
US6528052B1 (en) 2000-09-29 2003-03-04 The Board Of Trustees Of The Leland Stanford Junior University Method for in vivo ex vivo and in vitro repair and regeneration of cartilage and collagen and bone remodeling
DE19948184C2 (en) 1999-10-06 2001-08-09 Fraunhofer Ges Forschung Electrochemical production of peroxodisulfuric acid using diamond coated electrodes
EP1282690B9 (en) 1999-10-06 2005-03-02 Tigenix N.V. Isolation of precursor cells and their use for tissue repair
US6685936B2 (en) 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US6599520B2 (en) 1999-10-14 2003-07-29 Osteotech, Inc. Method of inducing new bone growth in porous bone sites
CA2387580A1 (en) 1999-10-15 2001-04-26 Mount Sinai Hospital Synthetic substrate for tissue formation
AU781449B2 (en) 1999-10-29 2005-05-26 Philadelphia Health & Education Corporation Isolation and expansion of human marrow stromal cells
US20050037490A1 (en) 1999-10-29 2005-02-17 Lawrence Rosenberg Medium for preparing dedifferentiated cells
US20040033599A1 (en) 1999-10-29 2004-02-19 Lawrence Rosenberg Medium for preparing dedifferentiated cells
US6280718B1 (en) 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
US20010044413A1 (en) 1999-12-01 2001-11-22 Glenn Pierce In situ bioreactors and methods of use thereof
CA2392615A1 (en) 1999-12-06 2001-06-07 The General Hospital Corporation Pancreatic stem cells and their use in transplantation
US6541249B2 (en) 1999-12-22 2003-04-01 Human Genome Sciences, Inc. Immortalized human stromal cell lines
WO2001048147A1 (en) 1999-12-28 2001-07-05 Iso Tis N.V. Cell culture medium containing growth factors and l-glutamine
US6811776B2 (en) 2000-12-27 2004-11-02 The Regents Of The University Of Michigan Process for ex vivo formation of mammalian bone and uses thereof
US20020142457A1 (en) 1999-12-28 2002-10-03 Akihiro Umezawa Cell having the potentiality of differentiation into cardiomyocytes
US6479064B1 (en) 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6428802B1 (en) 1999-12-29 2002-08-06 Children's Medical Center Corp. Preparing artificial organs by forming polylayers of different cell populations on a substrate
US6368859B1 (en) 1999-12-29 2002-04-09 Children's Medical Center Corporation Methods and compositions for producing a fascial sling
US20020063763A1 (en) 2000-11-29 2002-05-30 Mantell David Allen Apparatus and method for removing air bubbles from an ink jet printhead
AU784361C (en) 1999-12-30 2007-03-15 Imclone Systems Incorporated Progenitor cell preservation factors and related methods and products
US6544506B2 (en) 2000-01-05 2003-04-08 Yeda Research & Development Co. Ltd. Veto cells effective in preventing graft rejection and devoid of graft versus host potential
US7455983B2 (en) 2000-01-11 2008-11-25 Geron Corporation Medium for growing human embryonic stem cells
EP1248519A4 (en) 2000-01-18 2004-03-31 Univ Leland Stanford Junior AMPLIFICATION OF STEM CELLS OR PRECURSORS BY BETA-CATENIN
CA2389924A1 (en) 2000-01-24 2001-07-26 Jozef S. Mruk Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes
DE60143078D1 (en) 2000-01-31 2010-10-28 Uwe Waldemar Rothenpieler PAX2 FOR THE TREATMENT OF KIDNEY DISEASES
US6770478B2 (en) 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
US6610535B1 (en) 2000-02-10 2003-08-26 Es Cell International Pte Ltd. Progenitor cells and methods and uses related thereto
US6797514B2 (en) 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
EP1261694B1 (en) 2000-02-26 2008-01-16 Artecel, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
AU2001239947A1 (en) 2000-02-29 2001-09-12 Curis, Inc. Methods and compositions for regulating adipocytes
US6630153B2 (en) 2001-02-23 2003-10-07 Smith & Nephew, Inc. Manufacture of bone graft substitutes
US6849454B2 (en) 2000-03-07 2005-02-01 St. Jude Children's Research Hospital Highly efficient gene transfer into human repopulating stem cells by RD114 pseudotyped retroviral vector particles
US7160724B2 (en) 2000-03-09 2007-01-09 University Of South Florida Human cord blood as a source of neural tissue for repair of the brain and spinal cord
US6607522B1 (en) 2000-03-16 2003-08-19 General Hospital Corporation Methods for tissue welding using laser-activated protein solders
US20010049139A1 (en) 2000-03-23 2001-12-06 Eric Lagasse Hepatic regeneration from hematopoietic stem cells
GB2362752B (en) 2000-03-24 2002-06-05 Innogy Ltd Method of operating a fuel cell
GB2365964B (en) 2000-03-24 2002-07-10 Innogy Ltd Membrane moisture measurement
US7008394B2 (en) 2000-03-29 2006-03-07 Bioaccess, Inc. System and method for processing bone marrow
US6683192B2 (en) 2000-03-30 2004-01-27 Curis, Inc. Small organic molecule regulators of cell proliferation
GB2360789A (en) 2000-03-30 2001-10-03 Christopher Mason Method of producing tissue structures
US6613798B1 (en) 2000-03-30 2003-09-02 Curis, Inc. Small organic molecule regulators of cell proliferation
US6673606B1 (en) 2000-04-12 2004-01-06 The Children's Hospital Of Philadelphia Therapeutic uses for mesenchymal stromal cells
US7195711B2 (en) 2000-04-13 2007-03-27 Transvivo Inc. Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration
US7572374B2 (en) 2000-04-13 2009-08-11 Transvivo, Inc. Anticoagulant and thrombo-resistant hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration
US6802820B1 (en) 2000-04-13 2004-10-12 Transvivo, Inc. Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration
US7585412B2 (en) 2000-04-13 2009-09-08 Transvivo, Inc. Specialized hollow fiber membranes for plasmapheresis and ultrafiltration
GB0009506D0 (en) 2000-04-17 2000-06-07 Innogy Ltd Ion exchange membrane
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US7473555B2 (en) 2000-04-27 2009-01-06 Geron Corporation Protocols for making hepatocytes from embryonic stem cells
DE60120151D1 (en) 2000-04-28 2006-07-06 Childrens Medical Center ISOLATION OF MESENCHYMAL STEM CELLS AND THEIR USE
US6828145B2 (en) 2000-05-10 2004-12-07 Cedars-Sinai Medical Center Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
US20040087016A1 (en) 2000-05-12 2004-05-06 University Of Utah Research Foundation Compositions and methods for cell dedifferentiation and tissue regeneration
US6988004B2 (en) 2000-05-16 2006-01-17 Bioheart, Inc. Method for inducing angiogenesis by electrical stimulation of muscles
US8273570B2 (en) 2000-05-16 2012-09-25 Riken Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
WO2001088104A2 (en) 2000-05-17 2001-11-22 Geron Corporation Neural progenitor cell populations
CA2346362C (en) 2000-05-26 2010-06-15 Stemcell Technologies Inc. Novel antibody compositions for preparing enriched mesenchymal progenitor preparations
DE10026482A1 (en) 2000-05-29 2001-12-13 Augustinus Bader Process for the production of a bioartificial graft
US6767699B2 (en) 2000-05-31 2004-07-27 Chiron Corporation Method for the quantitation of alphavirus replicon particles
US7049072B2 (en) 2000-06-05 2006-05-23 University Of South Florida Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
WO2001094541A2 (en) 2000-06-05 2001-12-13 University Of South Florida Human mesenchymal progenitor cell
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
US6632620B1 (en) 2000-06-22 2003-10-14 Andrew N. Makarovskiy Compositions for identification and isolation of stem cells
WO2001097872A1 (en) 2000-06-22 2001-12-27 Austin Sam L Bioadhesive compositions and methods of preparation and use
EP1302534A4 (en) 2000-06-26 2004-06-16 Renomedix Inst Inc CELL FRACTIONS CONTAINING CELLS CAPABLE OF DIFFERENCING INTO NEURAL CELLS
BR0111948A (en) 2000-06-26 2004-08-24 Rxkinetix Inc Composition for delivery of hematopoietic growth factor
US6759039B2 (en) 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
EP1301525B1 (en) 2000-07-06 2015-09-02 Sarepta Therapeutics, Inc. Transforming growth factor beta (tgf-beta) blocking agent-treated stem cell composition and method
US6719970B1 (en) 2000-07-10 2004-04-13 Alkermes Controlled Therapeutics, Inc. Method of generating cartilage
DE20012003U1 (en) 2000-07-11 2000-10-12 Braun, Michael, 71522 Backnang Device for introducing particles into a body tissue, in particular muscle tissue
AU2001273421A1 (en) 2000-07-13 2002-01-30 Bioheart, Inc. Deployment system for myocardial cellular material
US20030032143A1 (en) 2000-07-24 2003-02-13 Neff Thomas B. Collagen type I and type III compositions for use as an adhesive and sealant
WO2002008389A2 (en) 2000-07-26 2002-01-31 Scimed Life Systems, Inc. Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
JP2004504834A (en) 2000-08-01 2004-02-19 イスム リサーチ ディベロップメント カンパニー Directed differentiation of embryonic cells
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
CA2456008A1 (en) 2000-08-19 2002-02-28 Axordia Limited Stem cell differentiation
EP1312668A4 (en) 2000-08-25 2004-07-07 Asahi Chemical Ind STEM CELL CULTURE MEDIUM AND CULTURE METHOD USING SAME
DE10042484A1 (en) 2000-08-29 2002-03-28 Merck Patent Gmbh Preparing human cartilage implants, useful for repairing damaged joints, comprises culturing autologous chondrocytes in alginate gel at reduced oxygen partial pressure
US6673603B2 (en) 2000-09-01 2004-01-06 Modex Therapeutiques, S.A. Cell paste comprising keratinocytes and fibroblasts
EP1325953A4 (en) 2000-09-12 2006-03-22 Yukio Kato Method of culturing mesenchymal stem cells
ES2288995T3 (en) 2000-09-18 2008-02-01 Organogenesis Inc. METHOD FOR THE TREATMENT OF A PATIENT THAT USES A CONSTRUCTION OF CULTIVATED CONJUNCTIVE FABRIC.
US6660523B2 (en) 2000-09-21 2003-12-09 Schering Corporation Dendritic cells; methods
AU2001294922A1 (en) 2000-10-02 2002-04-15 Thomas F. Cannon Automated bioculture and bioculture experiments system
US20020146817A1 (en) 2000-10-02 2002-10-10 Cannon Thomas F. Automated bioculture and bioculture experiments system
US6734000B2 (en) 2000-10-12 2004-05-11 Regents Of The University Of California Nanoporous silicon support containing macropores for use as a bioreactor
AU2002213143A1 (en) 2000-10-12 2002-04-22 Institute Of Materials Research And Engineering Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells
US20020045260A1 (en) 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
US8383806B2 (en) 2000-10-20 2013-02-26 University Of Medicine And Dentistry Of New Jersey Method of reversing carboplatin resistance by inhibition of HGFIN
AU2002255458A1 (en) 2000-10-20 2002-08-19 University Of Medicine And Dentistry New Jersey Medical School Hematopoietic growth factor inducible neurokinin-1 gene
US20030202938A1 (en) 2000-10-20 2003-10-30 Pranela Rameshwar Hematopoietic growth factor inducible neurokinin-1 gene
US7052517B2 (en) 2000-10-24 2006-05-30 Vita Special Purpose Corporation Delivery device for biological composites and method of preparation thereof
AU2002243363A1 (en) 2000-11-06 2002-07-24 V.I. Technologies, Inc. Use of aziridino-compounds in the treatment of immune dysfunctions
WO2002042422A2 (en) 2000-11-10 2002-05-30 Arbor Vita Corporation Molecular interactions in hematopoietic cells
US6576464B2 (en) 2000-11-27 2003-06-10 Geron Corporation Methods for providing differentiated stem cells
US20030027331A1 (en) 2000-11-30 2003-02-06 Yan Wen Liang Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
US20040072259A1 (en) 2001-11-29 2004-04-15 Scadden David T. Methods and products for manipulating hematopoietic stem cells
US20020136709A1 (en) 2000-12-12 2002-09-26 Nucleus Remodeling, Inc. In vitro-derived adult pluripotent stem cells and uses therefor
US20020077687A1 (en) 2000-12-14 2002-06-20 Ahn Samuel S. Catheter assembly for treating ischemic tissue
AU2002239810A1 (en) 2001-01-02 2002-07-16 The Charles Stark Draper Laboratory, Inc. Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
WO2002060426A2 (en) 2001-01-03 2002-08-08 President And Fellows Of Harvard College Compounds regulating cell proliferation and differentiation
US6616912B2 (en) 2001-01-05 2003-09-09 Spectrum Laboratories, Inc. Bi-component microporous hollow fiber membrane structure for in vivo propagation of cells
US20040079248A1 (en) 2001-01-10 2004-04-29 Yaron Mayer Printer capable of printing simultaneously on both sides of the page
WO2002057430A2 (en) 2001-01-20 2002-07-25 Cardion Ag Pluripotent adult stem cells derived from regenerative tissue
CZ20032082A3 (en) 2001-01-31 2003-11-12 Interface Biotech A/S Enhanced in vitro cultivation process of mammalian cells for autologous implantation and transplantation methods
US7045098B2 (en) 2001-02-02 2006-05-16 James Matthew Stephens Apparatus and method for removing interfering substances from a urine sample using a chemical oxidant
EP3246396B1 (en) 2001-02-14 2020-01-29 Celularity, Inc. Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
EP2316919B1 (en) 2001-02-14 2015-10-07 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US7326564B2 (en) 2001-02-20 2008-02-05 St. Jude Medical, Inc. Flow system for medical device evaluation and production
GB2372875B (en) 2001-03-02 2003-04-16 Innogy Ltd Process for operating a regenerative fuel cell
US6884228B2 (en) 2001-03-06 2005-04-26 Baxter International Inc. Automated system adaptable for use with different fluid circuits
US6582386B2 (en) 2001-03-06 2003-06-24 Baxter International Inc. Multi-purpose, automated blood and fluid processing systems and methods
US6706008B2 (en) 2001-03-06 2004-03-16 Baxter International Inc. Automated system and method for withdrawing compounds from blood
US6808503B2 (en) 2001-03-06 2004-10-26 Baxter International Inc. Automated system and method for pre-surgical blood donation and fluid replacement
WO2002070506A2 (en) 2001-03-07 2002-09-12 Websar Innovations Inc. Conversion of cbd to δ8-thc and δ9-thc
US7341062B2 (en) 2001-03-12 2008-03-11 Bioheart, Inc. Method of providing a dynamic cellular cardiac support
US20020132343A1 (en) 2001-03-19 2002-09-19 Clark Lum System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation
WO2002074925A2 (en) 2001-03-20 2002-09-26 University Of Virginian Patent Foundation Methods for identifying and purifying smooth muscle progenitor cells
EP1370194B1 (en) 2001-03-23 2013-01-23 Histogenics Corporation Composition and methods fro the production of biological tissues and tissue constructs
US7056738B2 (en) 2001-03-23 2006-06-06 Tulane University Early stage multipotential stem cells in colonies of bone marrow stromal cells
AU2002258637A1 (en) 2001-03-27 2002-10-08 Board Of Regents The University Of Texas System Biodegradable, electrically conductiong polymer for tissue engineering applications
US6629612B2 (en) 2001-03-30 2003-10-07 Carl H. Critz Biological filtration station
WO2002078449A2 (en) 2001-04-02 2002-10-10 Advanced Cell Technology, Inc. Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
AU2002256086A1 (en) 2001-04-09 2002-10-21 Medtronic, Inc. Methods of isolating blood components using a centrifuge and uses thereof
US6841386B2 (en) 2001-04-10 2005-01-11 Viacell, Inc. Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein
CA2367636C (en) 2001-04-12 2010-05-04 Lisa Mckerracher Fusion proteins
KR100449141B1 (en) 2001-04-19 2004-09-21 (주)라이프코드 Method for differentiating a mesenchymal stem cell into neural cells
GB2374722B (en) 2001-04-20 2003-05-28 Innogy Technology Ventures Ltd Regenerative fuel cell with pH control
EP1383869B1 (en) 2001-04-24 2009-06-10 Dolores Baksh Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
JP2003284570A (en) 2001-04-25 2003-10-07 Chemo Sero Therapeut Res Inst Von Willebrand factor (vWF) cleaving enzyme
JP4260627B2 (en) 2001-04-25 2009-04-30 コーネル リサーチ ファンデイション インコーポレイテッド Device and method for cell culture system based on pharmacokinetics
US20050130297A1 (en) 2001-04-26 2005-06-16 Societe Nouvelle Cell Tissue Progress Cell and tissue culture device with temperature regulation
CA2446226C (en) 2001-05-09 2008-12-30 Bayer Pharmaceuticals Corporation A cryopreservation bag assembly for mammalian cell lines
US6582955B2 (en) 2001-05-11 2003-06-24 Spectrum Laboratories, Inc. Bioreactor with application as blood therapy device
US6814961B1 (en) 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
US20020197240A1 (en) 2001-05-15 2002-12-26 Chiu Ray C. Marrow stem cell (MSC) transplantation for use in tissue and/or organ repair
WO2002092794A2 (en) 2001-05-17 2002-11-21 Isotis N.V. Isolation method of mesenchymal cells
US6461853B1 (en) 2001-05-17 2002-10-08 Hong Zhu Method for surface culture of microorganisms and cells in flexible culture bags
US20040152190A1 (en) 2001-05-31 2004-08-05 Masaya Sumita Method of separating and concentrating cells for kidney regfneration
AUPR540301A0 (en) 2001-06-01 2001-06-28 Walter And Eliza Hall Institute Of Medical Research, The A method of purification of cells
EP1407261A4 (en) 2001-06-13 2006-11-22 Massachusetts Inst Technology IN VIVO BIOREACTORS
DE10130512B4 (en) 2001-06-25 2007-08-16 Bionethos Holding Gmbh Device for pressure perfusion for growing and / or treating cells
DE10130657A1 (en) 2001-06-27 2003-01-16 Axaron Bioscience Ag New endothetially expressed protein and its use
US6685971B2 (en) 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
CN1827766B (en) 2001-06-28 2010-08-25 徐荣祥 In vitro cell culture methods
US6626950B2 (en) 2001-06-28 2003-09-30 Ethicon, Inc. Composite scaffold with post anchor for the repair and regeneration of tissue
US6972195B2 (en) 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
EP1414944A4 (en) 2001-07-10 2004-09-15 Massachusetts Inst Technology METHODS FOR EX VIVO PROPAGATION OF SOMATIC STEM CELLS
US7883891B2 (en) 2001-07-17 2011-02-08 Massachusetts Institute Of Technology Unique properties of stem cells
US20030017587A1 (en) 2001-07-18 2003-01-23 Rader William C. Embryonic stem cells, clinical applications and methods for expanding in vitro
DE10134667A1 (en) 2001-07-20 2003-02-06 Neuroprogen Gmbh Leipzig Process for the production of isolated cell cultures, culture medium for the cultivation of cell cultures and cell culture
WO2003009857A1 (en) 2001-07-23 2003-02-06 Viacell, Inc. Treatment of muscular dystrophy with cord blood cells
EP1421182A4 (en) 2001-07-24 2005-03-23 Es Cell Int Pte Ltd Methods of inducing differentiation of stem cells
US20030049236A1 (en) 2001-07-27 2003-03-13 Arhus Amt Immortalized stem cells
AU2002321889A1 (en) 2001-08-03 2003-02-24 Stemsource Llc Devices and method for extraction of bone marrow
WO2003014313A2 (en) 2001-08-06 2003-02-20 Bresagen, Ltd. Alternative compositions and methods for the culture of stem cells
US20040235160A1 (en) 2001-08-07 2004-11-25 Mitsuo Nishikawa Process for preparing hematopoietic stem cells
US20050003527A1 (en) 2001-08-09 2005-01-06 Shona Lang Cell culture method for obtaining prostate-like acini
US20030211603A1 (en) 2001-08-14 2003-11-13 Earp David J. Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
AUPR703601A0 (en) 2001-08-15 2001-09-06 Peter Maccallum Cancer Institute, The Identification and isolation of somatic stem cells and uses thereof
JP2003052360A (en) 2001-08-20 2003-02-25 Japan Science & Technology Corp Culture method of mesenchymal stem cells using basement membrane extracellular matrix
WO2003018767A2 (en) 2001-08-27 2003-03-06 Advanced Cell Technology, Inc. Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
US6617152B2 (en) 2001-09-04 2003-09-09 Corning Inc Method for creating a cell growth surface on a polymeric substrate
US20030104997A1 (en) 2001-09-05 2003-06-05 Black Ira B. Multi-lineage directed induction of bone marrow stromal cell differentiation
US8802432B2 (en) 2001-09-07 2014-08-12 Fox Chase Cancer Center Methods and cell cultures for promoting organogenesis and tissue development
WO2003023018A2 (en) 2001-09-12 2003-03-20 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
US6790455B2 (en) 2001-09-14 2004-09-14 The Research Foundation At State University Of New York Cell delivery system comprising a fibrous matrix and cells
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
JPWO2003027281A1 (en) 2001-09-20 2005-01-06 協和醗酵工業株式会社 Skeletal muscle stroma-derived multipotent stem cells
AU2002325758A1 (en) 2001-09-20 2003-04-01 Centre For Translational Research In Cancer Cultured stromal cells and uses thereof
JP2004248505A (en) 2001-09-21 2004-09-09 Norio Nakatsuji Undifferentiated fusion cell of somatic cell derived from es cell deficient in part or all of transplantation antigen and method for producing the same
US6805860B1 (en) 2001-09-30 2004-10-19 Eckhard Alt Method of transluminal application of myogenic cells for repair or replacement of heart tissue
US6767740B2 (en) 2001-10-09 2004-07-27 Roger Anton Sramek Stem cell and dental pulp harvesting method and apparatus
US6645763B2 (en) 2001-10-12 2003-11-11 Naoya Kobayashi Immortalized bone marrow mesenchymal stem cell
AU2002363322A1 (en) 2001-10-26 2003-05-19 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
US20040151700A1 (en) 2001-10-30 2004-08-05 Harlan David M. Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury
WO2003038075A1 (en) 2001-10-30 2003-05-08 Renomedix Institute Inc. Method of inducing differentiation of mesodermal stem cells, es cells or immortalized cells into nervous system cells
AUPR856501A0 (en) 2001-10-30 2001-11-29 Peter Maccallum Cancer Institute, The Detection of haematopoietic stem cells and progeny and uses thereof
EP1447443A4 (en) 2001-10-31 2006-06-07 Renomedix Inst Inc Immortalized mesenchymal cells and utilization thereof
US20040214314A1 (en) 2001-11-02 2004-10-28 Friedrich Srienc High throughput bioreactor
AU2002361601A1 (en) 2001-11-06 2003-05-19 Mark C. Fishman Stem and progenitor cell capture for tissue regeneration
CN1612691A (en) 2001-11-08 2005-05-04 加利福尼亚大学董事会 Methods and compositions for correction of cardiac conduction disturbances
JP2005508393A (en) 2001-11-09 2005-03-31 アーテセル・サイエンシズ・インコーポレーテツド Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
CA2472019A1 (en) 2001-11-09 2003-05-22 Viacell, Inc. Production of cell suspensions
KR20090115984A (en) 2001-11-09 2009-11-10 아르테셀 사이언스, 인크. Endocrine pancreatic differentiation of stromal cells derived from adipose tissue and uses thereof
EP1442115B9 (en) 2001-11-15 2009-12-16 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
WO2003044158A1 (en) 2001-11-15 2003-05-30 Becton, Dickinson And Company Methods and devices for the integrated discovery of cell culture environments
DE10156201C1 (en) 2001-11-15 2002-10-17 Voith Paper Patent Gmbh To process high consistency paper fiber materials, an initial high consistency volume is held in a stack for a dwell time, to be taken off at the bottom by a circulation flow for dilution and delivery as a suspension
US20060281179A1 (en) 2001-11-15 2006-12-14 Yoshiki Sasai Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof
DE10158680B4 (en) 2001-11-30 2004-04-08 Universitätsklinikum Hamburg-Eppendorf Process for ex vivo expansion and differentiation of multipotent stem cells
US6712850B2 (en) 2001-11-30 2004-03-30 Ethicon, Inc. Porous tissue scaffolds for the repair and regeneration of dermal tissue
US7514075B2 (en) 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20040224403A1 (en) 2001-12-07 2004-11-11 Robarts Research Institute Reconstituting hematopoietic cell function using human embryonic stem cells
US20050008626A1 (en) 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US6951752B2 (en) 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
EP1451299A4 (en) 2001-12-11 2008-03-05 Cytograft Tissue Engineering I Tissue engineered cellular sheets, methods of making and use thereof
US20050019910A1 (en) 2001-12-13 2005-01-27 Mutsumi Takagi Human cell culture medium and culture method
US20030113910A1 (en) 2001-12-18 2003-06-19 Mike Levanduski Pluripotent stem cells derived without the use of embryos or fetal tissue
AU2002361784A1 (en) 2001-12-20 2003-07-09 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
ATE464373T1 (en) 2001-12-21 2010-04-15 Mount Sinai Hospital Corp CELLULAR COMPOSITIONS AND METHODS FOR THE PREPARATION AND USE THEREOF
WO2003060061A1 (en) 2001-12-21 2003-07-24 Organogenesis Inc. Chamber with adjustable volume for cell culture and organ assist
US6695791B2 (en) 2002-01-04 2004-02-24 Spiration, Inc. System and method for capturing body tissue samples
US6777227B2 (en) 2002-01-09 2004-08-17 John L. Ricci Bio-reactor and cell culture surface with microgeometric surfaces
AU2003202988A1 (en) 2002-01-14 2003-07-30 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
FR2834899B1 (en) 2002-01-18 2005-06-10 Didier Pourquier NEW THERAPEUTIC APPLICATION OF G-CSF, GM-CSF AND SCF FACTORS
FR2834898B1 (en) 2002-01-18 2005-06-10 Didier Pourquier NEW THERAPEUTIC APPLICATION OF G-CSF, GM-CSF AND SCF
US20040014209A1 (en) 2002-01-23 2004-01-22 Lassar Andrew B. Compositions and methods for modulating cell differentiation
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
US7033823B2 (en) 2002-01-31 2006-04-25 Cesco Bioengineering, Inc. Cell-cultivating device
AU2003217350A1 (en) 2002-02-08 2003-09-02 University Of Chile Proliferated cell lines and uses thereof
EP1474512A2 (en) 2002-02-13 2004-11-10 Axordia Limited Method to modify differentiation of pluripotential stem cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
WO2003072064A2 (en) 2002-02-28 2003-09-04 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for regulating adipogenesis
AU2003224702A1 (en) 2002-03-12 2003-09-29 Oregon Health And Science University Stem cell selection and differentiation
AUPS112802A0 (en) 2002-03-15 2002-04-18 Monash University Methods of inducing differentiation of stem cells into a specific cell lineage
US20050201991A1 (en) 2002-03-19 2005-09-15 Peter Andrews Stem cell culture
US20040009589A1 (en) 2002-03-26 2004-01-15 Shulamit Levenberg Endothelial cells derived from human embryonic stem cells
GB0207214D0 (en) 2002-03-27 2002-05-08 Univ Loughborough A catalyst for lowering the reduction overpotential of polysulfide species
CA2503681A1 (en) 2002-04-05 2003-10-23 Marc K. Hellerstein Method for isolating and measuring proliferation of long-term label retaining cells and stem cells
WO2003087292A2 (en) 2002-04-08 2003-10-23 Millenium Biologix Inc. Automated tissue engineering system
US7060494B2 (en) 2002-04-09 2006-06-13 Reliance Life Sciences Pvt. Ltd. Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof
ITTO20020311A1 (en) 2002-04-10 2003-10-10 Medestea Int Spa PROCEDURE FOR THE PREPARATION OF STEM CELLS FROM MUSCLE FABRIC AND HUMAN FAT FABRIC AND STEM CELLS OBTAINABLE BY T
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US20050208029A1 (en) 2002-04-17 2005-09-22 Akihiro Umezawa Method of forming pancreatic beta cells from mesenchymal cells
US20040161419A1 (en) 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
AUPS187202A0 (en) 2002-04-22 2002-05-30 Griffith University Method for culturing stem cells
EP1622645B1 (en) 2002-04-23 2013-10-23 Roger Williams Hospital Compositions and methods for stem cell delivery
AU2003234231A1 (en) 2002-04-24 2003-11-10 Rutgers New polyarylates for drug delivery and tissue engineering
EP1501537A4 (en) 2002-04-24 2008-01-16 Queensland Inst Med Res Mannose binding lectin and uses thereof
AU2003249606A1 (en) 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
ITMI20021008A1 (en) 2002-05-13 2003-11-13 San Raffaele Centro Fond METHOD FOR ESTABLISHING AND EXPANDING MULTIANGIOBLASTIC MULTI-ANGULAR STEM CELLS
US7119071B2 (en) 2002-05-21 2006-10-10 University Of Medicine And Dentistry Of New Jersey Amino terminal substance P compositions and methods for using the same
US20040091936A1 (en) 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
ATE408666T1 (en) 2002-05-28 2008-10-15 Toyo Boseki METHOD OF CULTURE, STORAGE AND INDUCE DIFFERENTIATION OF CELLS AND DEVICE FOR USE IN SUCH METHOD, AND METHOD OF USE THEREOF.
US7048922B2 (en) 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
US20030022390A1 (en) 2002-05-30 2003-01-30 Stephens James Matthew Method and kit for making interfering substances in urine undetectable
US6914279B2 (en) 2002-06-06 2005-07-05 Rutgers, The State University Of New Jersey Multifunctional biosensor based on ZnO nanostructures
US7989851B2 (en) 2002-06-06 2011-08-02 Rutgers, The State University Of New Jersey Multifunctional biosensor based on ZnO nanostructures
US8377683B2 (en) 2002-06-06 2013-02-19 Rutgers, The State University Of New Jersey Zinc oxide-based nanostructure modified QCM for dynamic monitoring of cell adhesion and proliferation
US7160719B2 (en) 2002-06-07 2007-01-09 Mayo Foundation For Medical Education And Research Bioartificial liver system
FI113099B (en) 2002-06-25 2004-02-27 Ensto Electric Oy Arrangements in connection with a system for functional control
US20050282733A1 (en) 2002-06-27 2005-12-22 Prins Johannes B Differentiation modulating agents and uses therefor
WO2005014775A2 (en) 2002-06-28 2005-02-17 University Of Florida Research Foundation, Inc. Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a
US6730510B2 (en) 2002-07-02 2004-05-04 Organogenesis, Inc. Culture dish and bioreactor system
US20050136093A1 (en) 2002-07-05 2005-06-23 Polyzenix Gmbh Implant for transport and release for pharmacologically active agents as well as a process for producing the same
AU2003243831B2 (en) 2002-07-11 2008-07-24 Sugar Research Australia Limited Transgenic plants used as a bioreactor system
US20040009158A1 (en) 2002-07-11 2004-01-15 Washington University Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
JP2005532810A (en) 2002-07-16 2005-11-04 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム Methods for transplanting mesenchymal stem cells for tissue repair and tissue formation
WO2004006863A2 (en) 2002-07-17 2004-01-22 Rutgers, The State University Therapeutic devices for patterned cell growth
AU2003259152A1 (en) 2002-07-23 2004-02-09 Boston Scientific Limited Cell therapy for regeneration
FR2842943B1 (en) 2002-07-24 2005-07-01 Commissariat Energie Atomique METHOD FOR MANUFACTURING ANISOTROPIC CONDUCTIVE POLYMER FILM ON SEMICONDUCTOR WAFER
US7422736B2 (en) 2002-07-26 2008-09-09 Food Industry Research And Development Institute Somatic pluripotent cells
ES2560847T3 (en) 2002-07-31 2016-02-23 Yves Saint-Laurent Parfums Stem cells from adipose tissue and differentiated cells from these cells
US7732203B2 (en) 2002-08-17 2010-06-08 Ajoll University Industry Cooperation Foundation Method for transdifferentiating mesenchymal stem cells into neuronal cells
GB2393726A (en) 2002-08-21 2004-04-07 Regenesys Tech Ltd Ion exchange membranes formed from hydrolysed polymers
US20050271639A1 (en) 2002-08-22 2005-12-08 Penn Marc S Genetically engineered cells for therapeutic applications
US20040161412A1 (en) 2002-08-22 2004-08-19 The Cleveland Clinic Foundation Cell-based VEGF delivery
US20040037811A1 (en) 2002-08-22 2004-02-26 The Cleveland Clinic Foundation Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
AU2003265094A1 (en) 2002-08-26 2004-03-11 Neuronova Ab Method for culturing stem cells
DE10244859B4 (en) 2002-09-20 2007-01-11 Leibniz-Institut Für Polymerforschung Dresden E.V. Bioreactor with modular structure, in particular for ex-vivo cell proliferation
AU2003275140A1 (en) 2002-09-23 2004-04-08 Massachusetts Institute Of Technology Theree-dimensional construct for the design and fabrication of physiological fluidic networks
WO2004029231A1 (en) 2002-09-26 2004-04-08 Institut National De La Sante Et De La Recherche Medicale Compositions and methods for amplification of human stem cells
US20040062753A1 (en) 2002-09-27 2004-04-01 Alireza Rezania Composite scaffolds seeded with mammalian cells
US20040121464A1 (en) 2002-09-30 2004-06-24 Rathjen Peter David Method for the preparation of cells of mesodermal lineage
US20050031587A1 (en) 2002-10-04 2005-02-10 Yamanouchi Pharmaceutical Co., Ltd. Immune response induction method
CN1720055A (en) 2002-10-04 2006-01-11 组织技术公司 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
US20040067585A1 (en) 2002-10-07 2004-04-08 Yu-Chi Wang Cell cultivation surface and method of making the same
US7776594B2 (en) 2002-10-10 2010-08-17 Wright Medical Technology, Inc. Bone marrow infusion chamber and method
US20040219563A1 (en) 2002-10-16 2004-11-04 Michael West Method using gene trapped stem cells for making pathways of stem cell differentiation and making and isolating differentiated cells
AU2003284875A1 (en) 2002-10-17 2004-05-04 Vacanti, Joseph P. Biological scaffolding material
US20040151729A1 (en) 2002-10-28 2004-08-05 George Michalopoulos Novel long-term three-dimensional culture system
WO2004042033A2 (en) 2002-11-01 2004-05-21 The Board Of Trustees Of The Leland Stanford Junior University Circulating stem cells and uses related thereto
US20050244970A1 (en) 2002-11-01 2005-11-03 Hongbing Zhang Stem cell libraries
CA2505251A1 (en) 2002-11-05 2004-05-27 Brigham And Women's Hospital, Inc. Mesenchymal stem cells and methods of use thereof
US20050003534A1 (en) 2002-11-07 2005-01-06 Eliezer Huberman Human stem cell materials and methods
WO2004044127A2 (en) 2002-11-08 2004-05-27 Viacell, Inc. Stem cell populations
WO2004044158A2 (en) 2002-11-08 2004-05-27 The Johns Hopkins University Human embryonic stem cell cultures, and compositions and methods for growing same
JP2006505266A (en) 2002-11-08 2006-02-16 株式会社リプロセル Stem cell amplification factor
KR100452403B1 (en) 2002-11-19 2004-10-12 한국과학기술연구원 Hybrid bioreactor for cell culture
US20040101959A1 (en) 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
US20050112762A1 (en) 2002-11-26 2005-05-26 The Corporation Of The Trustees Of The Sisters Of Mercy In Queensland Method for culturing dendritic cells
US20060228798A1 (en) 2002-11-27 2006-10-12 Catherine Verfaillie Homologous recombination in multipotent adult progenitor cells
WO2004050826A2 (en) 2002-11-29 2004-06-17 Technion Research & Development Foundation Ltd. Method of dynamically culturing embryonic stem cells
US20040110286A1 (en) 2002-12-06 2004-06-10 The John P. Robarts Research Institute Method for making hematopoietic cells
US20050031598A1 (en) 2002-12-10 2005-02-10 Shulamit Levenberg Engineering three-dimensional tissue structures using differentiating embryonic stem cells
US20040115804A1 (en) 2002-12-13 2004-06-17 Yu-Show Fu Cell system for generating somatic cells
US7252995B2 (en) 2002-12-13 2007-08-07 Yu-Show Fu Method of generating neurons from stem cells and medium for culturing stem cells
AU2003303071B2 (en) 2002-12-16 2009-04-23 Technion Research & Development Foundation Ltd. Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
DE10327988B4 (en) 2002-12-18 2009-05-14 Alpha Plan Gmbh Filter module for the treatment of liquids
US20040128077A1 (en) 2002-12-27 2004-07-01 Automated Cell, Inc. Method and apparatus for following cells
US20040126405A1 (en) 2002-12-30 2004-07-01 Scimed Life Systems, Inc. Engineered scaffolds for promoting growth of cells
US7071001B2 (en) 2003-01-10 2006-07-04 Dnk Associates, Inc. System and method for in vitro bleeding time testing
US20040143863A1 (en) 2003-01-10 2004-07-22 Linheng Li Hematopoietic stem cell niche cells
US20050002914A1 (en) 2003-01-15 2005-01-06 Rosen Michael R. Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures
WO2004065616A2 (en) 2003-01-16 2004-08-05 The General Hospital Corporation Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
BRPI0406931A (en) 2003-01-27 2006-01-03 Harvest Technologies Inc Method for the production of a coagulant from anticoagulated whole blood, Kit for the preparation of a coagulant from anticoagulated whole blood, and human blood fraction
US20040151706A1 (en) 2003-01-27 2004-08-05 Alex Shakhov Collection and storage of biological specimens containing stem cells from healthy individuals for future use in treatment of their own cytopathological illnesses or other medical conditions
US7186554B2 (en) 2003-01-28 2007-03-06 Stanford University Methods and compositions for human bladder epithelial cell culture
CA2514474C (en) 2003-01-30 2014-05-06 Avner Yayon Freeze-dried fibrin matrices and methods for preparation thereof
WO2004069172A2 (en) 2003-01-30 2004-08-19 The Government of the United States of America as represented by the Department of Veterans Affairs Multilineage-inducible cells and uses thereof
CN1768133A (en) 2003-01-31 2006-05-03 加利福尼亚大学董事会 Isolate or generate stem cells using ISLET1 as a marker
US20040197310A1 (en) 2003-02-12 2004-10-07 Sanberg Paul R. Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction
WO2004072264A2 (en) 2003-02-12 2004-08-26 Johns Hopkins University School Of Medicine Fate determination by hes 1 in hematopoietic stem-progenitor cells and uses thereof
AU2004210726A1 (en) 2003-02-13 2004-08-26 Zenon Technology Partnership Supported biofilm apparatus and process
US7175763B2 (en) 2003-02-13 2007-02-13 Zenon Technology Partnership Membrane supported biofilm process for autotrophic reduction
US7300571B2 (en) 2003-02-13 2007-11-27 Zenon Technology Partnership Supported biofilm apparatus
WO2004071283A2 (en) 2003-02-13 2004-08-26 Anthrogenesis Corporation Use of umbilical cord blood to treat individuals having a disease, disorder or condition
CN100361907C (en) 2003-02-13 2008-01-16 泽农技术合伙公司 Supported biofilm device and reactor and method for handling liquids
US7303676B2 (en) 2003-02-13 2007-12-04 Zenon Technology Partnership Supported biofilm apparatus and process
US7294259B2 (en) 2003-02-13 2007-11-13 Zenon Technology Partnership Membrane module for gas transfer
US20070155661A1 (en) 2003-02-14 2007-07-05 The Board Of Trustees Of The Leland Standord Junior University Methods and compositions for modulating the development of stem cells
GB0304030D0 (en) 2003-02-21 2003-03-26 King S College London Teeth
US7416884B2 (en) 2003-02-26 2008-08-26 Georgia Tech Research Corporation Bioreactor and methods for tissue growth and conditioning
US20060172304A1 (en) 2003-02-27 2006-08-03 Elaine Fuchs Method for modulating epithelial stem cell lineage
AU2003900944A0 (en) 2003-02-28 2003-03-13 The University Of Queensland Cell isolation & enrichment
DE602004030172D1 (en) 2003-03-10 2010-12-30 Japan Science & Tech Agency Method for labeling mesenchymal stem cells using different markers
US7153650B2 (en) 2003-03-13 2006-12-26 Geron Corporation Marker system for preparing and characterizing high-quality human embryonic stem cells
WO2004087870A2 (en) 2003-03-25 2004-10-14 The Johns Hopkins University Neuronal cell lineages and methods of production thereof
WO2004087896A2 (en) 2003-03-31 2004-10-14 Pfizer Products Inc. Hepatocyte differentiation of stem cells
EP1608411B1 (en) 2003-04-01 2010-09-29 United States Government as represented by the Department of Veteran's Affaires Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure.
US20040197375A1 (en) 2003-04-02 2004-10-07 Alireza Rezania Composite scaffolds seeded with mammalian cells
AU2003231015B2 (en) 2003-04-19 2009-10-08 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health Postnatal stem cells and uses thereof
US7494811B2 (en) 2003-05-01 2009-02-24 Lifenet Health In vitro growth of tissues suitable to the formation of bone and bone forming tissue formed thereby
SG150387A1 (en) 2003-05-02 2009-03-30 Insception Bioscience Inc Apparatus and methods for amplification of blood stem cell numbers
AU2004242091C1 (en) 2003-05-07 2009-12-24 La Jolla Institute For Molecular Medicine Administration of hyaluronic acid to enhance the function of transplanted stem cells
US7485460B2 (en) 2003-05-21 2009-02-03 Tulane University Health Sciences Center Enhanced growth of adult stem cells with Dkk-1
WO2005001033A2 (en) 2003-05-22 2005-01-06 The Cleveland Clinic Foundation Tolerance induction and maintenance in hematopoietic stem cell allografts
EP1653865A2 (en) 2003-05-23 2006-05-10 Angiotech International Ag Anastomotic connector devices
US20050014255A1 (en) 2003-05-29 2005-01-20 Board Of Regents, The University Of Texas System Stem cells for clinical and commercial uses
AU2003902776A0 (en) 2003-06-03 2003-06-19 Monash University Method for expanding cells
WO2005003300A2 (en) 2003-06-04 2005-01-13 University Of South Carolina Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same
WO2005010524A1 (en) 2003-06-04 2005-02-03 Curis, Inc. Stem cell-based methods for identifying and characterizing agents
US7425440B2 (en) 2003-06-10 2008-09-16 The Automation Partnership (Cambridge) Limited Culture flask
DE10326750B4 (en) 2003-06-13 2006-07-27 Gerlach, Jörg, Dr.med. Process for the preparation of a cell preparation and cell preparations prepared in this way
DE10326764A1 (en) 2003-06-13 2004-12-30 Biotest Ag Endothelium-protective perfusion solution, an apparatus and method for preserving the endothelium in isolated hollow organs and biological vessels
DE10362002B4 (en) 2003-06-23 2006-10-12 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Adult pluripotent stem cells
WO2005012480A2 (en) 2003-06-25 2005-02-10 Macropore Biosurgery Inc. Systems and methods for separating and concentrating regenerative cells from tissue
ES2433493T3 (en) 2003-06-25 2013-12-11 Ottawa Hospital Research Institute Methods and compositions to modulate the growth of pluripotential cells and differentiation
CA2529718C (en) 2003-06-27 2012-10-23 Universite Laval Method of isolating cells from umbilical cord
WO2005001080A2 (en) 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
WO2005003320A2 (en) 2003-07-02 2005-01-13 Regents Of The University Of Minnesota Neuronal differentiation of stem cells
US7384786B2 (en) 2003-07-16 2008-06-10 Scimed Life Systems, Inc. Aligned scaffolds for improved myocardial regeneration
WO2005007799A2 (en) 2003-07-17 2005-01-27 Gamida-Cell Ltd. Methods for ex-vivo expanding stem/progenitor cells
ITRM20030376A1 (en) 2003-07-31 2005-02-01 Univ Roma PROCEDURE FOR THE ISOLATION AND EXPANSION OF CARDIOC STAMIN CELLS FROM BIOPSIA.
AU2004261899A1 (en) 2003-08-01 2005-02-10 Norimasa Nakamura Scaffold-free self-organized 3D synthetic tissue
EP2266500B1 (en) 2003-08-01 2015-04-01 CellSeed Inc. Three-dimensional tissue structure
US20050032122A1 (en) 2003-08-06 2005-02-10 Shiaw-Min Hwang Optimizing culture medium for CD34<+> hematopoietic cell expansion
US7074615B2 (en) 2003-08-15 2006-07-11 Becton, Dickinson And Company Peptides for enhanced cell attachment and cell growth
WO2005029224A2 (en) 2003-09-12 2005-03-31 Arkados, Inc. Method and system for distributed content management and delivery
DK1670511T3 (en) 2003-09-15 2009-11-23 Res Dev Foundation Crypto-antagonism of activin and TGF-B signaling
RU2373958C2 (en) 2003-09-25 2009-11-27 Рутгерс, Дзе Стейт Юниверсити Polymer, essentially radiopaque products for embolic therapy
WO2005044972A2 (en) 2003-11-06 2005-05-19 Nunc A/S A three-dimensional carrier for culturing microbiological material
WO2005065079A2 (en) 2003-11-10 2005-07-21 Angiotech International Ag Medical implants and fibrosis-inducing agents
WO2005051316A2 (en) 2003-11-20 2005-06-09 Angiotech International Ag Polymer compositions and methods for their use
CA2536242A1 (en) 2003-11-20 2005-06-09 Angiotech International Ag Implantable sensors and implantable pumps and anti-scarring agents
US20050208095A1 (en) 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
US7368169B2 (en) 2003-12-01 2008-05-06 Rutgers, The State University Of New Jersey Hydrazide compounds with angiogenic activity
TWI338714B (en) 2003-12-02 2011-03-11 Cathay General Hospital Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid
EP1694345A1 (en) 2003-12-04 2006-08-30 Regents Of The University Of Minnesota Compositions and methods for the treatment of lysosomal storage disorders
CA2548464C (en) 2003-12-09 2013-02-12 Ben-Gurion University Of The Negev Research And Development Authority Pulse-medium perfusion bioreactor with improved mass transport for multiple 3-d cell constructs
GB0329449D0 (en) 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
US20050137517A1 (en) 2003-12-19 2005-06-23 Baxter International Inc. Processing systems and methods for providing leukocyte-reduced blood components conditioned for pathogen inactivation
JP2007520462A (en) 2003-12-19 2007-07-26 バイアセル インコーポレーティッド Use of human umbilical cord blood-derived pluripotent cells for the treatment of diseases
US7172696B1 (en) 2004-01-02 2007-02-06 Spectrum Laboratories, Inc. Radial dispersion mass transfer device having a semi-permeable tubular hollow fiber membrane wound around a porous core
WO2005072764A2 (en) 2004-01-16 2005-08-11 Novocell, Inc. Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
US7192776B2 (en) 2004-01-28 2007-03-20 James Matthew Stephens Synthetic urine and method of manufacturing same
NZ584288A (en) 2004-02-06 2011-10-28 Elan Pharm Inc Methods and compositions for treating tumors and metastatic disease
WO2005075636A1 (en) 2004-02-09 2005-08-18 The University Of Queensland Molecular markers associated with metanephric development and renal progenitors
RU2252252C1 (en) 2004-04-09 2005-05-20 Тепляшин Александр Сергеевич Method for isolation of mesenchymal stem cells
US7855074B2 (en) 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US7785883B2 (en) 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
US20070298015A1 (en) 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
WO2005107760A1 (en) 2004-04-30 2005-11-17 Irm Llc Compounds and compositions as inducers of keratinocyte differentiation
US20090214382A1 (en) 2004-05-05 2009-08-27 Wilson Burgess Methods of sterilizing biological mixtures using alpha-keto acids
US7658738B2 (en) 2004-05-14 2010-02-09 Ethicon Endo-Surgery, Inc. Medical devices for use with endoscope
US7361493B1 (en) 2004-05-26 2008-04-22 The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs Production of urokinase in a three-dimensional cell culture
WO2005116186A1 (en) 2004-05-26 2005-12-08 Millenium Biologix Inc. Advanced tissue engineering system
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
JP4831687B2 (en) 2004-07-23 2011-12-07 株式会社カネカ Method for inducing differentiation from mesenchymal stem cells to odontoblasts
CH697191A5 (en) 2004-07-29 2008-06-25 Biospectra Ag Multiple bio-reactor device.
US7588938B2 (en) 2004-08-04 2009-09-15 The United States Of America As Represented By The Secretary Of The Navy Neural stem cell-collagen-bioreactor system to construct a functional embryonic brain-like tissue
WO2006019043A1 (en) 2004-08-17 2006-02-23 Kyushu Institute Of Technology Porous sheet member for cell culture and, utilizing the same, bioreactor and culturing method
DE102004044429B4 (en) 2004-09-14 2009-04-30 Biotest Ag Process for the preparation of a composition containing von Willebrand factor
CN101506355B (en) 2004-09-24 2012-06-27 成血管细胞系统公司 Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof
KR20070085288A (en) 2004-09-24 2007-08-27 안지오블라스트 시스템스 인코퍼레이티드 Methods for Enhancing Proliferation and / or Survival of Mesenchymal Progenitor Cells
EP1802978B1 (en) 2004-10-14 2011-11-23 Genentech, Inc. Cop1 molecules and uses thereof
AU2005302258B2 (en) 2004-11-01 2010-10-21 Wisconsin Alumni Research Foundation Platelets from stem cells
US7439057B2 (en) 2004-11-16 2008-10-21 La Jolla Bioengineering Institute Convective flow tissue assembly
PT1819230E (en) 2004-12-07 2012-08-07 Univ Miami Red cell-derived microparticles as hemostatic agents for the control of hemorrhage and for treatment of bleeding disorders
US20060166364A1 (en) 2004-12-22 2006-07-27 Introgen, Inc. Use of flexible bag containers for viral production
US7682823B1 (en) 2005-01-04 2010-03-23 Larry Runyon Bioreactor systems
US9163208B2 (en) 2005-01-04 2015-10-20 Larry Runyon Method and system for bioreaction
US8999289B2 (en) 2005-03-22 2015-04-07 President And Fellows Of Harvard College Treatment of protein degradation disorders
WO2006102488A1 (en) 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
CN101248171B (en) 2005-04-12 2015-11-25 迈索布拉斯特股份有限公司 Isolation of adult pluripotent cells by tissue-nonspecific alkaline phosphatase
WO2006113881A2 (en) 2005-04-19 2006-10-26 The Johns Hopkins University Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
WO2006116381A2 (en) 2005-04-22 2006-11-02 Imquest Biosciences, Inc. Plasma or serum fraction for treatment or prevention of abnormal cell proliferation
US20070011752A1 (en) 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
WO2006122060A1 (en) 2005-05-06 2006-11-16 Zymogenetics, Inc. Compositions and uses of secreted polypeptide, zsig98
US7919307B2 (en) 2005-05-09 2011-04-05 Alpha Plan Gmbh Supply system for cell culture module
US7831293B2 (en) 2005-05-10 2010-11-09 Advanced Clinical Solutions, Inc. Method of defining a biological target for treatment
CA2608048A1 (en) 2005-05-10 2006-11-16 United States Of America Department Of Veteran's Affairs Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media
US20090280153A1 (en) 2005-05-10 2009-11-12 Angiotech International Ag electrical devices, anti-scarring agents, and therapeutic compositions
WO2006124021A1 (en) 2005-05-12 2006-11-23 Angiotech International Ag Compositions and methods for treating diverticular disease
EP1888741B1 (en) 2005-05-27 2013-04-17 Viacell, Inc. Treatment of ischemia using stem cells
KR20080019270A (en) 2005-06-02 2008-03-03 인 모션 인베스트먼트, 리미티드 Automated cell therapy system
EP1893738B1 (en) 2005-06-10 2018-12-05 Nunc A/S Culture insert carrier, culture insert and culture insert system
EP1739165A1 (en) 2005-06-29 2007-01-03 Cellution Biotech B.V. Method and apparatus for cultivating cells utilizing wave motion
WO2007015782A1 (en) 2005-07-29 2007-02-08 Ecole Polytechnique Federale De Lausanne Molecular variant fibrinogen fusion proteins
US8486621B2 (en) 2005-08-11 2013-07-16 Cornell Research Foundation, Inc. Nucleic acid-based matrixes
US7943374B2 (en) 2005-08-21 2011-05-17 Markus Hildinger Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
US20070197957A1 (en) 2005-10-03 2007-08-23 Hunter William L Implantable sensors, implantable pumps and anti-scarring drug combinations
US20070198063A1 (en) 2005-10-03 2007-08-23 Hunter William L Electrical devices and anti-scarring drug combinations
US20070196421A1 (en) 2005-10-03 2007-08-23 Hunter William L Soft tissue implants and drug combination compositions, and use thereof
WO2007041593A2 (en) 2005-10-03 2007-04-12 Combinatorx, Incorporated Anti-scarring drug combinations and use thereof
US7888119B2 (en) 2005-10-14 2011-02-15 University Of Central Florida Research Foundation, Inc. Tissue substitutes comprising stem cells and reduced ceria
US20070116612A1 (en) 2005-11-02 2007-05-24 Biopath Automation, L.L.C. Prefix tissue cassette
WO2007071072A1 (en) 2005-12-22 2007-06-28 Corporation De L'ecole Polytechnique De Montreal High-rate perfusion bioreactor
US20070258963A1 (en) 2006-01-13 2007-11-08 Osiris Therapeutics, Inc. Mesenchymal stem cells expressing TNF-alpha receptors
EP1991668A4 (en) 2006-02-03 2011-06-15 Harvard College CELL GROWTH ON POLYMERIC FILMS AND ITS APPLICATIONS IN BIOTECHNOLOGY
US20110171182A1 (en) 2006-03-23 2011-07-14 Pluristem Ltd. Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
US20110293583A1 (en) 2006-03-23 2011-12-01 Pluristem Ltd. Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
EP2366775B1 (en) 2006-03-23 2015-04-22 Pluristem Ltd. Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
WO2007115367A1 (en) 2006-04-07 2007-10-18 The University Of Queensland Porous polymer blend structures
WO2007115368A1 (en) 2006-04-07 2007-10-18 The University Of Queensland Porous polymer structures
CN101460606A (en) 2006-04-12 2009-06-17 辛尼克萨生命科学(私人)有限公司 High flux biological processing device
WO2007127848A1 (en) 2006-04-26 2007-11-08 University Of Louisville Research Foundation, Inc Isolation of membrane vesicles from biological fluids and methods of using same
EP2029722B1 (en) 2006-05-22 2019-10-16 Biovest International, Inc. Method and system for the production of cells
US8642307B2 (en) 2006-05-25 2014-02-04 Nalge Nunc International Corporation Cell culture surface chemistries
EP2032614A2 (en) 2006-06-06 2009-03-11 Rutgers, The State University Of New Jersey Iodinated polymers
US20080153077A1 (en) 2006-06-12 2008-06-26 David Henry Substrates for immobilizing cells and tissues and methods of use thereof
US20070295651A1 (en) 2006-06-26 2007-12-27 Martinez F Jesus Dialysis bag system
US8497126B2 (en) 2006-06-30 2013-07-30 Corning Incorporated Method of making enhanced cell growth surface
US20100086481A1 (en) 2006-07-11 2010-04-08 Baird Alison E Differential expression of molecules associated with intra-cerebral hemorrhage
WO2008006168A1 (en) 2006-07-12 2008-01-17 Angioblast Systems, Inc. Treatment of excessive neovascularization
WO2008008435A2 (en) 2006-07-14 2008-01-17 Rutgers, The State University Methods, systems, and compositions for extracellular matrix production
HU3285U (en) 2006-07-24 2007-05-29 Tamas Dr Molnar Tissue sample container
WO2008011664A1 (en) 2006-07-24 2008-01-31 The University Of Queensland Method of producing a population of cells
WO2008017128A1 (en) 2006-08-11 2008-02-14 The University Of Queensland Scaffold treatment - device and method
WO2008028241A1 (en) 2006-09-06 2008-03-13 The University Of Queensland Microbioreactor
ATE493074T1 (en) 2006-10-06 2011-01-15 Bard Peripheral Vascular Inc TISSUE HANDLING SYSTEM WITH REDUCED OPERATOR EXPOSURE
US20080113440A1 (en) 2006-10-06 2008-05-15 Leica Biosystems Melbourne Pty Ltd Method and Apparatus for Tissue Sample Processing
WO2010033640A1 (en) 2008-09-16 2010-03-25 Rutgers, The State University Of New Jersey Bioresorbable polymers synthesized from monomer analogs of natural metabolites
AU2007340273B2 (en) 2006-10-17 2012-08-30 Rutgers, The State University Of New Jersey N-substituted monomers and polymers
US7879793B2 (en) 2006-10-18 2011-02-01 Baylor College Of Medicine Treatment of medical condition with A2 domain of von willebrand factor
US20080095690A1 (en) 2006-10-24 2008-04-24 Wei Liu Nano-sized needle crystal mullite film and method of making
US20080103412A1 (en) 2006-11-01 2008-05-01 Yem Chin Removing Tissue
EP1935429A1 (en) 2006-12-22 2008-06-25 CSL Behring GmbH Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates
MX2009007688A (en) 2007-01-18 2009-09-28 Baxter Int Fibrin gel for controlled release of tgf-beta and uses thereof.
WO2008103744A1 (en) 2007-02-20 2008-08-28 Rutgers, The State University Of New Jersey Nerve guidance tubes
DE602008005987D1 (en) 2007-02-22 2011-05-19 Corning Inc SUBSTRATES FOR CELL CULTURE AND MANUFACTURING METHOD THEREFOR
JP4931636B2 (en) * 2007-02-24 2012-05-16 株式会社セイコーアイ・インフォテック Pinch valve, equipment
US20080221479A1 (en) 2007-03-07 2008-09-11 Ritchie Paul G Integrated Imaging and Biopsy System with Integrated Utilities
WO2008112163A1 (en) 2007-03-09 2008-09-18 Corning Incorporated Gum coatings for cell culture, methods of manufacture and methods of use
US8080418B2 (en) 2007-03-09 2011-12-20 Corning Incorporated Method of making a three dimensional cell culture matrix
US8983570B2 (en) 2007-03-27 2015-03-17 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treatment of the spine
WO2008116261A1 (en) 2007-03-27 2008-10-02 The University Of Queensland Production of particles
CA2683443A1 (en) 2007-04-13 2008-10-23 Catalyst Biosciences, Inc. Modified factor vii polypeptides and uses thereof
US20080268165A1 (en) 2007-04-26 2008-10-30 Curtis Robert Fekety Process for making a porous substrate of glass powder formed through flame spray pyrolysis
AU2008259839A1 (en) 2007-05-31 2008-12-11 The Children's Hospital Of Philadelphia Compositions and methods for modulation of ADAMTS13 activity
US8367078B2 (en) 2007-06-06 2013-02-05 University Of Florida Research Foundation, Inc. Kinase inhibitor compounds
MX352732B (en) 2007-06-07 2017-12-06 Bayer Animal Health Gmbh Control of ectoparasites.
TW200916583A (en) 2007-06-08 2009-04-16 Novathera Ltd Cell expansion
US8377864B2 (en) 2007-06-19 2013-02-19 Baxter International Inc. Fibrin gel for controlled release of PDGF and uses thereof
US7906076B2 (en) 2007-07-02 2011-03-15 University Of Massachusetts Method and apparatus for biopsy sample processing
US9109193B2 (en) 2007-07-30 2015-08-18 Ge Healthcare Bio-Sciences Corp. Continuous perfusion bioreactor system
US9381216B2 (en) 2007-08-06 2016-07-05 Mesoblast, Inc. Methods of generating, repairing and/or maintaining connective tissue in vivo
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
AU2008291695A1 (en) 2007-08-31 2009-03-05 Sugar Industry Innovation Pty Ltd Production of hyaluronic acid
JP2010538108A (en) 2007-08-31 2010-12-09 コーニング インコーポレイテッド Reaction surface of polymer substrate
MX2010003019A (en) 2007-09-19 2010-04-30 Pluristem Ltd Adherent cells from adipose or placenta tissues and use thereof in therapy.
US7923241B2 (en) 2007-10-10 2011-04-12 Corning Incorporated Cell culture article and methods thereof
US8105822B2 (en) 2007-10-10 2012-01-31 Corning Incorporated Biosensor article and methods thereof
US20100297234A1 (en) 2007-10-19 2010-11-25 Ilene Sugino Method of using an extracellular matrix to enhance cell transplant survival and differentiation
US20120219737A1 (en) 2007-10-19 2012-08-30 University Of Medicine And Dentistry Of New Jersey Production of extracellular matrix, conditioned media and uses thereof
CA2703447C (en) 2007-10-23 2013-08-06 Becton, Dickinson And Company Multi-chambered tissue containment system for molecular and histology diagnostics
ES2422629T3 (en) 2007-10-23 2013-09-12 Becton Dickinson Co Fluid displacement tissue container for molecular and histological diagnosis
MX2010004426A (en) 2007-10-23 2010-05-03 Becton Dickinson Co Container system for tissue stabilization for molecular and histopathology diagnostics.
CN101835428B (en) 2007-10-23 2012-01-04 贝克顿·迪金森公司 Tissue container for molecular and histology diagnostics incorporating a breakable membrane
US20100021954A1 (en) 2008-07-23 2010-01-28 Sophie Deshayes High capacity nanoparticulate immobilization surface
WO2009058146A1 (en) 2007-10-31 2009-05-07 Celonova Bioscience, Inc. Vasodilator eluting blood storage and administration devices with a specific polyphosphazene coating and methods for their manufacture and use
CN101952309A (en) 2007-12-21 2011-01-19 Ifxa有限公司 Protease inhibitor
US20100331254A1 (en) 2007-12-26 2010-12-30 Metamorefix Pulverized fibrin clots and pharmaceutical compositions containing them
US8354274B2 (en) 2008-01-30 2013-01-15 Geron Corporation Synthetic surfaces for culturing cells in chemically defined media
WO2009099539A2 (en) 2008-01-30 2009-08-13 Corning Incorporated (meth)acrylate surfaces for cell culture, methods of making and using the surfaces
US8329469B2 (en) 2008-01-30 2012-12-11 Geron Corporation Swellable (meth)acrylate surfaces for culturing cells in chemically defined media
US20090227027A1 (en) 2008-03-07 2009-09-10 Baker Wendy A Coated cell culture surfaces and methods thereof
US8932858B2 (en) 2008-03-07 2015-01-13 Corning Incorporated Modified polysaccharide for cell culture and release
US20090233334A1 (en) 2008-03-11 2009-09-17 Excellgene Sa Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scale
US20120028352A1 (en) 2008-03-17 2012-02-02 Agency For Science, Technology And Research Microcarriers for Stem Cell Culture
US20110143433A1 (en) 2008-03-17 2011-06-16 Agency For Science, Technology And Research Microcarriers for Stem Cell Culture
US9458431B2 (en) 2008-03-17 2016-10-04 Agency For Science, Technology And Research Microcarriers for stem cell culture
US8828720B2 (en) 2008-03-17 2014-09-09 Agency For Science, Technology And Research Microcarriers for stem cell culture
US20120219531A1 (en) 2008-03-17 2012-08-30 Agency For Science, Technology And Research Microcarriers for Stem Cell Culture
TWI465247B (en) 2008-04-11 2014-12-21 Catalyst Biosciences Inc Modified Factor VII polypeptide and use thereof
US8532748B2 (en) 2008-04-23 2013-09-10 Devicor Medical Products, Inc. Devices useful in imaging
EP2310039B1 (en) 2008-05-02 2014-07-16 University Of Western Ontario Fgf-9 and its use relating to blood vessels
WO2009140452A2 (en) 2008-05-15 2009-11-19 University Of Miami Isolation of stem cell precursors and expansion in non-adherent conditions
BRPI0909541A2 (en) 2008-05-27 2016-10-11 Pluristem Ltd '' method for treating inflammatory bowel disease ''
WO2010005527A1 (en) 2008-06-30 2010-01-14 Angioblast Systems, Inc. Treatment of eye diseases and excessive neovascularization using a combined therapy
WO2010005557A2 (en) 2008-07-07 2010-01-14 Arteriocyte Medical Systems, Inc. Biological therapeutic compositions and methods thereof
US20100028311A1 (en) 2008-07-09 2010-02-04 Baxter International Inc. Using of scaffold comprising fibrin for delivery of stem cells
WO2010014253A2 (en) 2008-08-01 2010-02-04 University Of Florida Research Foundation, Inc. Ant4 inhibitor compounds and methods of use thereof
EP3124601A1 (en) 2008-08-14 2017-02-01 Mesoblast International Sàrl Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions
SG10201601279SA (en) 2008-08-18 2016-03-30 Mesoblast Inc Monoclonal Antibody STRO-4
WO2010026574A2 (en) 2008-09-02 2010-03-11 Pluristem Ltd. Adherent cells from placenta tissue and use thereof in therapy
CN105708862B (en) 2008-09-02 2020-11-06 普拉里斯坦有限公司 Adherent cells from placental tissue and their use in therapy
EP2331957B1 (en) 2008-09-02 2016-11-02 Pluristem Ltd. Methods of selection of cells for transplantation
US20100075410A1 (en) 2008-09-20 2010-03-25 Virendra Desai Reusable Tissue Biopsy Kit with Padded Cassette
US8785173B2 (en) 2008-09-24 2014-07-22 Medimmune, Llc Methods for purification of viruses
EP2344634A4 (en) 2008-09-24 2012-08-29 Medimmune Llc Methods for cultivating cells, propagating and purifying viruses
CA2737763C (en) 2008-10-11 2019-04-09 Rutgers, The State University Of New Jersey Phase-separated biocompatible polymer compositions for medical uses
EP2346984A4 (en) 2008-10-22 2013-10-30 Biovest Int Inc Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products
US20100183585A1 (en) 2008-10-30 2010-07-22 University Of Kentucky Research Foundation Methods and compositions for treating tumors and metastases through the modulation of latexin
US20110275573A1 (en) 2008-11-03 2011-11-10 Metamorefix Ltd. Tissue adhesive
JP2012509960A (en) 2008-11-24 2012-04-26 コーニング インコーポレイテッド 3D cell culture article and method thereof
CA2746422A1 (en) 2008-12-09 2010-06-17 University Of Florida Research Foundation, Inc. Kinase inhibitor compounds
WO2010071826A2 (en) 2008-12-19 2010-06-24 University Of Florida Research Foundation, Inc. Methods for treating osteoclast-related disease, compounds and compositions thereof
US9156037B2 (en) 2009-01-15 2015-10-13 Children's Medical Center Corporation Microfluidic device and uses thereof
US8802702B2 (en) 2009-01-15 2014-08-12 The General Hospital Corporation Compounds for reducing drug resistance and uses thereof
US8399245B2 (en) 2009-02-18 2013-03-19 Terumo Bct, Inc. Rotation system for cell growth chamber of a cell expansion system and method of use therefor
US8051947B2 (en) 2009-03-12 2011-11-08 E.I. Du Pont De Nemours And Company Energy absorbing thermoplastic elastomer
WO2010111255A1 (en) 2009-03-23 2010-09-30 Hememics Biotechnologies, Inc. Desiccated biologics and methods of preparing the same
EP2419123A1 (en) 2009-04-14 2012-02-22 Humagene, Inc. Novel post-translational fibrinogen variants
USD620732S1 (en) 2009-04-15 2010-08-03 Spectrum Laboratories, Llc Beverage container holder
US8235067B2 (en) * 2009-05-15 2012-08-07 Alphabio, Inc. Encapsulated valve system
TW201042038A (en) 2009-05-28 2010-12-01 Corning Inc Synthetic microcarriers for culturing cells
WO2010138486A1 (en) 2009-05-29 2010-12-02 Corning Incorporated Substrates for adhering, culturing and assaying cells
JP5467154B2 (en) 2009-07-24 2014-04-09 イー・エム・デイー・ミリポア・コーポレイシヨン Supply bag structure
US9068182B2 (en) 2009-07-28 2015-06-30 Corning Incorporated Synthetic polysaccharide microcarriers for culturing cells
EP2361968B1 (en) 2010-02-26 2014-11-19 Corning Incorporated Synthetic polysaccharide microcarriers for culturing cells
JP5956337B2 (en) 2009-07-31 2016-07-27 ラトガース,ザ ステート ユニバーシティ オブ ニュー ジャージー Bioabsorbable polymers synthesized from monomeric analogs of natural metabolites
FR2949195B1 (en) 2009-08-24 2011-10-14 Lfb Biomedicaments STORAGE POUCH OF THERAPEUTIC SOLUTION
US20120156779A1 (en) 2009-08-27 2012-06-21 Ge Healthcare Bio-Sciences Ab Method for cell expansion
WO2011044567A1 (en) 2009-10-11 2011-04-14 Rutgers, The State University Of New Jersey Biocompatible polymers for medial devices
JP2013507931A (en) 2009-10-16 2013-03-07 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー Closed line separation system of adherent bone marrow stem cells for regenerative medicine applications
FR2952041B1 (en) 2009-10-29 2012-02-03 Sartorius Stedim Biotech Sa SOLDERED POCKET WALL MULTILAYER FILM FOR BIOPHARMACEUTICAL PRODUCT.
JP4903252B2 (en) * 2009-11-30 2012-03-28 株式会社日立製作所 Cell culture equipment
EP2977445B1 (en) 2009-11-30 2018-07-25 Pluristem Ltd. Adherent cells from placenta and use of same in disease treatment
US9057045B2 (en) 2009-12-29 2015-06-16 Terumo Bct, Inc. Method of loading and distributing cells in a bioreactor of a cell expansion system
US20120315696A1 (en) 2010-02-15 2012-12-13 Alfred Luitjens METHOD FOR THE PRODUCTION OF Ad26 ADENOVIRAL VECTORS
CN102892487B (en) 2010-03-09 2015-06-17 Emd密理博公司 Disposal bag container with sensor
EP2561066B1 (en) 2010-04-23 2016-03-30 Pluristem Ltd. Adherent stromal cells derived from plancentas of multiple donors and uses thereof
US20130157353A1 (en) 2010-05-12 2013-06-20 Xpand Biotechnology B.V. Cell-culture-bag
WO2011142667A1 (en) 2010-05-12 2011-11-17 Xpand Biotechnology B.V. Cell - culture - bag
TWI534015B (en) 2010-05-17 2016-05-21 滿捷特科技公司 System for reducing ink color mixing effects in printer
EP2575831B1 (en) 2010-05-27 2016-04-20 Pluristem Ltd. Skeletal muscle regeneration using mesenchymal stem cells
US20120087868A1 (en) 2010-10-08 2012-04-12 Gabriele Todd Nanoparticle-loaded cells
WO2012068263A2 (en) 2010-11-17 2012-05-24 Emd Millipore Corporation Feed bag construction
US20120237557A1 (en) 2010-11-30 2012-09-20 Rutgers, The State University Of New Jersey Bioactive carbon-nanotube agarose composites for neural engineering
FR2968197B1 (en) 2010-12-01 2013-12-20 Sartorius Stedim Biotech Sa FLEXIBLE POUCH FOR BIOPHARMACEUTICAL USE HAVING A PLURALITY OF OUTPUT PORTS.
US9220810B2 (en) 2010-12-10 2015-12-29 Florida State University Research Foundation, Inc. Mesenchymal stem cells (MSC) expansion methods and materials
US8961948B2 (en) 2011-01-17 2015-02-24 Rutgers, The State University Of New Jersey Molecular surface design of tyrosine-derived polycarbonates for attachment of biomolecules
EP3260533B1 (en) 2011-03-22 2019-09-11 Pluristem Ltd. Methods for treating radiation or chemical injury
US20140017209A1 (en) 2011-03-22 2014-01-16 Pluristem Ltd. Methods for treating radiation or chemical injury
EP2694639A1 (en) 2011-04-08 2014-02-12 The University of Akron Thermoresponsive cell culture supports
CN103476924A (en) 2011-04-15 2013-12-25 普拉里斯坦有限公司 Methods and systems for harvesting cells
US8668886B2 (en) 2011-04-24 2014-03-11 Therapeutic Proteins International, LLC Separative bioreactor
EP2710118B1 (en) 2011-05-17 2018-02-07 Terumo BCT, Inc. Systems and methods for expanding high density non-adherent cells
PL2718416T3 (en) 2011-06-06 2020-05-18 ReGenesys BVBA Expansion of stem cells in hollow fiber bioreactors
WO2012171026A2 (en) 2011-06-10 2012-12-13 Biovest International, Inc. Methods for high yield virus production
WO2012171030A2 (en) 2011-06-10 2012-12-13 Biovest International, Inc. Method and apparatus for antibody production and purification
DE102012200938B4 (en) 2012-01-23 2016-08-18 Alpha Plan Gmbh Biological and medical engineering modular system
DE102012200939B4 (en) 2012-01-23 2016-05-12 Alpha Plan Gmbh Bioreactor for the cultivation of cells and tissue cultures as well as yeasts and bacteria as objects
FR2993572B1 (en) * 2012-07-23 2016-04-15 Emd Millipore Corp CIRCUIT FOR BIOLOGICAL LIQUID COMPRISING A PINCH VALVE
CN104583386A (en) 2012-08-20 2015-04-29 泰尔茂比司特公司 Concentrates components of the fluid circulated through the cell growth chamber
CN104540933A (en) 2012-08-20 2015-04-22 泰尔茂比司特公司 Method for loading and distributing cells in a bioreactor of a cell expansion system
EP2909302A4 (en) 2012-08-28 2016-07-27 Biovest Int Inc Biomanufacturing suite and methods for large-scale production of cells, viruses, and biomolecules
WO2014036488A1 (en) 2012-08-31 2014-03-06 Biovest International, Inc. Methods for producing high-fidelity autologous idiotype vaccines
WO2014037863A1 (en) 2012-09-04 2014-03-13 Pluristem Ltd. Methods for prevention and treatment of preeclampsia
EP2894378B1 (en) * 2012-09-05 2019-07-10 Hitachi, Ltd. Valve mechanism, cell cultivation apparatus using same, and cell cultivation method
RU2615179C2 (en) 2012-09-06 2017-04-04 Плуристем Лтд. Devices and methods of cell culturing
CA2883826A1 (en) 2012-10-31 2014-05-08 Pluristem Ltd. Method and device for thawing biological material
AU2013373765A1 (en) 2013-01-15 2015-07-09 Memjet Technology Limited Compact pinch valve
US10351910B2 (en) 2013-02-20 2019-07-16 Pluristem Ltd Gene and protein expression properties of adherent stromal cells cultured in 3D
DE102013203082B4 (en) 2013-02-25 2014-10-09 Alpha Plan Gmbh Testing and drying device for functional testing of dialyzers
DE102013203306B4 (en) 2013-02-27 2015-10-22 Alpha Plan Gmbh Use for two-sided cultivation of a pore-containing membrane for cells and tissue cultures as well as yeasts and bacteria as objects
WO2014141111A1 (en) 2013-03-14 2014-09-18 Pluristem Ltd. Methods for prevention and treatment of graft-versus-host disease
WO2015004609A2 (en) 2013-07-09 2015-01-15 Pluristem Ltd. Adherent cells from placenta and use thereof in treatment of injured tendons
EP3105311A1 (en) 2014-02-10 2016-12-21 Univercells NV System, apparatus and method for biomolecules production
WO2015118148A1 (en) 2014-02-10 2015-08-13 Univercells Nv System, apparatus and method for biomolecules production
WO2015118149A1 (en) 2014-02-10 2015-08-13 Univercells Nv System, apparatus and method for anti-rsv antibodies and formulations
US20170081638A1 (en) 2014-02-28 2017-03-23 Florida State University Research Foundation, Inc. Materials and methods for expansion of stem cells
JP6134287B2 (en) * 2014-03-31 2017-05-24 株式会社コガネイ Throttle valve
US10143795B2 (en) * 2014-08-18 2018-12-04 Icu Medical, Inc. Intravenous pole integrated power, control, and communication system and method for an infusion pump
AU2016218037B2 (en) 2015-02-09 2020-12-17 Univercells Technologies S.A. System, apparatus and method for the production of cells and/or cell products
AU2016332061B2 (en) * 2015-10-01 2022-04-07 Repligen Corporation Valve assembly with directional flow path
EP3368176A2 (en) 2015-10-26 2018-09-05 Lonza Limited A manufacturing facility for the production of biopharmaceuticals
US20180010082A1 (en) 2016-06-03 2018-01-11 Lonza Ltd Bioreactor With Higher Agitation Rates
AR109564A1 (en) 2016-09-01 2018-12-26 Takeda Vaccines Inc METHODS TO PRODUCE ENTEROVIRUS C FOR THE PRODUCTION OF VACCINES
JP6148392B1 (en) * 2016-10-05 2017-06-14 富士インパルス株式会社 Valve device and seal device
JP7377009B2 (en) 2018-05-31 2023-11-09 旭有機材株式会社 pinch valve
BR112020025375A2 (en) * 2018-06-11 2021-03-16 Eaton Intelligent Power Limited BREATHING SYSTEM FOR EVAPORATIVE EMISSIONS FROM A FUEL TANK POSITIONED IN A STEAM LINE
JP7486730B2 (en) * 2020-10-08 2024-05-20 アイ ピース,インコーポレイテッド valve

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010019705A1 (en) * 1997-09-22 2001-09-06 Waldemar Ruediger Apparatus for synthesis of multiple organic compounds with pinch valve block
DE102014116592A1 (en) * 2014-11-13 2016-05-19 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Multi-channel tube valve
US20190344269A1 (en) * 2016-07-28 2019-11-14 Kyle K. Johnson Self-Contained Nucleic Acid Processing
WO2019155027A1 (en) * 2018-02-09 2019-08-15 General Electric Company Apparatus for fluid line management in a bioprocessing system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP4487033A4 *

Also Published As

Publication number Publication date
CN118765358A (en) 2024-10-11
EP4487033A4 (en) 2026-02-25
US12152699B2 (en) 2024-11-26
JP2025507708A (en) 2025-03-21
EP4487034A4 (en) 2026-02-25
US20230272863A1 (en) 2023-08-31
US20230272862A1 (en) 2023-08-31
EP4487034A1 (en) 2025-01-08
US12209689B2 (en) 2025-01-28
EP4487033A1 (en) 2025-01-08
JP7836899B2 (en) 2026-03-27
WO2023164133A1 (en) 2023-08-31
JP2025507659A (en) 2025-03-21
JP7814531B2 (en) 2026-02-16
CN118541557A (en) 2024-08-23

Similar Documents

Publication Publication Date Title
WO2023164137A1 (en) Multiple-tube pinch valve assembly
US9463275B2 (en) Infusion pump
US5549460A (en) IV fluid delivery system
US9028456B2 (en) Infusion pump
US5511951A (en) IV fluid delivery system
DE19903624C2 (en) Variable valve timing controller
JP2007526424A (en) Peristaltic pump
US20170321810A1 (en) Bi-Stable Electrically Actuated Valve
WO1996005435A9 (en) Iv fluid delivery system
DE69025368T2 (en) Multi-valve internal combustion engine
EP2894378A1 (en) Valve mechanism, cell cultivation apparatus using same, and cell cultivation method
KR20030068405A (en) Valve driving apparatus
DE102005004805B4 (en) An intake air quantity control device and method for a vehicle engine
US20250215871A1 (en) Linear peristaltic pump
DE102014219250B4 (en) VALVE GEAR DEVICE
DE602006000067T2 (en) Variable valve timing mechanism for four-stroke internal combustion engine
EP4246025A2 (en) Valve block body and device for arranging the valve block body on a drive body
EP1918536B1 (en) Valve unit of internal combustion engine
US6736097B2 (en) Apparatus and method for maintaining controlled orientation of a roller lifter follower used in conjunction with a variable phased valve lifter
CN110898289A (en) A pressure pump and pressure pump control system
WO2006124839A2 (en) Variable overhead valve control for engines
CN223165071U (en) Directional valve
CN114483550B (en) Peristaltic pump with double-pipeline cut-off function
KR102373293B1 (en) Air control valve device for fuel cell system
IE862502L (en) Cam assembly

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23760694

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2024550569

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 202380023967.9

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2023760694

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2023760694

Country of ref document: EP

Effective date: 20240930